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Abstract 
The overall aim of this thesis was to address deficiencies in the understanding of the role 
of exercise and exercise testing in the management of children with Cystic Fibrosis 
(CF), as well as how the disease influences on the ability of children to exercise. In the 
pursuit of these aims, seven studies were performed. 
To compare aerobic fitness, lung function and physical activity levels in children with 
CF and healthy controls, participants completed an activity questionnaire and an activity 
diary as well as wearing activity accelerometers that detected movement for seven days. 
To assess the relationship between genotype and fitness, the genotype was categorised 
according to previously described CFTR mutation classes and correlated with aerobic 
fitness and anaerobic power. To compare resting energy expenditure in girls with CF 
and healthy controls, an indirect calorimeter with a metabolic cart was used. Leg 
strength in female athletes with CF was also compared with that in healthy matched 
controls. In addition, muscle metabolism in female athletes with CF was compared with 
healthy matched controls using a 31-phophorous magnetic resonance spectroscope. In 
another study, changes in lung function were compared with measures of fitness on 
admission to hospital and on discharge. The ten- meter and twenty- meter shuttle tests 
were assessed for repeatability and criterion validity using the treadmill test as the gold 
standard. Finally, the effectiveness of aerobic training and resistance training programs 
in hospitalised children with CF were assessed in a randomised controlled study. 
viii 
Children with mild CF were more active than healthy children, and those with moderate 
to severe CF had activity levels that were similar to control children. Activity levels in 
children with CF correlated well with aerobic capacity and quality of life but not with 
lung function. The detrimental effects of pancreatic insufficiency on activity levels and 
the cardiorespiratory status of girls were most apparent after the onset of puberty. In 
patients with one copy of the delta F508 gene, there was a statistically significant 
relationship between the class of the second CFTR mutation and aerobic capacity, 
anaerobic power and body mass index. Female athletes with mild CF had a significantly 
lower peak aerobic capacity, anaerobic power and leg strength than healthy matched 
controls. However, their resting energy expenditure and daily activity levels were 
significantly higher than healthy controls. Female athletes with mild CF demonstrated 
deficient anaerobic metabolism, as well as inefficient and deficient oxidative metabolism 
compared to healthy controls. When comparing changes in lung function and exercise 
tests in children with moderate to severe CF disease, exercise testing demonstrated the 
greatest magnitude of change after hospitalisation. The ten-meter and twenty-meter 
shuttle tests were found to be reproducible, valid assessments of maximal function 
limited aerobic capacity. Aerobic training produced the greatest improvement in quality 
of life, whereas resistance training improved weight gain and lung function." 
In conclusion, the studies reported in this thesis demonstrate that exercise testing is an 
important adjunct to conventional clinical and lung function measures currently used to 
assess disease severity and response to therapy in children with CF. While there is some 
impact of CF disease on exercise ability, exercise training was also shown to improve 
outcome in children admitted to hospital for intravenous therapy. 
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CHAPTER 1 
Introduction and review of the literature 
1.1 Overview 
Cystic Fibrosis (CF) is an inherited autosomal recessive disorder that in white Caucasian 
populations, affects 1 in 2500 newborns [Wilcken et al, 1983; Forstner and Durie, 1991]. 
The disease is characterised by chronic suppurative lung disease, bronchiectasis and 
premature death from respiratory failure. According to the North American consensus 
guidelines [Rosenstein and Cutting, 1998], the diagnosis of CF is suggested by the 
presence of characteristic clinical features such as chronic sinopulmonary disease, 
gastrointestinal and nutritional abnoramalities, and male urogenital abnormalities, 
together with an abnormally elevated sweat chloride concentration. Identification of two 
CF gene mutations, and, or, demonstration of an abnormal nasal epithelial ion transport 
arew alternative diagnostic criteria. 
The Cystic Fibrosis Transmembrane Regulator (CFTR) gene is located on 
chromosome 7 and encodes for a protein product, the CFTR protein. This CFTR protein 
has been demonstrated to be the cyclic AMP dependent chloride channel in apical 
membranes of epithelial cells [Riordan et al, 1989; Rommens et al, 1989; Kerem et al, 
1989]. Ramjeesingh and colleagues [1999] have demonstrated that CFTR is not the only 
chloride channel present on epithelial cells. There are more than 900 known gene defects 
associated with CF. The most common defect is known as delta F 50? and up to 95% of 
patients have at least one copy of this allele [Cystic Fibrosis Genetic Analysis 
Consortium, 1990; Forstner and Durie, 1991]. The dysfunctional CFTR results ' to 
abnormal chloride and sodium transport channel in the apical membrane of epithelial 
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cells [Smith et al, 1992]. Tsui [1992] and Welsh and Smith [1993] proposed molecular 
mechanisms by which genetic mutations disrupt the function of cystic fibrosis 
transmembrane regulators (CFTR). By categorising these mechanisms into four different 
classes, it is not only possible to better understand the pathophysiology of the disease 
process, but new therapies targetted at altering CFTR functioning are being developed 
according to the class of the mutation [Denning et al, 1992b]. Tsui [1995] subsequently 
refined the classification to incorporate five different classes of mutations. For class I 
mutations, there is a premature termination of the CFTR mRNA translation caused by 
either base substitutions that create stop codons or by mutations that shift the reading 
frame and result in defects in protein production. Examples of class I mutations are 
G542X and W1282X. The most common mutation, delta F508, and the N1303K 
mutation belong to class II mutations and result in defects in protein processing. In class 
II mutations, the CFTR protein is degraded in the endoplasmic reticulum and fails to 
reach its intended site of action at the plasma membrane. Class III mutations, of which 
G551D is an example, are regulatory mutations in which protein reaches the surface of 
the cell but fails to respond normally to activation signals. Class IV mutations also result 
in protein reaching the plasma membrane but it has altered channel properties which 
result in defects in protein conduction. The mutations R117H and R347P are examples 
of class IV mutations. Class V mutations result in reduced level of ribonucleic acid 
(RNA) for CFTR. 
Generalised exocrine gland dysfunction results in abnormalities of several organ 
systems. Abnormal mucus m the lungs contributes to the development of chronic 
obstruction, infection and inflammation. Exocrine pancreatic insufficiency occurs in 
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approximately 85% of patients with CF and despite enzyme replacement therapy, 
malabsorption of fat and micronutrients occur [Forstner and Durie, 1991]. Pancreatic 
function is closely Mated to the specific mutation the patient carries and mutations 
associated with exocrine pancreatic sufficiency are dominant to those associated with 
pancreatic insufficiency [Kristidis et al, 1992]. The mutations associated with pancreatic 
sufficiency are predominantly those that have readily detectable channel actMty (eg. 
R117H and A455E) whereas the mutations with little activity (eg. delta F508, G551D) 
or those that result in quantitative reduction in CFTR (eg. W1282X) are associated with 
pancreatic insufficiency [Sheppard et al, 1993]. Biliary cirrhosis and infertility may also 
occur in patients with CF. 
In Australia, Cystic Fibrosis is usually diagnosed on the routine newborn screen 
collected on day 3 of life. This blood sample is assayed for immunoreactive trypsinogen 
(IRT), a pancreatic enzyme. The top 2% of the day's values are retested in triplicate for 
IRT. Since January 1993, half of this group (the top 1%) are screened for the delta F508 
gene using the blood collected on the initial newborn screen. Delta F08 is the most 
common gene found in CF in Australia with up to 95% of patients having at least one 
copy of this gene. The diagnosis of CF is confirmed with a sweat test using pilocarpine 
iontophoresis [Gibson and Cooke, 1959]. A chloride concentration of greater than 
60mmol /l is diagnostic of CF. The exocrine pancreatic function of patients with CF can 
be assessed by measuring faecal chymotrypsin concentration [Brown et al, 1988]. It can 
also be assessed by.pancreatic stimulation tests [Hadorn et al, 1968, Kopleman et al, 
1988]. Pancreatic stimulation tests may aid in the diagnosis of patients with borderline 
sweat test results [Gaskin et al, 1982a]. 
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Life expectancy among patients with CF has dramatically improved in the past 
twenty years and the mean survival is around 34 years [Fitzsimmons, 1993; Curtis et al, 
1997]. However, there remains a significant gender difference in survival rates. TMg is 
most evident in females with CF under the age of 20 years, who are 60% more likely to 
die than males of the same age [Rosenfeld et al, 1997]. Rosenfeld et al, [1997] 
demonstrated that while nutritional status, pulmonary function and airway microbiology 
were independent predictors of survival, none of these parameters could account for the 
gender difference in survival rates. 
Exercise is an integral part of the growth and development of children. 
Assessment of the exercise tolerance of patients with CF provides important information 
about the disease severity [Cropp et al, 1982] and the psychological well being of the 
patient [Orenstein et al, 1989], Furthermore, as maximal aerobic capacity is an 
independent predictor of survival in CF [Nixon et al, 1992], exercise testing has benefits 
in terms of estimating prognosis. Despite the role of exercise in the daily lives of 
children, exercise testing in children is based on protocols developed for adults and for 
the most part, has not been validated in children [Cooper, 1995]. As exercise testing in 
the laboratory setting can be threatening to young children, the development of valid 
field tests, llirich measure maximal function limited aerobic capacity have the potential 
to assist in the assessment and management of children with CF, 
This thesis will focus on measures of aerobic fitness, muscle strength, quality of 
life and activity levels in children with Cystic Fibrosis as well as the impact of 
conditioning programs on these measures. 
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1.2 Measures of fitness in children 
1.2.1 Introduction 
The parameter most commonly assessed when gauging a child's fitness is aemfale 
fitness. Other measures of fitness, which are less frequently used in children, include 
anaerobic performance and muscle strength. Aerobic fitness, anaerobic performance and 
muscle strength each measure different aspects of fitness, but currently there is no 
consensus as to which is the best assessment of fitness. 
Aerobic fitness is defined as the ability to accomplish endurance performance 
that mainly depends on aerobic metabolism [Leger, 1996]. Aerobic metabolism in turn 
relies predominantly on the oxidative pathway to produce energy for muscle function. 
Anaerobic tasks, in contrast, are high intensity activities that predominantly depend on 
the non-oxidative pathway. Muscle strength is the maximal tension a muscle group 
exerts against a resistance [Gaul, 1996]. Typically, long distance running is a 
predominantly aerobic sport and weight lifting and sprinting are examples of anaerobic 
tasks. Despite the seemingly exclusive definitions of aerobic and anaerobic tasks, at the 
cellular level, both metabolic processes occur concurrently regardless of the activity. 
Thus, at the commencement of long distance running, the anaerobic pathway provides 
the necessary energy until oxygen transport to the muscle mitochondria is established. 
The anaerobic pathway is utilised again when the muscle stores are depleted, oxygen 
demand is greater than supply and lactate accumulates. Muscle strength promotes 
efficient movement and stability of joints, which reduces the risk of musculoskeletal 
injury. 
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1.2.2 Aerobic Fitness 
Aerobic fitness is a measure of cardiovascular health and has been demonstrated to be a 
prognostic factor in predicting the survival of patients with CF [Nixon et aly 1992]. 
Aerobic fitness has three principal components; maximal aerobic power or maximal 
oxygen uptake, mechanical efficiency of aerobic energy processes and the aerobic 
endurance. 
Maximal aerobic power 
The highest exercise intensity that can be maintained during aerobic muscle metabolism 
is defined as the maximal aerobic power [Leger, 1996]. Oxygen consumption in most 
adults exercising at progressively increasing intensity will increase steadily up to a 
maximum level, and then will plateau, despite further increases in workload. Maximal 
aerobic power corresponds to the plateau in oxygen consumption, (known as the V02 
max) during maximal exercise. Maximal oxygen consumption has an inverse 
relationship with fatigue during submaximal tasks [Leger, 1996]. Vaccaro and Mahon 
[1987], Armstrong et al> [1991], Mahon and Vaccaro [1991] and Freedson and 
Goodman [1993] haw all reported that oxygen consumption does not always plateau 
when children exercise maximally. Massicotte et al, [1985] recommended that this 
problem could be overcome by recording the highest oxygen consumption attained 
which is referred to as the V02 peak. Despite the lack of a defined plateau in oxygen 
consumption, Vaccaro and Mahon [1987] demonstrated that the reproducibility and 
reliability of exercise testing in children was similar to that in adults. Furthermore, 
Shuleva et al [1990] demonstrated that reliable exercise tests can be obtained in 
children as young as 3 years of age. 
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Oxygen consumption is usually expressed in absolute terms (liters per l&inute) 
and thus adults with a larger body mass attain higher absolute oxygen consumption 
values than children. This measurement is useful when comparing changes in aerobic 
power over short time intervals in a given individual but is less valuable over long time 
intervals when individuals may experience weight changes. Absolute oxygen 
consumption cannot be used to assess weight bearing exercise tests such as running on a 
treadmill [Buskirk and Longstreet Taylor, 1957]. In addition,,as the absolute oxygen 
consumption does not take into account differences in the load (that is, the body mass 
during weight bearing exercise) between individuals, interindividual comparisons are 
not possible [Kuipers et al> 1985]. Maximal oxygen consumption is therefore usually 
normalized for body weight (ml/kg/min) particularly in children [Krahenbuhl and 
Williams, 1992]. Maximal oxygen uptake relative to lean body mass has been shown to 
be the best method to assess both intra and inter individual differences in the status of 
the aerobic system during weight bearing exercise testing [Buskirk and Longstreet 
Taylor, 1957]. Lean body mass can be measured using skinfold thicknesses and the 
formulae provided by Durnin and Rahaman [1967]. 
There has been a recommendation that oxygen uptake be expressed in terms of 
biological age to account for pubertal development [Mirwald and Bailey, 1986]. Vanden 
Eynde et al, [1988] suggested that the biological age could be derived from the height 
velocity as plotted on a height - age curve. By expressing the maximal oxygen uptake in 
terms of the biological age, variations between countries due to differences in the age of 
onset of puberty are minimised [Molnar et al, 1973]. 
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Rogers et al [1995] examined the relationship between oxygen consumption and 
both body surface area (BSA), and body mass in children and adults. Analyses revealed 
that there was a stronger linear relationship between oxygen consumption and body 
surface area than oxygen consumption and body mass in both children and adults. 
Logarithmic transformation of the data demonstrated that a scaling factor of body mass 
and body surface area to the 0.75 power provided the most appropriate method of 
comparing oxygen consumption in children with that in adults. , 
The two "Gold standard" ergometers used for assessing maximal oxygen 
consumption are the cycle ergometer and the treadmill ergometer [Bar-Or, 1983]. 
Rowland [1993] demonstrated that maximal oxygen consumption obtained with 
treadmill testing was 7% to 19% greater than that with cycle testing. Thus, specific 
norms are required for each ergometer. The use of cycle ergometers in children is 
difficult. The cycle ergometer often has to be modified for body size during growth. The 
length of the pedal shaft and the distance between the seat and the handlebars are 
frequently inappropriate for children. Moreover, the specifications recommend a 13 cm 
crank length for 6 year old children and a 15 cm one for children 8 to 10 years of age 
[Klimt and Voight, 1971; Bar-Or, 1983]. These specifications often rule out the use of 
cycle ergometers in the assessment of children, as modifications to the crank length are 
not possible in the less sophisticated cycle ergometers. In addition, cycle ergometer 
testing is more likely to cause local muscle fatigue than treadmill feting. The latter test 
is a more natural movement and modifications are not required to the ergometer when 
testing different body sizes. The cycle ergometer test requires the child to keep an 
appropriate pace (revolutions per minute) which the examiner needs to measure. This is 
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not necessary in the treadmill test as the treadmill determines the incremental speed 
according to the preset protocol. While maximal oxygen consumption can be predicted 
from heart rate and submaximal power on the cycle ergometer using the Astrand and 
Ryhming nomogram [Astrand and Rytiming,1954], the nomogram underestimates 
oxygen consumption in children by 12% to 25% [Buono et al, 1989, Woynarowska, 
1980]. Correlation between predicted maximum oxygen consumption and measured 
oxygen consumption vary substantially between studies.. Woynarowska [19 80] 
demonstrated a correlation coefficient of 0.52 whereas Buono et al, [19B9] found that it 
was 0.89. 
Numerous protocols for measurement of maximal oxygen consumption using the 
treadmill have been described in the literature [Bar-Or, 1983; Docherty and Gaul, 1990; 
Freedson and Goodman, 1993]. The Bruce and Balke protocols [Docherty and Gaul, 
1990] were originally developed for adults, but, the Balke protocol is too long and 
involves too high a grade for fit children. A survey of paediatric exercise laboratories 
revealed that 50% used the Bruce or, modified Bruce protocol [Rowland, 1993]. 
Although the Bruce protocol is reliable [Cumming et al, 1978], the intensity of the 
increments between the stages are potentially too large for young children [Rowland, 
1993]. Large increments between stages may lead to short bursts of anaerobic 
metabolism, which is clearly undesirable when assessing aerobic fitness. The modified 
Bruce protocol has smaller increments and is presently the protocol of choice when 
testing using the treadmill to assess aerobic fitness in children [Docherty and Gaul, 
1990]. 
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Falgairette [1989] reviewed the published results of exercise tests on 7000 
children in studies on maximal oxygen uptake and concluded that there were great 
differences in maximal oxygen uptake between children of different ages. Further, the 
maximal oxygen consumption in boys who participated in competitive sport increased 
with age whereas it stayed constant in boys not involved in sport. Moreover, there was a 
decrease in maximal oxygen consumption in girls with age but, it stayed constant if they 
participated in sport. Kemper [1986] and Jones [1991] have concluded similar results 
with their respective studies. The range of the normal values for maximal oxygen uptake 
in children are plotted in Figure 1.1. 
While maximal oxygen consumption has been used to predict survival [Nixon et 
al, 1992], there are no published age, gender or disease severity related normal predicted 
values for patients with CF. Orenstein and Nixon [1991] compared the exercise 
tolerance of males and females with CF and demonstrated that males had significantly 
greater peak oxygen consumption than females. Orenstein and Nixon [1991] 
demonstrated that minute ventilation was also significantly greater in males with CF 
than females with CF which is similar to findings in healthy subjects [Aitken et al, 
1986], When minute ventilation was expressed in terms of ventilation per unit work 
load, however, there was no statistical difference between the genders. 
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TIGHT BINDING 
Mechanical Efficiency 
The child who consumes the least oxygen to undertake a given submaximal task is the 
most mechanically efficient Paniels and Daniels, 1992]. Children consume more 
energy than adults in weight bearing exercises [Astrand, 1952; MacDougall et al, 1983]. 
The oxygen consumption for a specific speed is greater in children than adults. 
Krahenbuhl et al, [1992] demonstrated that aerobic performance in children increases 
with age and growth. However, oxygen consumption during, submaximal tasks when 
expressed per unit body weight, is relatively static during growth [Bar-Or, 1983]. The 
improvement in aerobic performance has therefore been attributed to improved muscle 
efficiency. 
Aerobic reserve is a measure of muscle efficiency [Bar-Or, 1983] and is defined 
as the percent of maximal oxygen co&sumption required to undertake a given 
submaximal task. While the concept of aerobic reserve is useful to account for the 
greater aerobic performance in children as they grow, Leger [1986], Rowland [1993], 
and Unnithan and Eston [1990] have demonstrated differing values for the aerobic 
reserve for a given age and task. There are no studies of muscle efficiency in subjects 
withCF. 
Aerobic Endurance 
Aerobic endurance is the third component of aerobic fitness [Leger, 1996]. Aerobic 
endurance is the length of time a subject can participate in a task of static intensity 
before the oxygen demand of aerobic metabolism is no longer met. Anaerobic endurance 
is measured by the anaerobic threshold, which is the level of oxygen uptake during 
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exercise above which aerobic energy production is supplemented by anaerobic 
mechanisms. It is reflected by an increase in arterial blood lactate and the 
lactate/pyruvate ratio [Wasserman and Mcllroy, 1964]. 
Beaver et al, [1986] plotted the V- slope, which is the graphical relationship 
between alveolar carbon dioxide (VCO2) and alveolar oxygen (VO2). The point of 
deviation from the linear association of the V slope was defined as the aerobic threshold. 
In healthy subjects, the aerobic threshold is closely related to the anaerobic threshold as 
measured by blood lactate. However, Belman et al, [1992] demonstrated that the Beaver 
method of measuring the anaerobic threshold using the gas exchange method was not 
reliable in patients with chronic obstructive pulmonary disease. 
Conconi et al [1982] described a simple test to measure anaerobic threshold. The 
threshold occurs at the deflection point from the linear relationship between work load 
and heart rate. This method of assessing the anaerobic threshold has become one of the 
most frequently used exercise tests in sports medicine. Nikolaizik et al, [1998] have 
however, demonstrated that the Conconi test overestimated the anaerobic threshold in 
adult subjects with mild CF related lung disease raising the possibility that exercise 
training programs based solely on the Conconi method may result in overexertion of 
patients with CF. The Conconi test has not been evaluated in children. 
Changes in.aerobic endurance during growth have not been extensively 
documented. However, Berthoin [1994] demonstrated that the endurance time at any 
given submaximal exercise intensity was stable during growth. 
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1.2.3 Anaerobic power 
Power is defined as the amount of work performed in unit time where as work is the 
product offeree and velocity [Bar-Or, 1987]. Anaerobic power implies that the energy 
to perform the task is obtained through a biochemical pathway that does not require 
oxygen. In reality, some part of the energy for even the most intense supramaximal 
activity is obtained through the aerobic pathway [Bar- Or, 1987; Vandewalle et al, 
1987]. 
The contribution of energy through the aerobic pathway during predominantly 
anaerobic activity is greater in children than in adults [Hebestreit et al, 1993], and thus, 
anaerobic power is lower in children than in adults even when normalized for body mass 
or lean body mass [Bar-Or, 1983; Blimkie et al 1988; Kurowski, 1997;]. Anaerobic 
power does however, increase with the onset of puberty, [Paterson et al, 1986; Blimkie 
et al, 1988] and reaches peak adult levels in the second or third decade of life [Di 
Prampero and Cerretelli, 1969]. Blimkie et al [1988] and Mercier et al, [1992] 
demonstrated that peak power and mean anaerobic power increase throughout 
adolescence even when expressed in terms of muscle mass. Moreover, Blimkie et al, 
[1988] and Docherty and Gaul [1990] demonstrated gender differences in anaerobic 
performance. These differences were however, no longer present when power per lean 
mass was calculated. 
The mechanism for the changes in anaerobic performance noted with maturation 
has not been delineated. Eriksson et al [1974] suggested that the rate of anaerobic 
glycolysis is limited in prepubescent children by low concentrations of the muscle 
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enzyme phosphofructokinase. This hypothesis is supported by the finding of low lactate 
concentrations in the blood [Duche et al, 1992] and muscle [Eriksson et al, 1973], and 
less acidosis in blood after maximal exercise in prepubescent children [Kindermann et 
al, 1975]. Animal research has demonstrated that anaerobic performance is related to 
serum testosterone [Dux et al, 1982], but, salivary testosterone level has been shown to 
correlate with maximal blood lactate. [Fellman et al, 1988]. Furthermore, changes in 
testosterone activity cannot explain the puberty related increase in anaerobic 
performance among females. 
Daily activity frequently requires repeated bouts of anaerobic exercise rather 
than performance of sustained aerobic efforts. Therefore, an understanding of anaerobic 
performance may be of greater practical importance in the daily life of a patient with CF 
than the more classic concept of aerobic endurance. Despite extensive research on 
anaerobic exercise in healthy children, it remains unclear whether children with CF have 
a limited anaerobic capacity. Boas et al, [1996] reported a strong correlation between 
anaerobic capacity and body mass index in adolescent boys with CF. In addition, Shah et 
al, [1998] demonstrated that adult patients with CF and moderate lung disease had a 
significantly lower anaerobic performance than healthy controls. Lean body mass and 
arm muscle area correlated significantly with anaerobic performance in both the healthy 
controls and the subjects with CF. Lands et al [1993] used an isokinetic cycle ergometer 
to demonstrate that adult patients with CF had a significantly lower peak power than the 
healthy controls. Moreover, adult females with CF had a significantly lower peak power 
than their male counterparts, but, the difference was not statistically significant when 
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expressed per unit of lean body mass. There is clearly a need to investigate anaerobic 
power in children with CF. 
Anaerobic tests 
Anaerobic tests measure either the peak power a group of muscles can generate, or, the 
endurance of the muscles to sustain a high power output. As each type of anaerobic test 
measures different muscle groups and function, -they each have their own range of 
normal predicted values. The gold standard for assessing anaerobic performance in 
children is the Wingate test. It was developed by Ayalon et al, [1974] and has 
subsequently been validated in several studies. Its test- retest reliability ranges from 0.92 
to 0.97 [Bar- Or, 1987] and it has a low coefficient of variation within subjects between 
six and twelve years of age [Naughton et al, 1992], Inbar et al [1985] published norms 
for males for peak power using the Wingate test. They are presented in figure 1.2. 
The Wingate test requires the use of a fixed braking constant force cycle 
ergometer. The test is preceded by a warm up phase of moderate intensity cycling which 
is followed by three to four sprints each of two to three second duration. The test is then 
commenced with the child being instructed to pedal as fast as possible for a thirty second 
period. The parameters of assessment are the peak power output reached (Watts) and the 
mean power during the 30 second test. The fatigue index, which is the percent drop in 
power from peak level to the lowest level can also be calculated. The fatigue index 
correlates with the preponderance of fast twitch muscle fibers [Bar-Or et al, 1980] and 
thus, 
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FIGURE 1.2: Peak power of legs in males using the Wingate Anaerobic test. 
Values represented are the mean values with error bars representing +/ 
SD. Based on Inbar (1985). 
obviates the need for muscle biopsy to obtain such information. The Wingate test is well 
tolerated by children and the test remains the anaerobic test of choice. The cost of 
equipment and the possibility of post test nausea in young adults however, need to be 
considered before using the test in subjects with CF. 
The Force Velocity Cycling test measures peak power during a maximal five to 
eight second burst of cycling [Sargeant et al, 1981]. This test.was developed for adults 
and subsequently adapted for children. A constant force, isokinetic cycle is required for 
the test. Although there is a high correlation between peak power obtained by it and that 
obtained by the Wingate test [Van Praagh et al, 1990], the limitation of this test is that 
there are no available data about its reproducibility. 
Based on force -velocity principles, there is an optimal velocity at which the 
peak power is obtained [Wilkie, 1960], the optimal velocity in children being 110 
revolutions per minute [Sargeant, 1981; Dotan and Bar-Or, 1983]. An isokinetic cycle 
ergometer which maintains a constant pedal velocity was developed by Sargeant et al, 
[1981]. Both peak power and muscle endurance can be measured by the isokinetic cycle 
ergometer although the utility of the test is limited by the cost of the ergometer. 
Peak power can also be assessed using the Margaria step running test [Margaria, 
et al, 1966] which requires the subject to run up stairs at maximal speed. Mechanical 
peak power is calculated from the time it takes the subject to make two strides. As 
subjects differ in their style of sprinting up stairs, and as a given subject may vary from 
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one attempt to another in running style, it is difficult to make either inter- or intra-
tofividual comparisons using the results of this test. 
Sargent [1921] also introduced a vertical jump test to assess peak power. The test 
is a simple field test which can be easily learned by children. It is highly reproducible 
between jumps [Glencross, 1966] and compares well with the results obtained using the 
best assessment of anaerobic performance, the Wingate test [Bar-Or, 1983]. 
Isokinetic monoarticular anaerobic tests using isokinetic dynamometers can also 
be used to measure peak power as well as muscle endurance. Dynamometers calculate 
the peak power from the force generated and angular velocity. Several protocols have 
been developed using these instruments for assessing a wide range of muscle power. 
Bar-Or [1983] developed the McMaster Muscle Endurance Test (McMET) which 
measures peak power and muscle endurance of the knee flexors and extensors. Again, 
the results obtained using this test have been shown to correlate well with those obtained 
using the Wingate test [Bar-Or, 1983] but, the utility of the test is limited by the cost of 
the dynamometers. The isokinetic dynamometer, precisely matches the force applied by 
the subject and prohibits acceleration (hence the term isokinetic). This enables strength 
to be measured through a full range of motion at a constant velocity. The advantage of 
this method of testing is that short bursts of force, that are not maintained for the full 
range of motion of that muscle group, are not recorded and hence, cannot give a falsely 
high reading. 
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1.2.4 Muscle strength 
Strength is defined as the maximum force a muscle group can exert against resistance 
[Gaul 1996]. Muscle strength is necessary to stabilise joints and enable individuals to 
participate in activities of daily living without undue fatigue [Haskell et al, 1985]. The 
development of muscular strength helps muscles to endure long periods of submaximal 
force and delays the onset of fatigue. Muscle endurance is defined as the ability of a 
muscle group to generate force over an extended period of time* [Gaul, 1996]. 
In the laboratory setting, muscle strength can be measured by isokinetic testing, 
isotonic testing and isometric testing. In muscle strength assessments using isokinetic 
testing, the maximal force through a complete range of motion is measured while the 
speed of movement is kept constant. Isokinetic testing is by far the most widely used 
strength testing protocol In isotonic strength testing, the maximal muscle action occurs 
within a small portion of total range of motion. During isometric testing, force 
development occurs at a preset joint angle against an immovable resistance. 
Isokinetic Testing 
The term "isokinetic" refers to a constant force velocity, and isokinetic muscle action 
does not occur during normal movement. However, isokinetic testing enables 
measurement of maximum force at each point of the full range of motion of that'muscle 
group. The measurement of isokinetic muscle strength requires the use of specially 
designed dynamometers which alter the resistance according to the force applied to 
ensure a constant limb velocity. Isokinetic muscle action is recorded as the peak torque. 
This is the highest torque output by a muscle group as th&ilimb moves through a range of 
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motion [Burnie and Brodie, 1986]. Peak torque has been demonstrated to be an accurate 
and reproducible measure of strength in children [Molnar et al, 1979]. Children typically 
demonstrate greater peak torque with limb extensors than with limb flexors [Burnie and 
Brodie, 1986], but the muscle strength of the dominant and non dominant limbs in 
children is not significantly different [Sunnegardh et al, 1988]. 
There are several commercially available 'dynamometers such as Cybex, Kin 
Com and Biodex. However, almost all isokinetic research in children has been 
performed using the Cybex II or Kin Com versions. There are no available data 
comparing the two dynamometers. 
When the strength of a group of muscles is measured during rotational motion, it 
is described as the torque. The use and interpretation of isokinetically derived torque is 
subject to error as a result of mechanical imperfections in the equipment used [Taylor et 
al, 1991]. At high velocities, the momentum of the accelerating limb is absorbed by the 
dynamometer which decelerates the limb in order to maintain constant velocity through 
the range of motion. This can result in impact artifact and may be incorporated in the 
torque reading [Sapega et al, 1982]. This artifact has however been shown to be less 
common when testing children, and this is thought to be due to a smaller limb mass and 
total torque values [Winter et al, 1981]. Further, gravity has an influence on the 
measurement of torque and some dynamometers have inbuilt correction devices to 
account for the effect of gravity. Despite these limitations, there have been some studies 
on the liability and applicability of isokinetic strength testing of children. Molnar et al, 
[1979] demonstrated a small variability between test-retest assessments and between 
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different examiners. These differences were not statistically significant and were 
confirmed by Sunnegardh et al, [1988] in later studies. 
Isotonic Testing 
The most widely used isotonic protocol is termed the one repetition maximum (1RM) 
and requires the subject to bench press or leg press a supramaximal load twice. The 
National Strength and Conditioning Association (NSCA) has recommended that 
prepubescent children should not undertake isotonic testing using the one repetition 
maximum protocol as used by Blimkie et al, [ 1989] as the risk of injury is high. 
Watkins and Docherty [1996] have described the 10 repetition maximum 
protocol, which requires the subject to bench press 40% of body weight with 10 
repetitions. This protocol has been shown to be well tolerated by 10 to 12 year old 
children but nonetheless, isotonic testing is an uncommon test in children because of 
significant concerns about the rick of injury. 
Isometric Testing 
Isometric testing involves measuring the force applied against an immovable measuring 
device. Isometric testing can be performed using an isokinetic dynamometer by fixing 
the dynamometer's measuring arm at a chosen angle. The force generated by a specific 
muscle group is dependent on the joint angle and body position [Clarke, 1966]. 
Although normal predicted values for force generated at various joint angles have been 
published for adults, the data is poor for children [Ramsay et al> 1990]. The optimal joint 
angle for isometric testing depends on the muscle group being tested. Often more than 
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one angle is necessary to construct an isometric profile. The duration of the isometric 
test protocol typically ranges from 2 seconds to 5 seconds [Andersen and Henckel, 
1987] and includes a minimum of two trials with the average of the trials taken as the 
result of the test. Although simple to perform, isometric testing has no reproducibility or, 
reliability data in children and as such has limited use in the assessment of children with 
CF. 
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1.2.5 Summary 
• Aerobic fitness 
• Has been shown to predict survival in patients with CF. 
• Aerobic fitness has three principle components 
Maximal aerobic power - this is the highest exercise inte&sity that can be 
maintained during aerobic muscle metabolism and is 
best measured in1 children using either the cycle 
ergometer or treadmill ergometer. 
Mechanical Efficiency - this relates inversely to the amount of oxygen 
consumed during a given task and is best measured by 
the aerobic reserve. 
Aerobic endurance - this is the length of time a subject can participate in 
a task before the oxygen demand is no longer met and is 
measured by the anaerobic threshold. 
• Anaerobic performance 
• Is an important component of daily activity 
• Is measured by peak power or endurance. 
• The Wingate test is the current "gold standard" of measurement 
• Muscle strength 
• Is the maximum force a muscle group can exert against resistance 
• May be assessed by isokinetic, isotonic or isometric testing. 
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• Isokinetic testing is the most commonly used method utilising dynamometers to 
measure peak torque. 
• An ideal fitness test should really incorporate all three measures of fitness but this is 
not possible as muscle function assessed with each test is very different. 
• Aerobic fitness is most commonly assessed iri CF patients but there is a need to 
measure anaerobic performance and muscle strength as current data is very limited. 
. 1.3 The use of field tests to assess fitness 
1.3.1 Introduction 
Exercise tolerance reduces as the severity of the lung disease in CF progresses [Cropp et 
al, 1982]. Exercise tolerance has been demonstrated by Nixon et al, [1992] to be an 
independent predictor of survival. Furthermore, at the Cystic Fibrosis Consensus 
Conference in 1994, exercise tolerance was described as an important outcome measure 
in interventional trials [Ramsey and Boat, 1994]. 
While the treadmill and cycle ergometer remain the "gold standard' for exercise 
testing, these tests do not replicate children's daily activity [Cooper, 1995]. Furthermore, 
the equipment necessary for testing is expensive and not readily available. As these tests 
are performed in the laboratory setting, young children in particular can find the testing 
threatening and hence not perform to their maximal ability. Field tests are measures of 
fitness, which are undertaken without the need for highly specialised and expensive 
equipment. The aim of field tests is to replicate the "gold standard" tests such as the 
treadmill or cycle ergometer as closely as possible in a non threatening environment. 
1.3.2 Historical perspective 
Historically, the focus of field tests was initially on motor fitness where the efficiency of 
muscle function was assessed. The Kraus- Weber Minimal Fitness Test [Kraus and 
Hirschland, 1953] was one of the earliest field fitness assessments developed and was 
used to compare the fitness of European and American children. The principle 
assessment was of muscle strength and included sit ups, push ups and an endurance run. 
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The Canadian Association for Health, Physical Education and Recreation (CAHPER) 
introduced a similar battery of tests to Canadian schools in 1966 and in addition added 
tests of aerobic fitness. Australian schools adopted the CAHPER tests of fitness in 1967 
with the addition of static and explosive assessments of strength. 
In 1975, the American Alliance for Health, Physical Education, Recreation and 
Dance revised the fitness test to incorporate health related assessments in addition to the 
measures of physical performance. The health related assessments included 
anthropometric (growth and nutrition) details, which had not previously been 
documented in any of the fitness tests [Franks et al, 1988]. 
The Manitoba Physical Fitness Performance Test Manual and Fitness Objectives 
was published in 1980 and included measures of aerobic fitness, as well as assessments 
of strength, flexibility and anthropometric details. The revised version contained normal 
standards of fitness based on the Manitoba Schools Physical Fitness Survey [1989]. 
The New South Wales Schools Physical Fitness assessment was completed on 
7000 school children [Booth et al, 1998]. This assessment was unique in that it 
incorporated measures of aerobic fitness, muscle strength, muscle endurance as well as 
information on activity levels. The assessment of activity level was obtained by asking 
the children to document the number of hours of organised as well as miscellaneous 
sport played per week. 
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1.3.3 Fitness components measured in field tests 
Several components of fitness can be measured in field tests. The type of field test 
administered can be tailored so that the fitness parameter deemed to be of greatest clinical 
importance is measured. The components which can be assessed in these tests include 
muscle strength, power, endurance and body composition. 
The maximum force a muscle group can generate in one contraction is the 
"strength" of that muscle group [Sale, 1991]. The maximum weight a subject can lift is a 
commonly used field test of strength but to more precisely quantitate strength requires 
expensive equipment and hence, strength is not often assessed in field tests. Power refers 
to explosive strength or, the ability of muscles to contract forcefully and quickly. [Sale, 
1991]. Power can be evaluated in field assessments by throwing medicine balls, standing 
broad jumps or vertical jumps. Muscle endurance is the ability of a designated muscle 
group to perform repeated contractions. Field tests such as push ups, sit ups, and flexed 
arm hang (where the subjects hangs off a bar for as long as possible) all assess muscle 
endurance. 
The range of motion about a specific joint is referred to as flexibility [Hubley, 
1991]. Typically, field tests measure only a part of the range of motion. Quantitating 
flexibility usually requires the use of equipment such as a goniometer. 
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Body composition, in the field test setting consists of assessing lean body mass 
[Ross and Marfell- Jones, 1991]. This is accomplished with the use of calipers to measure 
skinfold thickness as described by Durnin and Rahaman [1967]. 
1.3.4 Commonly used field tests 
The step test is a quick, simple and portable field test. The subjects are required to step up 
and down a step of 15cm height at a rate of 30 steps per minute for„three minutes. Being 
externally paced, it has the additional benefit of not being dependent on patient 
motivation. However, while the test is reproducible [Balfour-Lynn et al, 1998], criterion 
validity has yet to be assessed against an accepted gold standard of exercise assessment 
(eg. treadmill or cycle ergometer). In addition, the step test does not measure a maximal 
functional capacity and the workload will vary according to the step height, and the 
weight and height of the subject. The test is therefore not suited to longer term clinical 
intervention trials [Orenstein, 1998]. 
The shuttle test is another inexpensive and portable field test which assesses 
maximal function limited cardiorespiratory fitness. The two shuttle tests commonly in use 
are the 10m shuttle walk which was developed by Singh et al, [1992] and the 20m shuttle 
run which was developed by Leger et al [1988]. These tests are effective measures of 
aerobic fitness as they estimate maximal oxygen uptake. The shuttle tests overcome the 
limitations of the 2- minute and 6- minute walk tests by being externally paced maximal 
tests, and therefore not dependent on patient motivation. Unlike the 2 and 6 minute walk 
tests and the step te$% the shuttle tests are standardized incremental, maximal tests. The 
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shuttle tests are also superior to the step test in that they provide a quantitative assessment 
of maximal functional capacity. As the outcome measures (such as maximal oxygen 
uptake, oxygen pulse) are recorded in terms of total or lean body mass, the shuttle tests 
are potentially an ideal assessment in long term clinical trials. Moreover, the validity of 
the 20m shuttle run has been assessed in healthy children [van Mechelin et al, 1986; 
Leger et al, 1988; Liu et al, 1992; McVeigh et al, 1995] athletes [Ramsbottom et al, 
1988], and a sedentary adult population [Paliczka et al 1987]. However, despite use in the 
assessment of exercise tolerance, neither of the shuttle tests have been validated in 
children with cystic fibrosis. 
1.3.5 Field tests in patients with Cystic Fibrosis 
A cardiorespiratory assessment of fitness is the most commonly used field test in CF. 
This is because aerobic fitness is a useful measure of disease severity [Cropp et al, 1982] 
and has important prognostic implications [Nixon et al, 1992]. Furthermore, as aerobic 
fitness is a measure of the overall impact of the disease on the subject [Nixon et al, 
1992], interventional clinical trials can use cardiorespiratory assessments of fitness as 
important outcome measures [Ramsey and Boat, 1994]. While there are several 
assessments of aerobic fitness in the field setting, only two tests have been validated in 
patients with CF. The tests are the six minute walk test [Nixon et al, 1996; Gulmans et al, 
1996] and the Great Ormond Street 3 minute Step test [Balfour- Lynn et al, 1998]. Both 
these tests have limitations when assessing fitness in children with CF. 
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Gulmans et al, [1996] assessed the validity of the six rninute walk test in children 
with CF by measuring the total distance walked in six minutes. Encouragement was 
offered after every 16m walked. Validity was assessed by correlating the distance walked 
with a maximal cycle ergometer exercise test in children with CF. Reproducibility was 
assessed by comparing the distance walked on two separate six minute walk tests. There 
was a significant correlation between the distance walked in the six minute walk test, and 
the maximal oxygen uptake and the peak work capacity during the cycle ergometer test. 
Further, the six minute walk test was demonstrated to be reproducible with no significant 
differences between the. distances walked when the test was repeated. The correlations 
between the distance walked and the maximal oxygen uptake suggest sufficient 
variability that the six minute walk test must be interpreted with care when considering 
individual patients [Cerny, 1996]. Inadequate or, unsafe exercise prescriptions may result 
if the exercise capacity is under, or overestimated. As the test is essentially self paced, 
the patient's attitude and motivation are a major factor in determining the distance 
walked [Guyatt et al, 1984; Swinburn et al, 1985]. For this reason, CF centers that utilise 
the six rninute walk test, use the fall in oxygen saturation (pulse oximetry) and peak heart 
rates as the critical outcome measures rather than the distance walked [Balfour-Lynn et 
al, 1998]. Thus, the six minute walk test has limited application in clinical interventional 
trials in patients with CF. 
Balfour-Lynn et al, [1998] validated the reproducibility of the step test in children 
with CF. Exercise tolerance from both the step test and the six minute walk test were 
compared by measuring the peak heart rate, minimum oxygen saturation (pulse oximetry) 
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and the modified Borg breathlessness score [Wilson and Jones, 1989]. The step test was 
demonstrated to be reproducible and the peak heart rate obtained was not significantly 
different to that obtained by the six minute walk test. 
1.3.6 Summary 
• field tests are inexpensive measures of fitness which obviate the need for expensive 
laboratory equipment. 
• To date, the six minute walk test [Gulmans et al, 1996] and the Great Ormond Street 
3 minute Step test [Balfour Lynn et al, 1998] have been validated in children with 
CF. However, both these tests have limitations. 
• The six .minute walk test being self paced is dependent on patient 
motivation. 
• The step test does not quantitate maximal functional capacity, has not been 
validated against a treadmill or cycle ergometer and is not suitable for 
longer term interventional trials. 
• The shuttle test is potentially a very useful incremental field test as it is an externally 
paced test which quantitates maximal functional capacity. The shuttle test however, 
has not been validated for use in children with CF. 
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1.4 Responses to exercise in patients with Cystic Fibrosis 
1.4.1 Introduction 
Exercise testing is an important method of assessing disease severity in the patient with 
CF. Cropp et al, [1982] demonstrated that adult patients with advanced CF disease, have 
a reduced exercise tolerance due to a reduced ventilatory capacity. Others have 
demonstrated that patients with CF have a reduced peak work capacity compared to 
normal controls on exercise testing using a cycle ergometer [Bellon et al 1984; Marcotte 
et al, 1986b]. Peak oxygen uptake has also been shown to be reduced in patients with CF 
compared to controls [Freeman et al 1993; Hjelthes et al 1984; Stranghelle et al, 1996]. 
1.4.2 Cardiorespiratory 
Orenstein and Nixon [1991] compared the exercise tests of young adult females with CF 
with males with CF of a similar age using cycle ergometer exercise testing. Females with 
CF had a significantly lower peak oxygen consumption and peak work load than males. 
McCool et al [1993] reported similar results. Gender differences in peak oxygen 
consumption have previously been demonstrated in healthy populations [Bar-Or, 1983] 
and have been attributed to a decrease in activity in females after puberty [Shepherd 
1977]. The reduced activity in girls was postulated to lead to muscle deconditioning 
resulting in reduced aerobic fitness. Another explanation is that, gender differences in 
lean body mass may have spuriously exaggerated the gender difference in peak aerobic 
capacity when reported in terms of total body mass [Davies, 1992]. Similarly, Orenstein 
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and Nixon's study [1991], by not correcting the peak oxygen consumption for lean body 
mass may have overestimated the gender difference. 
The ventilatory capacity only becomes a limiting factor in CF when pulmonary 
disease reaches an advanced stage [Cropp et al, 1982]. This occurs as the end expiratory 
lung volume, which is already increased in patients with severe disease, becomes further 
increased after exercise [Regnis et al, 1991] due to airway closure at relatively higher 
lung volumes. This premature closure produces a natural positive end expiratory pressure 
(PEEP). In contrast, in patients with mild disease, the end expiratory lung volume is 
reduced after exercise as airway closure does not occur at until low lung volume is 
reached. Premature airway closure in advanced lung disease is thought to be caused by 
mucous plugging [Regnis et al, 1991]. 
During exercise, patie&tts with mild lung disease achieve optimal alveolar 
ventilation by increasing tidal volume [Cerny et al3 1982]. However, as the severity of 
lung disease progresses, the ability to increase the tidal volume as it approaches vital 
capacity is reduced. Thus, in patients with moderate to severe lung disease, the 
ventilatory rate is increased to compensate for the inability to increase the tidal volume, 
[Levison and Cherniak, 1968]. In spite of the increased ventilatory rate, relative alveolar 
hypoventilation occurs due to an increased dead space. Moreover, Pianosi and 
Wolstein[1996] demonstrated that patients with CF have a decreased ventilatory response 
to carbon dioxide. The reduced chemosensitivity may further accentuate the relative 
alveolar hypoventilation during exercise in patients with CF [Germann and Orenstein, 
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1981]. This relative alveolar hypoventilation has been shown to result in carbon dioxide 
retention in studies measuring end tidal carbon dioxide during exercise [Cerny et al, 
1982; Cropp et al, 1982; Marcotte et al, 1986b]. In addition, Coates et al, [1988] 
demonstrated that patients with carbon dioxide retention had poorer lung function. In 
patients with CF who had an increased functional residual capacity, abdominal muscle 
activity has been demonstrated even when the patients were supine [Cemy et al}, 1982]. 
Patients with CF recruited abdominal muscles during expiration-at lower expiratory 
threshold loads than healthy controls. 
Adult patients with moderate to severe CF, have regions of air trapping 
predominantly in the apices of the lungs. Exercise improves the ventilation to these 
regions of the lungs [Kruhlak et al, 1986]. Although gas exchange, as measured by 
ventilation perfusion studies, is reduced in patients at rest, it improves during exercise in 
patients with CF [Dantzker et al, 1982]. 
Patients with CF utilise a larger proportion of their total oxygen consumption on 
respiratory muscles when exercising than do controls [Katsardis et al, 1986]. Thus, there 
is less reserve for use by the exercising peripheral muscles and therefore exercise 
tolerance may be limited. Further, exercise tolerance may also be limited by way of 
increased carbon dioxide production by peripheral muscles contributing to the ventilatory 
load of the respiratory system [Lands et al, 1992]. Subjects who are aerobically fit have, 
howeve% a lower ventilatory load and use fat as a fuel (reducing the carbon dioxide by 
product) as well as metabolising lactate more efficiently. • 
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Resting pulmonary function, specifically, forced expiratory volume in one second 
[FEVi], correlates with exercise induced oxygen desaturation (measured using pulse 
oximetry) in patients with CF [Versteegh et al, 1986]. However, when transcutaneous 
oximetry is used to measure desaturation, there is no significant relationship with resting 
pulmonary function [Pradal et al, 1990]. The reason for the difference in correlation 
between the two modes of measuring desaturation is unclear, although, transcutaneous 
oximetry is well known to have greater variations during exercise than pulse oximetry 
[Stranghelle et al, 1993]. Henke anad Orenstein [1984] demonstrated that desaturation 
during exercise occurred in 28% of subjects with an FEVI of less than 50% predicted and 
2% of subjects with an FEVI of greater than 50% predicted. Others [Marcotte et al, 
1986b; Freeman et al, 1993] have reported similar findings using an FEVI of 60% 
predicted or resting saturations of less than 95% as cutoffs for predicting which patients 
would desaturate with maximal exercise. Versteegh et al [1986] demonstrated that if the 
V02 max was less than 55% predicted, or if the anaerobic flireshold was less than 40% 
predicted, there was a significant increase in the risk of desaturation with exercise. 
Lebecque et al, [1987] demonstrated that if the gas exchange of the lungs was greater 
than 80% predicted, no desaturation occurred but, if the gas exchange was less than 65% 
predicted, all patients desaturated with exercise. Those patients with the lowest resting 
oxygen saturation appeared to have the greatest risk of desaturation during exercise 
[Goldringe/a/, 1964]. 
Studies have demonstrated exercise induced bronchospasm occurs in 22% 
[Kaplan et al, 1994] to 55% [Silverman et al, 1978] of patients with CF. Conversely, 
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bronchodilation and increases in ¥EV{ of up to 13% have also been demonstrated during 
exercise in patients with CF [Day and Mearns, 1973; Skorecki et al, 1976; Macfarlane 
and Heaf, 1990]. The presence of basal vagal tone in the airways of patients with CF is 
suggested by a similar increase in FEVi with the administration of anticholinergic drugs 
[van Haren et al, 1992]. Exercise has also been shown to result in a reduction in airway 
resistance and an increase in total lung capacity in patients with CF [Price et al, 1979; 
Bilton et al, 1991]. There is no correlation between atopic status of the patients with CF 
and the results of pulmonary function tests during exercise [Silverman et al, 1978; Holzer 
etal, 1984]. 
The cardiovascular responses to exercise in patients with CF are normal and 
generally do not limit exercise ability [Lands et al 1992]. There is a normal incremental 
increase in heart rate with exercise [Cerny et al, 1982], As exercise is usually limited by 
the ventilatory load, or, muscle deconditioning, the peak heart rate at maximal exercise is 
lower than in the normal population without CF [Orenstein et al, 1981]. Williams et al 
[1993] have however demonstrated that patients with CF and CF related liver disease, 
have higher cardiac output and a lower systemic vascular resistance index than patients 
with CF and no significant liver disease. In addition, using radionuclide 
angiocardiography, Matthay et al [1980] demonstrated that 45% of adult patients with 
moderate to severe CF disease had resting right ventricular ejection abnormalities. Using 
a similar technique, Benson et al [1984], demonstrated that 30% of adult patients with 
moderately severe CF disease had abnormal right ventricular function during exercise. 
Left ventricular function has been studied in adults with CF and has been demonstrated to 
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be either normal [Canny et ah 1984] or mildly abnormal [Benson et al, 1984]. The 
nutritional status of patients with CF may also impact on the cardiac function with 
patients who are malnourished having a lower stroke volume and thus, cardiac output 
than well nourished patients [Marcotte et al91986a]. 
1.4.3 Muscle Strength 
Adults with CF have been demonstrated to have weaker hamstrings and quadriceps 
muscles than controls when assessed using an isokinetic dynamometer [Darbee and 
Watkins, 1987] or a maximal voluntary contraction manoeuvre [Mier et al, 1990]. 
Conversely, Lands et al [1993] demonstrated that strength, assessed using an isokinetic 
cycle ergometer, and expressed per unit of lean body mass, was not significantly different 
in adult patients with CF. The only paediatric study of peripheral muscle strength in CF 
was performed by de Meer et al [1999]. B&that study, there were significant differences 
in muscle strength, assessed using a hand held myometer, between patients with CF and 
healthy controls, although implications of the study may be limited by the very small 
sample size. The differences in strength remained even after it were expressed per unit of 
lean body mass. The sample size was too small to perform statistical analysis on gender 
differences in the CF population. 
Studies assessing respiratory muscle strength using maximal peak inspiratory 
(PImax) and expiratory pressures (PEmax) have yielded mixed results. While Mier et al, 
[1990] demonstrated respiratory muscle weakness, Lands et al [1993] demonstrated no 
difference between adult patients with CF and healthy controls. Adult patients with CF 
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who were malnourished or severely hyperinflated (increased RV/TLC), had reduced 
maximal inspiratory pressures [Szeinberg et al, 1985]. It is thought that this occurs as 
hyperinflation may compromise muscle efficiency and thus strength by flattening the 
diaphragm and shortening the accessory and intercostal muscles [Webb and Dodd, 1995]. 
1.4.4 Muscle metabolism 
Skeletal muscles are classified into two principle fiber types on the basis of contractile 
and biochemical properties [Saltin and Gollnick, 1983]. Type I fibers are known as the 
"red fibers" as they are rich in myoglobin. As Type II fibers have considerably less 
myoglobin, they are known as "white fibers". Type I fibers are known as slow twitch 
fibers as they take comparatively longer to develop peak tension after activation 
compared to Type II fibers which are known as fast twitch fibers. Type I fibers owe the 
slower contractile properties to the relatively low activity of myosin adenosine 
triphosphatase (ATPase), lower activity of the regulatory protein troponin and the slower 
uptake of calcium by the sarcoplasmic reticulum. These same properties of the Type I 
fibers confer a high resistance to fatigue. Type I fibers are rich in oxidative enzymes 
while Type II fibers are rich in glycolytic enzymes. Type II fibers are sub classified into 
Type Ila, which have less glycolytic enzyme stores than Type lib. Type I slow twitch 
fibers are more efficient than Type II fast twitch fibers because they generate more work 
and tension per unit of substrate energy utilised [Gibbs and Gibson, 1972]. 
Fiber type distribution varies from muscle to muscle and endurance training can 
result in a higher proportion of Type I fibers. The pattern of activation of the fiber types 
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depends on the form of exercise. For low intensity exercise, Type I slow twitch fibers are 
recruited predominantly whereas, Type II fast twitch fibers are recruited at higher work 
rates at or above 78% of the maximal aerobic power [Essen, 1977]. Information 
regarding muscle fiber type in childhood is limited due to the ethical considerations of 
obtaining a muscle biopsy. Bell et al, [1980] demonstrated that prepubescent children 
have a higher proportion of Type I and lower proportion of Type II fibers when compared 
with adults. In addition, there is a greater portion of Type lib than Ha fibers during 
childhood. Colling-Saltin [1980] has however reported the opposite findings in terms of 
the proportions of Type Ha and lib in childhood and adulthood. Little is known about 
gender differences in skeletal muscle fibers in childhood. 
Skeletal muscle is fueled by chemical energy in the form of glycogen and lipids 
which are stored as adenosine triphosphate (ATP). The three sources of ATP utilized 
during exercise are ATP- creatine phosphate stores, oxidative (aerobic) metabolism and 
non oxidative (glycolytic) metabolism. Energy for muscular contraction is predominantly 
obtained by the oxidative pathway, through the Krebs cycle which occurs in 
mitochondria. Acetate produced by the catabolism of carbohydrates and fatty acids, 
becomes a substrate in the Krebs cycle in the mitochondria to produce ATP and carbon 
dioxide is released as a by product. This process requires delivery of oxygen to the 
mitochondria and the simultaneous removal of carbon dioxide. la the cytosol, glycogen is 
metabolised to glucose, which becomes a substrate in the Embden Meyerhof (glycolytic) 
pathway to produce pyruvate and ATP. Pyruvate is converted to acetyl coenzyme A 
which in turn becomes a substrate for the Krebs cycle in mitochondria. Thu^ at low and 
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moderate work intensities, energy is predominantly obtained by oxidative metabolism in 
mitochondria. 
Under conditions of high intensity work, pyruvate produced from the glycolytic 
pathway is metabolised under anaerobic conditions to lactic acid. Although lactic acid in 
turn may be catabolised to release energy, in high concentrations, it may inhibit the non 
oxidative (glycolytic) pathway. Further, lactic acid production results in disturbances in 
intracellular acid base balance. As the conditions of high intensity work persists, oxygen 
delivery and carbon dioxide removal from the mitochondria is insufficient to maintain the 
Krebs oxidative pathway. The net gain in ATP from the reduction in pyruvate is only 3 
for each glycosyl unit compared to 37 obtained during the aerobic state [Cooper et al 
1986]. Thus, in the high intensity state, glycogen (and glucose) is used at a considerably 
faster rate than in lower intensity aerobic state. When glycogen stores are depleted, other 
muscle fibres need to be recruited. With long term exercise training however, glycogen 
stores in muscles can be increased [Cooper et al, 1986]. In summary, therefore, the 
oxidative and non oxidative pathways run concurrently to generate energy. The relative 
dependence of the muscle fibers on either pathway is determined by the intensity of the 
work being undertaken. 
Because of the invasive nature of the studies, there is limited longitudinal data 
regarding changes in muscle metabolism during growth and developing! Children at 1 
year of age have 60% of the adult level of muscle ATP and creatine phosphate (CP). 
These reach adult levels by 12 years of age [Eriksson et al 1973,1974; Haralambie, 
42 
1982] while muscle glycogen levels reach adult levels by the age of 15 or 16 years 
[Eriksson et al, 1974]. The activity level of phosphofructokinase reaches adult levels by 
13 to 15 years of age [Haralambie, 1982] and by puberty, the activity of succinate 
dehydrogenase enzyme reaches adult levels [Haralambie, 1982]. 
The pathophysiology of decreased exercise tolerance in patients with cystic 
fibrosis is unknown. Investigations of in vivo oxidative capacity in calf muscles 
[Thompson et al, 1993] and forearm muscles [Kutsuzawa et al, 1992] of patients with 
chronic obstructive pulmonary disease have demonstrated decreased oxidative capacity, 
increased intracellular acidosis and a depletion of creatine phosphate. The fibroblasts and 
leucocytes of patients with CF have demonstrated mitochondrial abnormalities with an 
increased calcium concentration [Shapiro, 1989], lower respiratory chain enzyme 
complex 1 activity [Dechecchi et al, 1988] and a higher pH optimum for respiratory 
chain enzymes [Shapiro et al, 1979]. De Meer et al [1995] have also demonstrated that 
patients with CF have intracellular acidosis. All of these findings are consistent with a 
decreased oxidative capacity in the skeletal muscles of patients with CF. 
Subjects with CF and who are pancreatic insufficient but without overt diabetes 
have been demonstrated to have significanly increased peripheral insulin sensitivity 
[Moran et al, 1994]. As insulin inhibits glycogenolysis [Boiteux and Hess, 1981] the 
acquisition of energy through skeletal muscle glycogenolysis may be reduced in this 
group of subjects. Skeletal muscle glycogenolysis is necessary for aerobic and anaerobic 
work and therefore, this may be a cause of exercise limitation in subjects with CF. 
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1.4.5 Summary 
• Cardiorespiratory responses to exercise in patients with CF have been extensively 
studied. Reduced exercise tolerance appears to be related primarily to the reduced 
ventilatory capacity associated with advanced disease, while cardiovascular responses 
' are generally normal. 
• Females with CF have a significantly lower peak oxygen consumption and peak work 
load compared to males of similar age. 
• Studies on muscle strength in patients with CF are confounded by methodologic 
problems and conflicting results. 
• The pathophysiology of decreased exercise tolerance in patients with CF is unknown 
although abnormalities in muscle metabolism may be a potential contributing factor. 
Preliminary evidence does suggest a decreased oxidative capacity in the skeletal 
muscles of patients with CF but further studies are required to confirm these findings. 
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1.5 Measures of physical activity in children 
1.5.1 Introduction 
Physical activity has been defined by Casperson [1989] as "any body movement 
produced by skeletal muscles that results in energy expenditure". As daily physical 
activity is a behaviour, it needs to be measured in the field setting. Berenson [1986] 
demonstrated that physical activity behaviour patterns develop in childhood. As physical 
activity is necessary to maintain aerobic fitness [Orenstein et al, 1993b] and 
psychological well being [Dunlevy et al, 1994] in patients with CF, it is clearly important 
to establish good physical activity behaviour patterns as early as possible in childhood. 
Measures of physical activity provide a great deal of important information about 
the impact of the disease including cardiorespiratory capacity and psychological well 
being of the patient with CF [Orenstein et al, 1993b]. Measures of physical activity can 
be an important outcome measure in interventional trials. Measures of physical activity 
are also useful when prescribing nutritional supplementation for patients with CF [Reilly 
etal, 1999a]. 
1.5.2 Measures of activity 
Direct Observation 
There are several direct observation protocols used to measure physical activity in 
children [Hovell et al, 1978; Epstein et al, 1984; O'Hara et al, 1989]. They differ from 
each other in the location where the children are observed and in the frequency of 
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observational sampling. The direct observation method has several limitations in that it is 
very labour intensive and the observer, by his or her very presence, may alter the 
behaviour of the children being observed. Further, as the observation time is usually short 
in comparison to the child's whole day, the direct observation method assumes that the 
child maintains their level of observed activity for the whole day. As these limitations are 
significant, Sallis et al, [1991] have recommended that the direct observation method not 
be used to estimate daily energy expenditure. 
Self Report Measures 
The most widely used assessment of physical activity is self reporting. Self report 
measures are convenient, inexpensive and can be used in large sample studies. Self report 
measures can be (a) interviewer administered recall where the interviewer asks specific 
questions of the child [Sallis et al, 1988], (b) self administered recall where the child 
recalls their own activities [Sallis et al, 1991], (c) activity diary where the child lists 
activities throughout the day [Bouchard, 1983], and (d) proxy report where the parent or 
teacher records the child's activity [Murphy et al, 1988; Klesges et al, 1990]. 
The reliability coefficients for the various self report measures differ considerably 
[Sallis et a/, 1991]. The Bouchard activity diary [Bouchard et al, 1983] and the seven day 
activity diary by Bratteby et al [1997], which is a modification of the Bouchard diary, 
have excellent validity. The seven day activity diary was compared with the gold 
standard of energy expenditure, doubly labelled water, and demonstrated to have an 
insignificant coefficient of variation [Bratteby et al, 1997].. 
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Mechanical Devices 
Pedometers monitor distance moved but are limited by individual variability in stride 
length and step rate. Nevertheless, Saris and Blinkhorst [1977] have demonstrated 
agreement between pedometer readings and observed activity among 4 to 6 year old 
children. Several activity monitors, or, accelerometers are currently available 
commercially. All detect acceleration and deceleration, but differ in the planes in which 
motion is detected. The Tritrac r&onitor detects motion in three planes but, the Caltrac 
monitor detects motion in only one plane. The limitation of the activity monitors is the 
inability to detect the intensity of work performed. The Caltrac motion detector has a 
interobserver reliability coefficient of 0.90 and a criterion validity coefficient (with direct 
observation as the criterion measure) of 0.57 [Klesges and Klesges, 1987]. When heart 
rate was used as the criterion measure, the coefficient of correlation was 0.49 [Sallis et 
al, 1990]. 
The WAM 7164 brand accelerometer is a small (5.1x 3.8x i.5cm), light (45g) 
uniaxial accelerometer. The accelerometer is designed to detect acceleration ranging in 
magnitude from 0.05 to 2.00 G with a frequency response from 0.25 to 2.5 Hz. Data can 
be collected over intervals of 1 second and the daily activity counts are recorded and 
downloaded when the device is returned for analysis. Janz [1995a, 1995b], Trost et al, 
[1998] and Freedson et al, [1998] have demonstrated excellent correlation between 
activity counts as measured by the accelerometer and energy expenditure during exercise 
testing. 
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Heart rate monitors allow physiological measurement of daily activity which has 
the advantage of being able to trace activity patterns over the monitored period. 
Livingstone et al [1992] reported that heart rate converted to energy expenditure using 
individually determined heart rate/ oxygen consumption regression equations differed 
from the energy expenditure obtained by doubly labelled water by between -16.9% and 
18.8%. Luke et al, [1997] simultaneously measured heart rate and motion (using an 
accelerometer) and compared the results with direct measure energy expenditure using 
gas analysis on a treadmilL These studies demonstrated an excellent correlation with 
between the combined modalities (heart rate and motion) and the measured energy 
expenditure. 
Orenstein et al, [1993b] compared two activity monitors (Large Scale Integrated 
monitor and Caltrac) and two activity questionnaires (Harvard Alumni Survey and 
Physical activity Survey) and have concluded that although there were good correlations 
between the activity monitors and questionnaires, the activity questionnaires captured 
different aspects of activity to the monitors. They have suggested that a combination of 
the two modalities may provide the best accuracy. 
Although- doubly labelled water has become the gold standard for assessing 
energy expenditure in free living subjects [Noland et al, 1990], the cost and demanding 
methodology involved is prohibitive for population studies [Bratteby et al, 1997], This 
method assesses the rate of carbon dioxide production based on the differences in the 
disappearance rates of 2H20 and I8H20 in urine samples over 14 days following the 
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1.3: Absolute energy expenditure as measured by heart rate monitoring and 
doubly labelled water. 
Heart rate monitoring denoted by open bars and doubly labelled water 
by crossed bars. 
Arrows depict World Health Organization estimates of energy intake 
requirements. 
Adapted from Livingstone et al, 1992. 
stable isotope dosing. The total energy expenditure is calculated from standard 
respiratory gas exchange equations [Coward, 1988]. The age related predicted normal 
values for total energy expenditure using heart rate monitors and the doubly labelled 
water method as well as the estimated daily energy intake requirements are shown in 
Figure 1.3. 
1.5.3 Energy Expenditure in Cystic Fibrosis 
The only two studies that have utilised doubly labelled water in patients with CF were 
performed in children under the age of two years [Shepherd et al, 1988] and in children 
between the ages of six and nine years [Tomeszko et al, 1994]. Shepherd et al [1988] 
demonstrated that children with CF, under the age of two years, had 25% higher total 
daily energy expenditure than healthy controls of the same age. The children with CF 
were clinically well without significant lung disease or malnutrition. Tomeszko et al, 
[1994] demonstrated that children with CF and mild lung disease, expended 12 % more 
total daily energy than healthy controls. The resting energy expenditure was 9% greater 
ill subjects with CF than healthy controls. In subgroup analysis using genotypes, children 
with CF who had a genotype of delta F 508 homozygous, expended 23% more total daily 
energy than healthy controls but, interestingly, had similar resting energy expenditure to 
children with CF of other genotypes. Tomezsko et al, [1994] concluded that the increased 
total energy expenditure in delta F508 homozygous children may be due to either 
increased physical activity in these children or, an unidentified genotype related 
mechanism. 
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Spicher et al, [1991] measured total energy expenditure using the heart rate 
method and demonstrated that adolescents with CF and mild lung disease had similar 
energy expenditure compared to healthy controls. Spicher et al, [1991] also demonstrated 
that the resting energy expenditure was significantly greater in children with CF 
compared to healthy controls and suggested that children with CF compensated for their 
increased resting energy expenditure by being less physically active during the day. This 
was not supported by Tomezsko's [1994] study where the "non resting" energy 
expenditure was increased. This difference in results may be due the intrinsic difficulties 
of converting heart rate to energy expenditure. Livingstone et al, [1992] demonstrated 
that when heart rates were used to predict energy expenditure, the results ranged from -
16.9% to +18.8% of the true energy value as obtained by doubly labelled water. 
Assuming the heart rate to energy expenditure formulae was accurate, another 
explanation for the difference in energy expenditure between the Spicher [1991] and 
Tomezsko [1994] studies is that the energy cost of activity may have been greater for the 
children in Spicher's study. The concept of increased energy cost for the same physical 
activity for patients with CF was first suggested by Grunow et al, [1993]. However, 
recent personal communication from Shepherd's laboratory [1999] suggest that the 
increased energy cost of activity only occurs in patients with severe disease. As the 
subjects in Spicher's study had mild disease, it is unlikely that the difference between the 
studies can be explained by increased energy cost alone. 
Several studies have been performed measuring the resting energy expenditure in 
patients with CF. Initially Vaisman et al [1987], and subsequently, Buchdahl et al [1988], 
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Girardet et al [1994], O'Rawe et al [1992] and Thomson et al 1996] have all used 
indirect calorimetry to measure resting energy expenditure. There is universal agreement 
that patients with CF have an increased resting energy expenditure compared to healthy 
controls. There is however controversy about the relationship between CF genotype and 
resting energy expenditure. O'Rawe et al [1992] demonstrated that subjects homozygous 
for delta F508 had a significantly greater resting energy expenditure than subjects who 
had a heterozygous genotype. Thomson et al [1996] demonstrated similar findings in 
clinically well children with CF under the age of 2 years. Fried et al, [1991] and 
Tomezsko et al [1994] however, found no significant difference between subjects who 
were homozygous and heterozygous for the delta F 508 gene. 
The doubly labelled water method measures total energy expenditure (resting 
energy and physical activity) and has not been validated in patients with CF who may 
have different metabolic demands than healthy subjects. There are no published data on 
physical activity levels of children with CF. This information is necessary to ascertain 
both the impact of the disease on the child and to make nutritional recommendations. 
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1.5.4 Summary 
• Measures of physical activity can provide important information about the impact of 
disease in patients with CF. 
• Physical activity may be measured by 
• Direct observation" 
• Self report measures including diaries 
• Mechanical devices such as pedometers or accelerometers 
• Heart rate monitors 
• Assessment of energy expenditure by doubly labelled water 
• The currently available information on physical activity levels in patients with CF is 
based on studies extrapolating results from measurements of total energy expenditure 
and resting energy expenditure. 
• Measures of physical activity, such as a seven day activity diary or an accelerometer, 
both of which have been validated against measures of total energy expenditure in 
healthy children have the potenial to be simpler tools for assessing activity levels in 
CF patients. 
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1.6 Exercise training programs in Cystic Fibrosis 
1.6.1 Introduction 
Lung function and exercise tolerance are maintained in patients with mild Cystic 
Fibrosis, but deteriorate as the disease progresses [Cropp et al, 1982]. Patients with high 
levels of aerobic fitness iiave a much better long term survival than those with lower 
levels of fitness [Nixon et al, 1992]. Exercise training programs aim to preserve and 
improve aerobic fitness and are recognised as essential components of pulmonary 
rehabilitation [Lacasse et al, 1996]. 
Exercise training programs have been studied extensively in adults with CF 
[O'Neill et al, 1987; Heyerman et al, 1991; De Jong et al, 1994]. There are, however, 
only a limited number of studies performed in children with CF and all were performed 
in the outpatient setting and had small sample sizes [Orenstein et al, 1981; Zach et al, 
1982; Edlund et al, 1986; Andreasson et al, 1987; Gulmans et al, 1999]. A survey of CF 
referral centers by Kaplan et al [1991] demonstrated that only 21 % of the centers offer 
exercise programs for their patients although almost all the centers recommend exercise. 
There are no previous studies on the effect of training programs in children 
admitted to hospital with an intercurrent pulmonary exacerbation. Neither are there are 
any previous studies, on the effect of resistance framing in children with cystic fibrosis. 
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1.6.2 Aerobic training programs 
Oreastein et al [1981] compared the effect of a three month outpatient training program 
with no training in young adult patients with CF. The training program consisted of 
running for 30 rninutes per session, three sessions per week, at a speed that produced a 
heart rate of between 70 and 85% of peak maximal heart rate as determined by an initial 
exercise test. The results of the study demonstrated that after three months of training, the 
exercise group had a significant improvement in peak work capacity and maximal oxygen 
uptake when tested using a cycle ergometer. Respiratory muscle endurance also increased 
significantly in the exercise group. The control group had no significant changes with any 
of these parameters of assessment. Forced expiratory volume in one second was 
unchanged in the exercise group but decreased in the control group after the three month 
period of the study. The exercise group also had significantly lower heart rates for 
submaximal work loads than the control group. The investigators concluded that aerobic 
training programs are beneficial for patients with CF and Braggion et al, [1989] 
demonstrated similar benefits from providing aerobic (running) training for patients with 
CF. 
Holzer et al [1984] studied the effect of an unsupervised home exercise training 
program in children with CF. The training program consisted of running and push ups for 
30 rninutes per day for three months. There was a significant improvement in peak 
oxygen uptake after the training program. However, the improvements in peak work 
capacity, pulmonary function tests, and respiratory muscle strength were too modest to 
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reach statistical significance. Holzer et al [1984] suggested that poor compliance may 
have accounted for the equivocal benefit demonstrated. 
Blau et al [1991] demonstrated that adult CF patients, who underwent a daily four 
hour mountain climb for a period of 4 weeks, had significant improvements in maximal 
oxygen uptake, peak work capacity, oxygen pulse and anaerobic threshold. However, 
there were no significant changes to the pulmonary function tests after the training 
program. Similar results were obtained by Stranghelle et al [1988] who assessed fee 
benefit of an eight week trampoline exercise program in children with CF. Notably, the 
pulmonary function tests were unchanged after the training program. 
Andreasson et al [1987] enrolled patients with CF in a thirty month outpatient 
aerobic training program consisting of thirty minutes a day of trampolining, jogging and 
rope skipping. Although there was no significant change in peak work capacity when 
measured using a cycle ergometer, there were significant improvements in the functional 
residual capacity (FRC) and residual volume (RV) on pulmonary function testing. 
Keens [1994] and De Jong et al [1994] demonstrated that a 12 week home bicycle 
« w i s e program in adult patients with moderately severe disease produced significant 
improvements in peak work capacity, maximal oxygen uptake, maximal m t a t e 
ventilation and peak heart Tate. As with other aerobic training programs, there were no 
changes in pulmonary function tests. 
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Heijerman et al [1991] evaluated the effects of an exercise training program in 
patients with advanced lung disease. All the patients in the study were hypoxic at rest and 
required supplemental oxygen therapy during the training program. The training program 
was performed under supervision and consisted of 20 minutes of bicycling per session at 
75% of the individual's maximal power. The mean duration of the training program was 
5.4 weeks. Exercise testing of the patients after the training program revealed 
improvement in peak work capacity, maximal oxygen uptake and oxygen pulse. FEVi 
had improved by 5 % when pulmonary function testing was performed. The benefits of 
the training program were still apparent when the patient® were followed up one year 
later [Heijerman et al, 1992]. 
A seven week swimming training program for patients with CF by Zach et al, 
[1981] resulted in significant improvements in FVC, FEVi, and mid maximal expiratory 
flow rate (MMEFR) but these improvements were not maintained when remeasured 10 
weeks after the training program. Edlund et al [1986] compared children with CF who 
participated in a twelve- week swimming training program with children with CF who 
engaged in routine activities. After the training program, there was no significant 
improvement in pulmonary function, however, exercise endurance time, when assessed 
using a treadmill exercise test, improved significantly in the exercise group compared to 
the controls. The improvement in peak oxygen uptake in the exercise group was not 
significant when compared to the control group. Zach et al [1982] studied changes in 
pulmonary function after regular inhalation and chest physiotherapy was replaced by a 
swimming and running program over a 17-day period. The study demonstrated 
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significant improvements in pulmonary function that returned to the pre program levels 
after eight weeks. Zach et al [1982] concluded that regular physical exercise was an 
adequate replacement for conventional inhalation -chest physiotherapy routines. 
1.6.3 Resistance training 
Strauss et al [1987] demonstrated that residual volume and its ratio to total lung capacity 
decreased in adult patients with CF who participated in a six-month weight training 
program. There was no significant improvement in FEVi and MMEFR. The total body 
weight of the subjects as well as the muscle strength improved significantly. There are no 
previous studies on the effect of resistance training in children with CF. 
Strength training has been demonstrated to promote muscle growth and strength 
in healthy subjects [Frontera et al, 1988]. In addition to improving peripheral muscle 
function [Lands et al, 1993], strength training may enhance exercise tolerance in patients 
with CF. Stronger quadriceps femoris muscles may reduce the perception of muscle 
fatigue which is a common limiting symptom in patients with chronic obstructive 
pulmonary disease (COPD) [Killian et al, 1992; Hamilton et al, 1995]. Patients with CF 
may likewise have similar benefit from stronger quadriceps femoris muscles. 
Bernard et al [1999] demonstrated that the addition of strength training to aerobic 
training in patients with COPD was associated with significantly greater increases in 
muscle strength and mass than aerobic training alone. However, there was no additional 
improvement in exercise capacity. Likewise, strength training may represent a useful 
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addition to aerobic training in patients with CF, however, this patient group has not been 
studied. Skeletal muscle oxidative capacity, another potential factor involved in exercise 
intolerance,, has been demonstrated to increase significantly in patients with COPD with 
strength training [Frontera et al, 1990]. 
The effect of ventilatory muscle training programs is unclear with conflicting 
results obtained in previous studies. Keens et al [1977] demonstrated that the 
improvement in the ventilatory muscle capacity of patients with CF was twice that in 
control subjects after a four week ventilatory muscle training program. There was 
however, no significant improvement in pulmonary function. Asher et al [1982] 
demonstrated similar results after ventilatory muscle training. However, Sawyer and 
Clanton [1993] found that a ten week program resulted in significant improvements in 
FRC, TLC and exercise tolerance. 
1.6.4 The effect of hospital therapy 
Several studies have evaluated the effectiveness of Inpatient treatment of an acute 
pulmonary exacerbation on exercise tolerance. Patients treated with intravenous 
antibiotics and chest physiotherapy had significant improvements in pulmonary function, 
peak work capacity and maximal oxygen uptake [Cerny et al, 1984]. Alison et al [1994] 
demonstrated that patients with CF who were admitted to hospital with an acute 
pulmonary exacerbation for a 10 to 14 day period, had a 7% improvement in peak work 
capacity and a 7.1 minute improvement in peripheral-muscle endurance time. The 
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patients in this study received standard chest physiotherapy consisting of postural 
drainage, percussion and vibrations followed by forced expiratory technique. None of the 
subjects participated in an exercise training program. Alison et al [1994] and Michel et 
al, [1989] also demonstrated an improvement in lean body mass after hospital therapy. 
Rachinsky et al [1990] demonstrated that adult patients with CF, admitted to 
hospital with an acute pulmonary exacerbation, benefit from an in-hospital exercise 
training program. However, as there was no control group, it was unclear if the 
improvements were due to the routine hospital therapy or to the training program. There 
are no reports of in hospital training programs during acute pulmonary exacerbation 
where patients who received a training program were compared with a control group. 
Furthermore, the effect of training programs on the quality of life in patients with CF has 
not been reported. 
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1.6.5 Summary 
• The commonly used exercise training programs are aerobic training and resistance 
training. 
• Although exercise training programs have been extensively studied in adult patients 
with CF, the only paediatric studies have been performed in the non supervised, 
outpatient setting and were limited by small sample sizes' and concerns about 
compliance. 
• The results of these outpatient training programs have demonstrated variable benefit 
in terms of lung function. 
• The effect of supervised training programs while in hospital during an acute 
pulmonary exacerbation has not previously been evaluated in comparison to routine 
in hospital therapy alone. 
• There is also no published information on the effect of resistance training in children 
withCF. 
61 
CHAPTER 2 
Aims 
The overall aim of this thesis was to address deficiencies in the understanding of the role 
of exercise and exercise testing in the management of children with Cystic Fibrosis. It 
also examined how the disease may impact on the ability of the child to exercise. The 
specific aims of the studies may be grouped into three principal areas: 
1. To assess the impact of Cystic Fibrosis on the ability of children to exercise. In order 
to accomplish this aim, four studies were performed with the specific aims of: 
a) Comparing physical activity levels in children with Cystic Fibrosis with those 
in healthy controls, and relating activity levels to aerobic capacity, lung 
function and quality of life in the children with CF. 
b) Assessing the relationship between fitness and genotype in children with 
Cystic Fibrosis. 
c) Investigating previously demonstrated gender differences in execrise ability in 
children with CF by, 
i) Comparing resting energy expenditure and activity levels in girls 
with mild Cystic Fibrosis and normal lung function with those in 
healthy, matched controls. 
ii) Comparing muscle metabolism in girls with mild cystic fibrosis 
and normal lung function with that in healthy, matched controls. 
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2. To understand the role of exercise testing in the management of children with Cystic 
Fibrosis by: 
a) Comparing changes in lung function with measures of fitness in 
hospitalised children with Cystic Fibrosis. 
b) Assessing the validity of a field test of peak aerobic capacity (shuttle test) 
in children with Cystic Fibrosis. 
3. To determine the optimal exercise program for children admitted to hospital with an 
intercurrent pulmonary exacerbation by performing a randomised controlled study 
comparing aerobic training and resistance training and a non trained control group. 
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Chapter 3 
Methods 
3.1 Overview 
This chapter provides a detailed examination of the various techniques used for studies 
presented in the remainder of this thesis. The techniques were all selected on the basis of 
their reliability and suitability for use in children. The peak aerobic capacity and 
anaerobic power of subjects were measured in many of the studies in this thesis, 
employing standard protocols which are presented in detail in this chapter. To assess the 
subjective response to exercise, a rating of perceived exertion scale (Borg score) was 
used. This is the only validated subjective index of exertion and details of this scale are 
presented in this chapter. The gold standard of measuring energy expenditure is a method 
Utilising double labeled water [Noland et al, 1990]. However, this method is expensive to 
administer and is not readily available. In this thesis, physical activity was measured 
using an activity diary, which has been demonstrated to have an excellent correlation 
with doubly labeled water; an activity questionnaire; and activity accelerometers. These 
methods of measuring physical activity are non- invasive, easy and inexpensive to 
administer and have been demonstrated to be valid. To determine the optimal exercise 
program to use in children admitted to hospital with a pulmonary exacerbation, a study 
comparing aerobic Ixaining, resistance training, and a control group was performed. 
Details of the exercise programmes are presented in mis chapter. 
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3.2 Measures of Fitness 
The parameter most commonly assessed when gauging a child's fitness is aerobic fitness. 
Other measures of fitness, which are less frequently used in children, include anaerobic 
power and muscle strength. Aerobic fitness, anaerobic performance and muscle strength 
each measure different aspects of fitness. 
3.2.1 Peak Aerobic Capacity 
To assess peak aerobic capacity, subjects performed an incremental treadmill exercise 
test using the modified Bruce protocol [Bruce, 1971], which was chosen because unlike 
the other available protocols, the increments in intensity between the stages were gradual 
and therefore, appropriate for children with CF. Specific details of the modified Bruce 
protocol are presented in Table 3.1. Children recruited into the studies were instructed to 
wear appropriate foot wear and clothing. Short acting bronchodilators were withheld for 
12 hours prior to testing. The studies were all performed in an air conditioned respiratory 
function laboratory maintained at 21 degrees Celsius. The treadmill used for the studies 
performed in this thesis was the Cardiovit 100 (Schiller, Switzerland). The treadmill had 
an in built polargraphic gas analyzer which performed breath by breath gas analysis. The 
gas analyzer was calibrated prior to each exercise test as recommended by the American 
Thoracic Society [Clausen et al, 1997]. Minute ventilation (Ve), oxygen uptake (VO2), 
carbon dioxide production (VCO2) and respiratory quotients (RQ) were recorded 
continuously during the exercise test. Pulse oximetry, via a finger probe (Biox 3700e, 
Ohmeda, Boulder, CO USA) and heart rate and electrocardiogram (12 lead) were also 
performed continuously during the exercise test. The exercise test was terminated when 
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the subject reached exhaustion, or if stage 9 of the modified Bruce protocol was 
completed. Measurements were completed when the heart rate and pulse oximetry of the 
subjects returned to the resting value (+/- 5 beats per minute and oxygen saturation +/- 1 
%, respectively). 
Table 3.1 The modified Bruce protocol 
Stage 
1 
2 
3 
4 
5 
6 
7 
8 
9 
Duration (minutes) 
3 
-> 3 
3 
3 
3 
3 
3 
3 
3 
Speed (km/h) 
1.9 
1.9 
2.7 
4.0 
5.5 
6.8 
8.0 
8.8 
9.7 
Grade (%) 
0 
5 
10 
12 
14 
16 
18 
20 
22 
3.2.2 Anaerobic power 
Anaerobic power was measured by the Wingate test [Ayalon et al, 1974], using an 
electronically braked cycle ergometer (Lode Ergometer, Pro Med, Canada). The 
advantage the electronically braked cycle ergometer has over other mechanically braked 
cycle ergometers is that the force exerted on the pedals is measured instantaneously. This 
enables the cycle ergometer to be programmed to deliver either constant resistance, or, to 
alter the resistance in response to the subject's exerted force to" maximise the power 
output. All subjects who performed the Wingate test had a warm up period followed by 
the formal test. The warm up period consisted of the cycle ergometer being programmed 
to deliver a resistance of 0.6 or 0,7 watts per kilogram body weight for girls and boys, 
respectively. The subjects were encouraged to keep the speed at 100 revolutions per 
minute for 3 minutes. Pulse oximetry and heart rate, via a finger probe (Biox 3700e, 
Ohmeda, Boulder, CO USA) was monitored during the test. The test consisted of the 
subject pedaling as forcefully and fast as possible for 30 seconds. The electronic sensors 
in the pedals, would alter the ergometer resistance during the course of the test to 
maximise the subject's power output. At the completion of the study, the subject would 
continue cycling until heart rate returned to within 5 beats per minute of the resting value. 
The software provided by the manufacturer recorded the peak power output reached and 
the mean power output over the 30 second test. 
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3.2.3 Muscle strength 
Leg strength was measured using an isokinetic Cybex dynamometer (Lumex Inc, 
Ronkonkoma, NY). The strength tests were performed on the same day as the exercise 
tests. The muscles tested were the quadriceps femoris and the hamstrings of the n&Ur 
dominant leg. With the child comfortably seated, the limb to be tested was fixed securely 
to the dynamometer lever arm and the child was then instructed to exert maximum force 
against the lever arm. The same action was repeated after a three minute rest. The best of 
three repetitions was recorded as the strength of the tested muscle group. The maximal 
strength (measured in standard units, Newton meters) was recorded by the software 
provided by the manufacturer. The isokinetic dynamometer precisely matches the force 
applied by the subject and prohibits acceleration (hence the term isokinetic). This enables 
strength to be measured through a full range of motion at a constant velocity. The 
advantage of this method of strength testing is that short bursts of force, that are not 
maintained for the full range of motion of that muscle group, are not recorded and hence, 
cannot give a falsely high reading. 
3.3 Field tests: 10m and 20 m shuttle tests 
Shuttle tests require the child to walk (10m test) or, run (20m test), between two markers 
delineating the respective course, at a set incremental speed determined by a computer 
generated signal which was played by a standard audio cassette player. The test was 
terminated when the subject was unable to keep up with the paced signals. 
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The shuttle tests were performed with the subject wearing a firmly fitted facemask 
attached to the Cardiovit 100 Module (Schiller, Switzerland) which has an in-built gas 
analyzer allowing breath by breath gas analysis throughout the test. The gas analyzer was 
calibrated prior to each exercise test as recommended by the American Thoracic Society 
[Clausen et al, 1997]. Minute ventilation (Ve), oxygen uptake (V02), carbon dioxide 
production (VCO2) and respiratory quotients (RQ) were recorded continuously during the 
exercise test. The subject's heart rate was measured at rest and then continuously during 
testing using a heart rate monitor (Cardiosport, Australia). Pulse oximetry was measured 
via a finger probe (Biox 3700e, Ohmeda, Boulder, CO USA) throughout the test. The 
velocity for the 10m shuttle test is set at 1.8 km/hr for the first minute and increased by 
0.61 km/hr for every minute thereafter. The velocity for the 20m shuttle test is set at 
8km/h for the first minute and increased by 0.5km/h for every minute thereafter. 
3.4 Responses to exercise 
The methods used to assess the response to exercise by breath by breath gas analysis, 
oxygen saturation, and heart rate have been presented in the previous sections. In 
addition, a subjective measure of exertion, the validated Rating of Perceived Exertion 
scale, orBorg score [Borg, 1982] and the effects of exercise on muscle metabolism were 
also used to assess the response to exercise. These techniques are presented here. 
3.4.1 Rating of Perceived Exertion scale (Borg score) 
A psychophysical scale for measurement of the intensity of exercise has been developed 
by Borg [1982] and was used in these studies. The intensity of the exercise is linked to a 
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scale of numbers from zero (no sense of effort) to ten (maximal effort) and is presented in 
Table 3.2. Bie scale is visible to the subjects throughout exercise tests and the 
investigator records the subject's score at the conclusion of every minute of exercise. 
Table 3.2: The Rating of Perceived Exertion (Borg score) 
0 Nothing at all 
0.5 Very, very slight 
1 Very slight 
2 Slight 
3 Moderate 
4 Somewhat severe 
5 Severe 
6 Between severe and very severe 
7 Very severe 
8 Between very severe and extremely severe 
9 Extremely severe 
10 Maximal 
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3.4.2 Magnetic Resonance Spectroscopy (31- Phosphorous) 
Lean body mass was calculated using skinfold thickness and the equations provided by 
Durnin and Rahaman [1967] as shown below. Height was measured by a Harpenden 
stadiometer and weight by electronic scales. The subject then rested in a prone position 
for 10 minutes fi&the MR spectroscope, 31- Phosphorous (1.5 Tesla NMR Spectrometer, 
Philips SI5 HP) while resting data were obtained. The subjects' leg was secured at the 
waist, hips and two thirds of the distance from the anterior superior iliac crest and the 
medial condyle of the knee using straps. The subjects were then asked to exert maximal 
force for 2 seconds against a purpose- designed balloon by flexing the knee, followed by 
a 1 second rest period while lying prone in the MR spectroscope. The exercise was 
repeated until exhaustion, as determined by the Borg score [Borg, 1982]. A computerised 
audio-visual metronome, designed specifically for the study, guided the subject through 
each phase of the exercise. The force output exerted on the balloon for each contraction 
was measured using a calibrated pressure transducer (Vacumed, Ventura, CA) and total 
work (cumulative force output) was calculated for the complete exercise protocol in the 
spectroscope. The same exercise protocol was repeated three times for each subject but 
using a Cybex dynamometer (Lumex Inc, Ronkonkoma, NY) to assess the reproducibility 
of the total work output during the exercise protocol. Measurements of inorganic 
phosphorous (Pi), phosphocreatine (PCr) and intracellular pH were taken from the vastus 
lateralis muscle of the non dominant leg throughout the exercise. Comparison of the data 
from subjects with CF and healthy controls were made at rest, 25%, 50%, 75% and 100% 
of maximal work output. 
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3.5 Measures of physical activity 
3.5.1 New South Wales Schools Physical Fitness Assessment (NSW SPFA) 
This self reported fitness questionnaire estimates activity levels on the basis of the type, 
duration and frequency a child participates sport during the course of a school week and 
has been validated by Booth et al, [1998]. Both organised and informal sports are 
recorded. A compendium of the energy costs of several activities and sports, expressed in 
units of "mets" has previously been reported [Ainsworth et al, 1993]. A unit of met is 
defined as the oxygen consumption at rest and is equal to 3.5ml/ kg/ min. A sport with an 
energy cost of 5 mets will be of significantly greater intensity than a sport with an energy 
cost of 2 mets. The NSW SPFA uses the met value of the sports a child participates in to 
estimate the total weekly energy cost. As only the sports the child participates in are 
accounted for, activities of daily living are not included in the estimates of total energy 
utilistion. In the studies on activity levels performed in this thesis, subjects were 
requested to complete the NSW SPFA for the same days they completed the modified 
activity diary and wore the accelerometer. 
3.5.2 Activity diary 
The activity diary used in this thesi$ is a modification of the activity diary initially 
described by Bouchard et al [1983]. The modified activity diary has excellent correlation 
with the doubly labeled water method [Noland et al, 1990], which is the accepted gold 
standard in assessing total energy expenditure [Bratteby et al, 1997]. Subjects are asked 
to record the dominant activity of each fifteen minute period of the day and night on three 
week days and one weekend day in one week and the other two week days and the 
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alternative weekend day of the following week. Thus, a total of seven days over a two 
week period are recorded. The compendium of the energy costs of activities and sports, 
[Ainsworth et al, 1993] is used to estimate total energy utilisation for the seven days. In 
the studies on activity levels performed in this thesis, subjects were requested to complete 
the modified activity diary for the same days they completed the NSW SPFA and wore 
the accelerometer. 
3.5.3 Accelerometer 
The WAM 7164 brand accelerometer (Computer Science and Applications, Shalimar, 
Florida) is a small (5.1x 3.8x 1.5cm), light (45g) uniaxial accelerometer, worn on the hip. 
The accelerometer is designed to detect acceleration ranging in magnitude from 0.05 to 
2.00 G with a frequency response from 0.25 to 2.5 Hz. Data can be collected over 
intervals of 1 second and the daily activity counts are recorded and downloaded when the 
device is returned for analysis. Trost et al, [1998] and Freedson et al, [1998] have 
demonstrated excellent correlation between activity counts as measured by the 
accelerometer and energy expenditure during exercise testing. In studies in this thesis, 
subjects wore WAM 7164 accelerometer on their hips continuously on the days the 
activity diary was completed. Therefore, they wore it for three week days and one 
weekend day in one week and the other two week days and the alternative weekend day 
of the following week. Data were collected over intervals of 1 second and the daily 
activity counts were recorded and downloaded when the device was returned. The 
activity counts were converted to energy expenditure by the software provided by 
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Computer Science and Applications (Shalimar, Florida) based on prediction equations 
presented by Freedson et a!, [1998]. 
3.6 Exercise training 
3.6.1 Aerobic Training 
Children randomised to the aerobic training group participated in aerobic activities for 
five sessions each of thirty minutes duration per week. The aerobic activities comprised 
running on a non-motorised treadmill, or cycling on a stationary cycle at a speed that 
maintained the heart rate at seventy percent of the peak heart rate for thirty minutes. 
Subsequent to the exercise test performed on admission where expired gas analysis was 
performed, each subject performed a maximal exercise test (non motorised treadmill or 
cycle, without gas analysis), every five days to determine the individual's peak heart rate. 
The peak heart rate from the most recent exercise test was used to determine the target 
heart rate (70% of peak heart rate) for the training program. A portable pulse oximeter, 
(Biox 3700, Ohmeda, CO, USA) with a finger probe was used during training. If 
necessary, supplemental oxygen was administered to maintain an oxygen saturation of at 
least 90% as has previously been recommended [Heyerman et al, 1991]. The training was 
terminated earlier than the mandatory thirty minutes if the modified Borg score reached 
seven. Each training session was supervised by physiotherapists. 
3.6.2 Resistance Training 
Resistance training consisted of both upper and lower limb exercises against a non-
isokinetjte resistance machine which has an in-built graded incremental resistance dial 
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(Tidro-powers Keylink, Adelaide, South Australia). The subjects would increase the 
resistance on the machine to the maximal subjective resistance at the commencement of 
each training session and a value of 70% of that value was then used for that training 
session. The subjects were blinded to the resistance dial of the machine. At the chosen 
level of resistance, the subject performed five sets often repetitions. The procedure was 
repeated for both arms and legs. Subjects attended five sessions per week and were 
supervised by physiotherapists. 
3.7 Measures of CF disease status 
3.7.1 Shwachman Score 
This is a widely used clinico- radiological measure of disease severity in patients with CF 
[Shwachman and Kulczycki, 1958]. General activity, physical examination, nutritional 
status and chest radiograph are each assessed out of a 25 point scale and the final score is 
the sum of the four categories. A score of greater than 80 is consistent with a good 
clinical state whereas a score of less than 50 is consistent with severe disease. A summary 
of the Shwachman score is presented in Table 3.3. 
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Table 3.3 Shwachman score 
Points 
25 
20 
15 
10 
5 
General activity 
Full normal 
' activity 
Tires at end of 
day. Good school 
attendance. 
May rest 
voluntarily during 
day. Tires easily 
Home teacher, 
Dyspnoeic after 
short walk. Rests 
a great deal. 
Orthopneic. 
Confined to bed 
or chair. 
Physical 
examination 
Normal; no 
cough; clear lungs 
Resting 
respiration normal 
rare coughing. No 
clubbing. Clear 
lungs. 
Occasional cough. 
Respirations 
slightly elevated. 
Coarse breath 
sounds. Early 
clubbing. 
Frequent cough. 
Usually 
productive. 
Clubbing 2 to 3 +. 
Moderate 
emphysema. 
Rales present. 
Severe coughing 
spells. May have 
right heart failure. 
Clubbing 3 to 4-h 
Nutrition 
Weight and height 
above the 25th 
percentile 
Weight and height 
15 to 20th 
percentile 
Weight and height 
above 3rd 
percentile. 
Weight and height 
below 3rd 
percentile. 
Marked 
malnutrition. 
X ray findings 
Clear tang fields 
Minimal 
accentuation of 
bronchovascuiar 
markings. Early 
emphysema. 
Mild emphysema, 
patchy atelectasis. 
Increased 
bronchovascuiar 
markings. 
Moderate 
emphysema. 
Widespread 
atelectasis with 
minimal 
bronchiectasis. 
Extensive 
changes, marked 
bronchiectasis, 
lobar atelectasis 
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3.7.2 Quality of well being assessment 
To assess quality of life in the studies performed in this thesis, a quality of well being 
scale was used [Kaplan et al 1989]. The quality of well being scale has been validated in 
subjects with CF [Orenstein et al, 1989] and measures quality of life using four scales: 
mobility, physical activity, social activity and a symptom scale. Mobility and social 
activity are each divided into five graded levels and physical activity is divided into four 
graded levels (Table 3.4). Each of the twenty- three distinct symptom levels are assigned 
a score. The quality of well being scale is obtained by the formula: 
Quality of well being scale =1+ (Symptom score) + (Mobility score) + (Physical 
Activity score) + (Social activity score) 
The scale ranges from 0.0 (dead) to 1.0 (optimal function). The quality of well being 
scale was administered to the patients themselves if they were older than 14 years, the 
patients and a parent if the patients were aged 10 to 14 years, and the parent if the patient 
was younger than 10 years of age. The administration of each assessment took about 15 
minutes. 
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Table 3.4 Quality of well being Scale [Kaplan et al 1989] 
Mobility Scale Score 
TJ No limitations for health reasons -0.000 
4 Did not drive a car, health related; did not ride in a car as usual for age -0.062 
(younger than 15 years), health related; and/or did not use public 
transportation, health related; or had or would have used more help than 
usual for age to use public transportation, health related 
2 fehospital, health related -0.090 
Physical Activity Scale Score 
~4 No limitations for health reasons -0.000 
3 In wheelchair, moved or controlled movement of wheelchair without help -0.060 
from someone else; or had trouble or did not try to lift, stoop, bend over, 
or use stairs or inclines, health related; and/or limped, used a cane, 
crutches, or walker, health related; and/or had any other physical 
limitation in walking or did not try to walk as far or as fast as others the 
same age are able, health related 
1 In wheelchair, did not move or control the movement of wheelchair -0.077 
without help from someone else; or in bed, chair or couch for most or all 
of the day, health related 
Social Activity Scale Score 
5 No limitations for health reasons -0.000 
4 Limited in other {e.g. recreational) role activity, health related -0.061 
3 Limited in major (primary) role activity, health related -0.061 
2 Performed no major role activity, health related, but did perform self-care -0.061 
activities 
1 Performed no major role activity, health related, and did not perform or -0.106 
had more help than usual in performance of one or more self-care 
activities, health related 
Symptom/ problem scale Score 
1 Death (not on respondent's card) -0.727 
Loss of consciousness such as seizure (fits), fainting, or coma (out cold or -0.407 
knocked out) 
3 Burn over large areas of face, body, arms, or legs -0.387 
4 Pain, bleeding, itching, or discharge (drainage) from sexual organs - does -0.349 
not include normal menstrual (monthly) bleeding 
5 Trouble learning, remembering, or thinking clearly -0.340 
6 Any combination of one or more hands, feet, arms, or legs either missing, -0.333 
deformed (crooked) paralysed (unable to move), or broken — includes 
wearing artificial limbs or braces 
Pain, stiffness, weakness, numbness, or other discomfort in chest, -0.299 
stomach (including hernia or rupture), side, neck, back, hips, or any joints 
or hands, feet arms, or legs 
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8 Pain, burning, bleeding, itching, or other difficulty with rectum, bowel -0.292 
movements, or urination (passing water) 
9 Sick or upset stomach, vomiting or loose bowel -0.290 
10 General tiredness, weakness* or weight loss -0.259 
11 Cough, wheezing, or shortness of breath with or without fever, chills, or -0.257 
aching all over 
12 Spells of feeling upset, being depressed, or of crying -0.257 
13 Headache, or dizziness, or ringing in ears, or spells of feeling hot, or -0.244 
nervous, or shaky 
14 Burning or itching rash on large areas of face? body, arms or legs -0.240 
15 Trouble talking, such as lisp, stuttering, hoarseness, or being unable to -0.237 
speak 
16 Pain or discomfort in one or both eyes (such as burning or itching) or any -0.230 
trouble seeing after correction 
17 Overweight for age and height or skin defect of face, body, arms, or legs, -0.188 
such as scars, pimples, warts, bruises, or changes in colour 
18 Pain in ear, tooth, jaw, throat, lips, tongue; several missing or crooked -0.170 
permanent teeth — includes wearing bridges or false teeth; stuffy, runny 
nose; or any trouble hearing - includes wearing a hearing aid 
19 Taking medication or staying on a prescribed diet for health reasons -0.144 
20 Eyeglasses or contact lenses -0.101 
21 Breathing smog or unpleasant air -0.101 
22 No symptoms or problem (not on respondent's card) -0.000 
23 Standard symptom/problem -0.257 
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3.7.3 Nutritional Parameters 
Anthropometry is considered the most useful tool for assessing the nutritional status of 
children. The most commonly used anthropometric measurements are weight and height. 
f jp heights of the subjects were obtained using a stadiometer. The subjects were 
requested to stand with their heels against the base of the stadiometer and to take a deep 
inspiration, followed by expiration. The height was then taken. The bare weight of the 
subjects was taken using electronic weight scales. The anthropometric data were related 
to standard growth charts [World Health Organisation, 1986]. The anthropometric data in 
the studies in this thesis were interpreted by relating it a) to its position within the 
percentile distribution of the reference values; b) to reference values as a standard 
deviation score (Z score); and/ or c) by deriving the body mass index (BMI) from the 
subjects' weight and height (Weight/ heighr). The lean body mass of subjects was 
estimated using skinfold thickness using Harpenden skinfold calipers (Hans Rudolph, 
Inc. Kansas City, USA). The sum of skinfold thickness from four sites (biceps, triceps, 
subscapuar and suprailiac) was used in prediction equations [Durnin and Rahaman, 1967] 
to estimate body fat. The relationship between skinfold thickness and percent body fat is 
presented in Table 3.5. 
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Table 3.5 Proportion of fat in children (based on sum of measurements of skinfold 
in 4 locations: biceps, triceps, subscapular, suprailiac). [Durnin and Rahaman, 
1967] 
Sum of skinfold thickness values 
15mm 
20 mm 
25 mm 
30 mm 
35 mm 
40 mm 
45 mm 
50 mm 
55 mm 
60 mm 
65 mm 
70 mm 
75 mm 
Boys Girls 
Fat as a percent of total body mass 
9.0 
12.5 
153 
17.5 
19.5 
21.5 
23.0 
24.0 
25.5 
26.5 
27.5 
28.5 
29.5 
12.5 
16.0 
19.0 
21.5 
23.5 
25.0 
27.0 
28.5 
29.5 
30.5 
32.0 
33.0 
34.0 
3.7-4 Pulmonary function tests 
Pulmonary function measurements included forced expiratory volume in one second 
(FEVi) and forced vital capacity (FVC) using a spirometer (Sensormedics 2000, Yorba 
Linda, CA) and residual volume (RV) and total lung capacity (TLC) using a body 
plethysmograph (Sensormedics 2800 Autobox, Yorba Linda, CA). The calibration and 
performance of pulmonary function tests complied with American Thoracic Society 
Guidelines [1994]. The forced expiratory manoeuver was performed in the sitting 
posture with the head in a neutral position. Nose clips were worn by the subjects during 
the test. The test procedure was performed three times and the adequacy of performance 
was judged by monitoring the expiratory flow- volume relationship. If the three maximal 
expiratory flow volume curves appeared similar in configuration and matched within 5 
per cent in terms of vital capacity (VC), the test was deemed to be reproducible and 
values analysed according to the reference range presented by Polgar [1971]. 
3.7.5 Resting energy expenditure 
Resting energy expenditure was measured by open circuit, flow through ventilated hood 
indirect calorimeter with a computerized metabolic cart (Sensormedics 2900 Z, Yorba • 
Linda, CA). The metabolic cart has an inbuilt polargraphic gas analyser which measures 
oxygen and carbon dioxide production. The subjects all had their lean body mass 
calculated using skinfold thickness and the equations provided by Durnin and Rahaman 
[1967]. The subjects were requested to lie down on a bed with the ventilated hood 
placed over their head for 30 rninutes. If they so desired, the subjects could listen to 
music through headphones. All subjects fasted overnight for twelve hours before testing 
and medications were withheld during the twelve hour fast. The equations developed by 
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De Weir [1949] were used to calculate energy equivalency from oxygen consumption 
and carbon dioxide production. 
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CHAPTER 4 
Activity levels in children with and without Cystic Fibrosis and the relationship to 
aerobic capacity, lung function and quality of life. 
4.1 Introduction 
Physical activity has been defined as "any bodily movement produced by the skeletal 
muscles that results in energy expenditure" [Casperson, 1989] and is an integral part of 
the growth and development of children. Chronic illnesses, such as Cystic Fibrosis (CF), 
may limit physical activity by either respiratory [Godfrey and Mearns 1971; Marcotte et 
al, 1986b] or nutritional compromise [Coates et al, 1980; Marcotte et al, 1986a]s or due 
to other factors such as psychosocial stress [Blair et al, 1994]. When the inactivity 
results in deconditioning [Orenstein and Nixon, 1991] a negative feed back loop is 
formed thus making physical activity even more difficult. 
Maintaining high levels of physical activity is an important objective in the 
management of CF. Nixon et al [1992] have demonstrated that aerobic fitness is an 
independent predictor of survival in CF and that CF patients who had active lifestyles 
had more slowly progressive disease. Furthermore, aerobic fitness has been shown to 
correlate with quality of life m CF [Orenstein et al, 1989]. Although clinicians have long 
encouraged children with CF to be active, there is little information on the daily activity 
levels in these children. Boucher et al [1997], using an activity questionnaire in thirty six 
children with CF, found that activity levels were not related to lung function. To date, 
there have been no comparisons of activity levels in healthy children and those with CF. 
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This study, therefore aimed to compare the activity levels of children with CF 
and healthy controls between the ages of 10 and 16 years, and to correlate activity levels 
in children with CF with aspects of their disease including quality of life, aerobic 
capacity, lung function, nutritional status, and the frequency of antibiotic usage. 
4.2 Materials and methods 
Subjects 
One hundred and thirty eight patients with cystic fibrosis between the ages of 10 and 16 
years, attending the CF clinic at the Royal Alexandra Hospital for Children, Sydney 
were eligible for the study. The children had a wide range of disease severity as 
measured by the Shwachrnan score [Shwachman and Kulczycki, 1958]. This is a widely 
used clinico- radiological measure of disease severity in patients with CF. The cohort 
included children with both pancreatic sufficiency and insufficiency (as measured by 
faecal fat testing). The control group consisted of 129 children without CF including 
friends and family of the children with CF (n=72) and participants in the New South 
Wales Schools Physical Fitness Assessment [Booth et al, 1998] (n=57). The study was 
approved by the Ethics Committee of the Royal Alexandra Hospital for Children and 
written consent was obtained from all participants and their parents where applicable. 
Study Design 
All children in the study completed a New South Wales School Physical Fitness 
Assessment (NSW SPFA) on the same days they completed an activity diary [Bouchard 
et al, 1983] and wore a uniaxial accelerometer on the hip. The activity diary comprised a 
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record of the dominant activity of each fifteen minute period of the day and night. 
Children were asked to complete the diaries on three week days and one weekend day in 
one week and the other two week days and the alternative weekend day of the following 
week. Thus, a total of seven days over a two week period were recorded. Each child also 
wore a validated accelerometer [Klesges et al 1990; Melanson et al, 1995; Trost et al, 
1998], WAM 7164 (Computer Science and Applications, Shalimar, Florida) on the same 
day the activity diary was completed. Data were collected over intervals of 1 second and 
the daily activity counts were recorded and downloaded when the device was returned. 
In addition, the children with CF and their parents were asked to complete a 
validated quality of well being assessment [Orenstein et al, 1989]. An assessment of 
peak cardiorespiratory capacity was made using the modified Bruce protocol 
[Stranghelle, 1998] on a treadmill (Cardiovit 100, Schiller, Switzerland). Pulmonary 
filiation tests were obtained using spirometry (Sensormedics 2000, Yorba Linda, CA), 
and the anthropometric details (weight in kilograms, height in meters, skinfold 
assessment from the triceps, biceps, subscapular and suprailiac sites [Durnin and 
Rahaman, 1967]) were recorded for each child. A prospective assessment of antibiotic 
frequency as the number of days of antibiotic administration (oral and/or intravenous) 
for the twelve months following testing was made. This information was obtained by 
scrutiny of the medical records and patient/ parent recall. 
Data Analysis 
Th& disease severity of children with CF, assessed by the Shwachman score, was 
classified as mild (>70), moderate (50-70) and severe (<50). Measurements of lung 
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function were expressed as the percentage of normal predicted values. The measured 
aerobic capacity was expressed in terms of the lean body mass which was calculated 
using the skinfold assessment. The body mass index was expressed as a percent of the 
theoretical body mass index of a child of the same age and gender growing along the 
50th percentile for weight and height. This value was termed the body mass percentile 
(BMP). 
To analyse the information on the activity diary, the recorded activities were 
categorised into nine levels according to their average cost, representing multiples of 
Basal Metabolic Rates, from the lowest physical activity (level 1), representing rest or 
sleep, to the highest (level 9), representing high intensity, maximal work. The energy 
costs allotted to these activities in this study, were adopted from the validation study by 
Bratteby et al [1997]. In order to analyse daily energy expenditure, the children were 
divided into four groups depending on their gender (male, female) and age (<12years, > 
12 years). This was necessary, as normative studies using doubly labelled water in 
children without CF, demonstrated that the mean total daily energy expenditure varied 
according to the age and sex of the child [Livingstone et al, 1992]. The age cut off was 
chosen as the most significant differences were previously found when comparing 
children under the age of 12 years with children 12 years and older [Stephens and Craig, 
1988; Russell et ah 1992]. 
To analyse the data from the accelerometer, the activity counts were downloaded 
at fee end of the study period. The counts were converted to energy expenditure by the 
software provided by Computer Science and Applications (Shalimar, Florida) based on 
* 
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prediction equations presented by Freedson et al9 [1998] and the compendium of the 
energy costs which has previously been reported [Ainsworth et al91993]. 
The differences between children with and without CF, were assessed by a two 
tailed paired Student's t test. The agreement between the Bouchard activity diary and 
the accelerometer was illustrated using a Bland and Altaian plot [Bland and Altaian, 
1986]. Stepwise linear regression analysis was used to test for'any correlations between 
variables. Activity levels were divided into quartiles, with the 25% being the lowest 
activity level and 100% the highest activity. Duncan's Post Hoc test of analysis of 
variance (ANOVA), was then used to assess the relative effect of activity levels on 
aerobic capacity (VC^), nutrition (BMP), quality of life, disease severity (Shwachman 
score), and the use of antibiotics for intercurrent infections. Statistical significance was 
assigned for p values less than 0.05. 
A subgroup analysis was carried out on the children with CF. Each child who 
was pancreatic sufficient (PS) was matched in terms of gender, age and disease severity 
(using the Shwachman score, [Shwachman and Kuczycki, 1958]) with two children who 
were pancreatic insufficient (PI). This was done to increase the power of the study. A 
matched sample comparison was made of the mean aerobic capacity, quality of life, 
BMP, activity levels and days on antibiotics. 
4.3 Results 
All 138 children with CF and 118 of the 129 control children who were recruited into 
the study, completed all aspects of the study. The mean age of the children with CF 
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(11-7, SD 2.7 years) and the control children (11.4, SD 2.7 years) was not significantly 
different. Although the gender ratio varied between the children with CF (63males, 75 
females) and the control group (65 males, 53 females), this was also not significantly 
different. 
Activity levels were assessed by the Bouchard activity diary, the NSW SPFA and 
the accelerometer. The Bouchard activity diary score cdrrelated best with the 
accelerometer counts (r = 0.83, pO.Ol; n=256). The agreement between the Bouchard 
activity diary and the accelerometer count is presented using a Bland and Altaian plot in 
Figure 4.1. The mean difference between the energy expenditure obtained using the 
activity diary and the accelerometer was 3.73 MJ/day with the limits of agreement set at 
2.36 and 4.00 MJ/day. The NSW SPFA was less well correlated with accelerometer 
counts and Bouchard activity diary with a Pearsons correlation coefficient of r =0.44 
(p<0.05) and r = 0.42 (p<0.05) respectively. 
The energy expenditure based on the Bouchard activity diaries, according to age, 
gender and CF disease severity is presented in Table 4.1. Overall, children under the age 
of twelve years with CF were as physically active as children without CF with no 
significant differences in the gender combined mean of the Bouchard activity diary 
(11.49, SE 2.60 and 11.31, SE2.75 MJ/day), NSW SPFA (7.15, SE 1.8 and 7.02, SE 1.9 
MJ/day) and activity levels using the accelerometer (11.65, SE 2.90 and 11.40, SE 2.77 
MJ/day) between the CF and control groups respectively. However, children under 12 
years with mild disease (Shwachman score >70) were significantly more active than 
controls for both boys (p<0.01) and girls (p<0.01). 
89 
Children twelve years and older with CF were also as physically active as 
children without CF with no significant differences in the gender combined means of the 
Bouchard activity diary (12.78, SE 2.65 and 12.75, SE 2.78MJ/day), NSW SPFA (9.13, 
SE 1.70 and 8.73, SE 1.93MJ/day) and activity levels using the accelerometer (12.97, SE 
2.83 and 12.76, SE 2.77 MJ/day). Similar to children under 12 years of age, children 
between the ages of 12 and 16 with mild CF disease (Shwachman score > 70) were 
significantly more active than controls for both boys (p<0.01) and girls (pO.Ol). 
Children with CF in both age groups and with moderate disease (Shwachman score 50 to 
70) were not significantly different to controls. Children with severe CF disease 
(Shwachman score less than 50) tended to have lower mean activity levels than controls 
but this difference did not reach statistical significance. Girls with mild and moderate CF 
disease had significantly lower activity levels than boys of the same age and disease 
severity (p<0.05). Activity levels in girls with severe CF disease was not significantly 
different to boys with the same degree of disease severity and age (Table 4.1). 
There were significant differences between the three categories of disease 
severity with respect to BMP, aerobic capacity, quality of well being, lung function and 
antibiotics therapy for both boys (Table 4.2) and girls (Table 4.3). Activity levels in 
children with CF were also correlated with these aspects of their disease. Lung function 
(FEVi) correlated poorly with activity levels with r = 0.08 (Figure 4.2). Activity levels 
of children ^ith CF correlated well with aerobic capacity as measured by the treadmill 
exercise test (^=0.63, pO.Ol) (Figure 4.3), quality of well being (r2 = 0.61, p<0.01), 
and inversely with the number of days on antibiotics (r2 = 0.59, pO.Ol). ANOYA 
demonstrated that activity levels in children with CF, were most predictive of aerobic 
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capacity, followed by quality of well being and the number of days on antibiotics over a 
twelve month period. BMP and Shwachman scores correlated less well with activity 
levels with r2 = 0.20 (p<0.05) and r2 - 0.14 (p<0.05) respectively. In a subgroup of 
patients with severe disease (Shwachman score < 50; n— 14), the best correlates with 
activity levels were aerobic capacity (r = 0.74), quality of well being (r2 = 0.65), BMP 
(r2 = 0.58) and the number of days on antibiotics (r2 =0.52). 
Children with the highest activity levels (100% activity quartile) had 
significantly better nutritional status, aerobic capacity, quality of life and disease status 
than children with lower activity levels (Table 4.4). In addition, these variables were 
significantly less in children with the lowest activity level (25 % activity quartile) 
compared to children in the 50% and 75% activity quartile. 
The effect of pancreatic function on activity level, aerobic capacity, quality of 
well being, BMP and days of antibiotics was assessed by comparing children who were 
PS with children who were PI and matched 1:2, in terms of age, gender and disease 
severity. The data are presented according to age in Tables 4.5 (ages 10 to 12 years) and 
4.6 (ages 12 to 16 years). In children under 12 years of age (Table 4.5), there were no 
significant differences between the pancreatic sufficient (PS) and pancreatic insufficient 
(PI) children. In children between 12 and 16 years of age, PS girls were significantly 
better for all variables (p<0.05) while PS boys had significantly better quality of well 
being scores (p<0.05) and fewer days on antibiotics (p<0.05) when compared to PI girls 
and boys respectively (Table 4.6). In this age group, boys with PS had a significantly 
greater aerobic capacity than girls with PS. There were no other significant gender 
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differences in subjcets with PS. Similarly J& subjects with PI, the only statistically 
significant difference between the genders was in the aerobic capacity (Table 4.6). 
TABLE 4.1: Activity levels in children with and without Cystic Fibrosis according 
to age and gender 
Control 
Total CF 
MildCF 
Moderate CF 
Severe CF 
Activity levels (MJ/day)a 
Girls< 12 years 
10.80 + 1.75 
(n = 24) 
11.00 ±1.83 
(n = 37) 
11.24 ±1.92* 
(n=19) 
10.87 ±1.80 
(n=15) 
10.40 + 2.17 
(n=3) 
Boys < 12 years 
11.80 ±1.64 
(n = 25) 
12.15 ±1.92 
(n = 28) 
13.65 ±2,50* 
(n=15) 
12.00 ±2.12 
(n=10) 
11.40 ±2.60 
(n = 3) 
Girls > 12 years 
11.31 ±2.20 
(n = 29) 
11.70 ±2.20 
(n=38) 
13.81 ±2.70* 
(n = 22) 
11.60 ±2.15 
(n=12) 
10.95 + 2.23 
(n = 4) 
Boys > 12 years 
13.81 ±2.70 
(n = 40) 
13.94 ±2.56 
(n = 35) 
14.92 ±2.61* 
(n=16) 
13.90 ±2.72 
(n=15) 
13.40 ±2.54 
(n = 4) 
amean ± standard error values are shown 
* indicates significantly different from control value (p < 0.01) 
n indicates the number of subjects studied in each group 
Mild disease severity = Shwachman score >70 
Moderate disease severity = Shwachman score 50-70 
Severe disease severity = Shwachman score <50 
Table 4.2 BMP, aerobic capacity, quality of life, lung function and antibiotic usage 
of boys with Cystic Fibrosis according to age and disease severity. 
N 
BMP (%) 
Aerobic capacity 
(ml/kg/min) 
Quality of well 
being score 
FEVl (% 
predicted) 
Antibiotic 
therapy (days in 
year) 
Mild Disease 
Severity 
<12yrs 
15 
98.56 
(13.20) 
48.00 
(8.50) 
0.93 
(0.07) 
97.3 
(4.5) 
6.20 
(5.10) 
>12 yrs 
16 
99.90 
(11.60) 
51.30 
(7.90) 
0.94 
(0.06) 
95.4 
(5.0) 
7.60 
(4.10) 
Moderate Disease 
Severity 
<12yrs 
10 
85.40* a 
(13.60) 
41.35* a 
(6.40) 
0.80* a 
(0.13) 
70.6*a 
(4.2) 
12.20*a 
(6.20) 
>12yrs 
15 
75.70* b 
(11.55) 
37.28* b 
(6.80) 
0.76* b 
(0.14) 
66.1* b 
(7.2) 
15.10* b 
(7.23) 
Severe Disease 
Severity 
<12yrs 
3 
54.00"a 
(17.40) 
27.60"a 
(9.69) 
0.66"a 
(0.17) 
4UT" 
(9.8) 
24.59"a 
(11.20) 
>12 yrs 
4 
51.23"b 
(17.22) 
21.61"b 
(8.75) 
0.62"b 
(0-15) 
35.2"b 
(8.4) 
29.90"b 
(11.10) 
All values shown are mean ± standard error 
BMP is body mass percentile 
Mild disease severity = Shwachman score >70 
Moderate disease severi% = Shwachman score 50-70 
Severe disease severity = Shwachman score <50 
*
 a
 Significant difference between mild and moderate disease severity for boys <12 years 
(p<0.05, Students t test). 
a
 Significant difference between moderate and severe disease severity for boys < 12 
years (p<0.05, Students t test). 
* Significant difference between mild and moderate disease severity for boys >12 years 
(p<0.05, Students t test). 
Significant difference between moderate and severe disease severity for boys > 12 
years (pO.05, Students t test). 
Table 4.3 BMP, aerobic capacity, quality of life, lung function and antibiotic usage 
of girls with Cystic Fibrosis according to age and disease severity. 
N 
BMP (%) 
Aerobic capacity 
(ml/kg/rnin) 
Quality of well 
being score 
FEV1 
(%predicted) 
Antibiotic 
therapy (days in 
year) 
Mild Disease 
Severity 
<12yrs 
19 
97.56 
(15.90) 
38.00 
(7.60) 
0.92 
(0.08) 
96.2 
(4.0) 
7.80 
(4.20) 
>12yrs 
22 
96.90 
(13.20) 
41.30 
(8.60) 
0.93 
(0.07) 
92.4 
(5.0) 
8.70 
(3.10) 
Moderate Disease 
Severity 
<12yrs 
15 
84.00* a 
(14.90) 
33.65* a 
(6.90) 
0.81* a 
(0.16) 
74.5* a 
(7.2) 
12.56* a 
(5.90) 
>12 yrs 
12 
78.90* b \ 
(12.45) 
36.18*° 
(5.99) 
0.78* b 
(0.13) 
68.1* b 
(6.7) 
14.20* D 
(6.23) 
Severe Disease 
Severity 
<12yrs 
3 
59.00" a 
(16.28) 
26.90"a 
(7.79) 
0.69" * 
(0.10) 
46.0"a 
(8.9) 
22.90"a 
(10.20) 
>12 yrs 
4 
52.18+b 
(16.02) 
22 .6 r b 
(7.65) 
0.65"b 
(0.12) 
38.2"b 
(9.4) 
27.90"° 
(12.10) 
AH values shown are mean ± standard error 
BMP is body mass percentile 
Mild disease severity = Shwachman score >70 
Moderate disease severity = Shwachman score 50-70 
Severe disease severity = Shwachman score <50
 t__ 
*
 a
 Significant difference between mild and moderate disease severity for girls <12 years 
(p<0.059 Students ttest). 
a
 Significant difference between moderate and severe disease severity for girls < 12 
years (p<0.05, Students t test). 
* Significant difference between mild and moderate disease severity for girls >12 years 
(p<0.05, Students t test). 
Significant difference between moderate and severe disease severity for girls > 12 
years (p<0.05, Students t test). 
Table 4.4 Nutritional status, aerobic capacity, quality of life and disease severity 
presented according to the level of activity. 
BMP (%) 
Aerobic capacity 
(ml/kg/min) 
Quality of well being 
score 
Shwachman score 
Antibiotic therapy 
(days in year) 
Activity quartile 
25% 
53.72(15.39) 
22.87 (7.89) 
0.64(0.17) 
42.0 (12.0) 
27.80(12.10) 
50% 
75.70 
(12.76)* 
37.10(6.87)* 
0.79(0.13)* 
57.0 (13.0)* 
15.20(8.23)* 
75% 
76.80 
(14.20)* 
40.21 (7.54)* 
0.83(0.14)* 
65.0 (12.0)* 
13.80(9.87)* 
100% 
98.90 (14.72) 
50.32 (6.90) 
0.92 (0.08) 
88.0 (12.0) 
7.80 (4.28) 
* Significantly greater than 25% activity quartile and significantly less than 100% 
activity quartile (Duncans ANOVA, p <0.05). 
All values shown are mean ± standard error 
BMP is body mass percentile 
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TABLE 4-5: The effect of pancreatic insufficiency (PI) and pancreatic sufficiency 
(PS) on the activity levels, aerobic capacity, and quality of life of children with 
Cystic Fibrosis under 12 years of age. 
N 
BMP 
(%) 
Activity level 
(MJ/day) 
Aerobic capacity 
(ml/kg/min) 
Quality of well 
being score 
Antibiotic therapy 
(days in year) 
BOYS 
PI 
14 
98.05 + 18.10 
12.15 ±1.92 
41.61 ±7.45 
0.90 ±0.12 
11.40 + 4.20 
PS 
7 
98.45 + 16.90 
12.48 ±2.12 
43.20 ±9.22 
0.92 ±0.11 
10.95 ±5.70 
GIRLS 
PI 
12 
97.25 ±16.90 
11.00±1.83 
37.72 ±8.10 
0.88 ±0.11 
12.20 ±3.90 
PS 
6 
98.02+18.10 
11.15 ±2.10 
39.20 ±8.10 
0.90 ±0.12 
11.48 ±5.35 
All values shown are mean ± standard error 
BMP is body mass percentile 
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TABLE 4.6: The effect of pancreatic insufficiency (PI) and pancreatic sufficiency 
(PS) on the activity levels, aerobic capacity, and quality of life of children with 
Cystic Fibrosis 12 years of age and older. 
N 
BMP 
(%) 
Activity level 
(MJ/day) 
Aerobic capacity 
(ml/kg/min) 
Quality of well 
being score 
Antibiotic therapy 
(days in year) 
BOYS 
PI 
12 
96.80 + 2.60 
13.90 ±2.92 
43.78 ±8.33a 
0.70 ± 0.09 
15.70 + 5.09 
PS 
6 
99.47 ±1.61 
14.10 ±2.70 
45.48 ±2.87° 
0.82 ±0.10* 
6.40 ± 2.20* 
GIRLS 
PI 
16 
92.00 + 2.65 
12.00 ± 0.64 
29.93 ±2.20a 
0.69 + 0.15 
16.02 ±5.70 
PS 
8 
101.27 ±4.60* 
13.12 ±0.59* 
34.60 ±2.12*b 
0.87 ±0.11* 
7.45 ± 7.09* 
All values shown are mean ± standard error 
BMP is body mass percentile 
* significant difference between pancreatic insufficient and pancreatic sufficient children 
of same gender (p < 0.05). 
a
 significant difference between genders in children with pancreatic insufficiency, 
significant difference between genders in children with pancreatic sufficiency. 
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Figure 4.1 Bland and Altman plot comparing energy expenditure obtained using 
the Activity diary and Accelerometer. 
Difference: Energy expenditure using activity diary - accelerometer (MJ/day) 
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FIGURE 4.2: Relationship between lung function (FEVi) and activity levels in 
children with Cystic Fibrosis. 
FEVi forced expiratory volume in one second 
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Figure 4-3: Relationship between peak aerobic capacity (V02) and activity levels in 
children with Cystic Fibosis. 
VO2 Peak aerobic capacity (ml/kg/min) 
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4.4 Discussion 
This study has demonstrated that the activity levels of children with Cystic Fibrosis are 
not significantly different to activity levels in control children. In fact, children with 
"mild" Cystic Fibrosis were more active on a day to day basis than the control children. 
This difference may be due to the encouragement children with CF and their parents 
receive to be active. The mean activity levels of the control children in this study were 
not significantly different to the reported activity levels in 6890 school children as 
measured by the NSW SPFA [Booth et al, 1998]. This suggests that the control group in 
this study was an adequate representation of the larger population of children and is 
therefore a valid group for comparison with children with CF. 
Physical activity can be measured from a physiological or behavioural 
perspective. Methods such as activity diaries [Seliger et al, 1974], observational studies 
[Klesges et al, 1990; McKenzie, 1991], frequency questionnaires [Simmons-Morton et 
al, 1990], proxy measures [Saris, 1985; Noland et al, 1990], heart rate monitors [Durant 
et al, 1992], portable accelerometers [Freedson, 1991], and doubly labelled water 
[Davies, 1992] have all been utilised to measure activity levels. Freedson [1991] and 
Trost et al [1998] have demonstrated excellent correlation between activity counts as 
measured by the accelerometer and energy expenditure and intraclass correlation 
coefficients during exercise testing. We also demonstrated a good agreement between 
the accelerometer and the seven day activity diary in this study, although its primary use 
was to provide objective comparative data on activity levels between CF and non CF 
(controls) children. We used a modification of the Bpuchard activity diary, a seven day 
activity diary that has been validated using doubly labelled water by Bratteby et al, 
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[1997]. The modification to the Bouchard activity diary in this study was the energy 
cost assigned to each activity. The newly assigned energy cost was based on more 
recently published data suggesting the need for this modification [Ainsworth et al, 
1993]. 
Although doubly labelled water has become the gold standard for assessing 
energy expenditure in free living subjects [Davies, 1992], its cost and demanding 
methodology is prohibitive in population studies [Brattteby et al, 1997]. The only two 
studies that have incorporated doubly labelled water were in children with CF under the 
age of two years [Shepherd et al, 1988] and children between the ages of six and nine 
years [Tomezsko et al 1994]. The children in both study groups had mild disease, were 
pancreatic insufficient and demonstrated increased total daily energy expenditure. 
Tomezsko et al [1994] postulated that this may be due to the thermic effect of food, 
growth, increased daily voluntary activity or a cellular adaptive response resulting in an 
increased energy requirement for a given amount of physical activity. This study, using 
activity diaries, frequency questionnaires and portable accelerometers, has demonstrated 
increased levels of physical activity, as the likely explanation for the increased total 
daily energy expenditure in children with CF and mild disease. 
Children with CF, who had high activity levels (top quartile for the respective 
gender and age group), had significantly better aerobic capacity, quality of life, nutrition 
and significantly lower disease severity and less days on antibiotics than children with 
low activity levels (lowest quartile). However, similar to the findings of Boucher et al, 
[1997], this study found that lung function was not related to activity levels. This would 
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suggest that high activity levels do not necessarily reflect the level of lung function and 
may independently improve outcome. Home based exercise programs have previously 
been studied and demonstrated varying degrees of benefit [Blomquist et al, 1984; 
Andreason et al, 1987; De Jong et al, 1994]. The reason for the variability was attributed 
to poor compliance rather than the severity of lung disease [Holzer et al, 1984]. The 
health benefits of increased activity levels demonstrated in this study should aid in 
improving compliance. 
Although nutritional status correlated poorly with activity levels in the study 
group as a whole, in those with severe disease (Shwachman score <50), the association 
was much better. This may be explained by a decreased muscle mass, as a result of 
relative under nutrition [Russell et al, 1984] in severe disease, resulting in impaired 
functional ability and is consistent with the findings of Marcotte et al, [1986b] and 
Lands et al [1992]. The relationship between fat malabsorption and lung function has 
previously been reported [Kraemer et al, 1978; Gaskin et al, 1982b]. This study has also 
demonstrated for the first time that there were significantly lower levels of activity, 
aerobic capacity, and quality of life in girls between 12 and 16 years with pancreatic 
insufficiency compared with those who were pancreatic sufficient. These differences 
were not demonstrable in boys between 12 and 16 years and children under the age of 12 
years. There are two possible explanations for the results of the present study. It is 
acknowledged that boys with pancreatic insufficiency are better able to maintain 
nutrition than girls [Kraemer et al, 1978]. Better nutrition facilitates muscle growth and 
greater activity and hence, a better aerobic capacity and quality of life. It may be that 
with the onset of puberty, the increased nutritional demands for muscle and bone growth 
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results in relative deficiencies of micronutrients required for activity. This may be 
exacerbated in pancreatic insufficient post pubertal girls because of poorer oral intake 
and/or hormonal changes which is supported by their lower BMP compared to those 
with pancreatic sufficiency. An alternative explanation would be that the older girls with 
pancreatic insufficiency may have more severe disease. This is less likely as there was 
no evidence that girls with severe disease had significantly reduced activity levels and 
there was no correlation between lung function and activity levels. 
In conclusion, this study has demonstrated that children with mild CF were more 
active than children without CF, and, that those with moderate or severe CF had activity 
levels which were similar to control children. Activity levels in children with CF 
correlated with aerobic capacity, quality of life, nutritional status and inversely with 
days of antibiotics, but not with lung function. The effects of pancreatic insufficiency on 
activity level were most apparent in the cardiorespiratory status of girls after the age of 
12 years. Further studies are required to investigate the possible cause of this gender 
difference and why the pancreatic status is of greater importance after the onset of 
puberty. The results of the present study however provide important information in 
regard to the relationship between aerobic capacity, activity level and quality of life, all 
of which have significant bearing upon the prognosis of children with CF. 
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CHAPTER 5 
The relationship between genotype and fitness in children with Cystic Fibrosis 
5.1 Introduction 
Since the discovery of the genetic defect that causes Cystic Fibrosis (CF) by Riordan et 
al [1989], attempts have been made to correlate CF genotypes with clinical assessments 
[Kerem and Kerem, 1996]. To date, the correlations between genotype and prognosis, 
mortality and pulmonary function have been highly variable [Kerem et al, 1990; Mohon 
et al, 1993, Lester et al, 1994]. Kerem et al [1990], Santis et al [1990] and Campbell et 
al [1991] have demonstrated that patients homozygous for the delta F508 mutation have 
an earlier onset of disease, higher sweat chloride levels and a greater prevalence of 
pancreatic insufficiency. Despite this, patients with the delta F508 mutation have a wide 
range of severity of pulmonary disease and, severe pulmonary disease due to CF is not 
restricted to patients homozygous for the delta F508 genotype [Highsmith et al, 1994; 
MoulliereM/, 1994; Stern etal, 1995]. 
Tsui [1992] and Welsh and Smith [1993] proposed molecular mechanisms by 
which genetic mutations disrupt the function of cystic fibrosis transmembrane regulators 
(CFTR). By categorising these mechanisms into four different classes, it is not only 
possible to better understand' the pathophysiology of the disease process, but new 
therapies targetted at altering CFTR functioning are being developed according to the 
class of the mutation Penning et al, 1992b]. Tsui [1995] subsequently refined the 
classification to incorporate five different classes of mutations. 
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As several new therapies have been based on the CFTR mutation class, and 
exercise tolerance is a recommended outcome measure in interventional trials in CF 
[Ramsey and Boat, 1994], it is clearly important to assess the relationship between 
CFTR mutation class and exercise tolerance. There are no previously reported studies 
that have compared the exercise tolerance of patients on the basis of CFTR mutations. 
5.2 Materials and Methods 
Subjects 
Children aged 8 to 17 years who attended the CF clinic at the Royal Alexandra Hospital 
for Children, Sydney were eligible for the study. The subjects were excluded if there 
was a history of pulmonary exacerbation in the month preceding the test. 
Parameters of Assessment 
Lean body mass was calculated using skinfold thickness and the equations provided by 
Duxnin and Rahaman [1967]. Height was measured by a Harpenden stadiometer and 
weight by electronic scales. The body mass index was recorded on each subject. 
Subjects have the Shwachman score [Shwachman and Kulczycki, 1958], a clinico 
radiological measure of disease severity, recorded by their clinician at the yearly interval 
check of progress. This score was used to compare severity of the subjects both 
individually and collectively. 
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Pulmonary function tests consisted of measuring forced expiratory volume in one 
second (FEVi) and forced vital capacity (FVC) using a spirometer (Sensormedics 2000, 
Yorba Linda, CA) and the values presented by Polgar and Promadhat [1971] used as the 
reference range. 
Peak aerobic capacity was assessed using a modified Bruce protocol on an 
electronic treadmill (Cardiovit 100, Schiller, Switzerland). Breath by breath gas analysis 
was used to determine peak oxygen uptake (VO2), minute ventilation (VE), and 
respiratory quotient (RQ). Anaerobic power was measured using the Wingate test 
[Ayalon et al, 1974]. Peak power and mean power were corrected for lean body mass for 
all subjects. 
Children diagnosed with CF have their CFTR mutations recorded. This 
information was retrospectively obtained for the purposes of this study. The values for 
the peak aerobic capacity, anaerobic power, lung function, Shwachman score and body 
mass index for subjects with at least one copy of delta F508 mutation were compared 
according to the class of CFTR mutations (I-V) of the other mutation. Comparisons 
between subjects without one copy of delta F508 mutation were also made~according to 
the respective pah* of CFTR mutations they possessed. 
The study was approved by the Ethics Committee of the Royal Alexandra 
Hospital for Children and informed written consent was obtained from all participants 
and their parents where applicable. 
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Data Analysis 
The subjects were categorised into groups according to CFTR mutation. The five classes 
of CFTR mutations as described by Welsh and Smith [1993] and Tsui [1995] were 
adopted for mis study. Duncan's Post Hoc test of analysis of variance (ANOVA) was 
used to assess differences between the groups for each of the parameters of assessment. 
Statistical significance was assigned for p values less than 0.05. 
Power calculations revealed that 60 subjects (10 subjects per group) would be 
required to detect a 0.5 standard deviation difference in peak aerobic capacity and 
anaerobic power between the groups with a significance of 0.05% and power of 80%. 
The SPSS-PC+ package (version 5.0) [Nie 1975] was used for statistical analysis. 
5.3 Results 
Seventy children with CF participated in the study. The mean age of the subjects was 
14.1 (range 8.4 to 16.8) years and there was a wide range of disease severity as 
measured by the Shwachman score (mean 60.0; range 35 to 100). Only six of the 
subjects who participated in the study were pancreatic sufficient. The demographic 
details of the study population are displayed in Table 5.1. 
In CF patients with at least one copy of the delta F508 mutation, subjects with a 
second mutation in class I had a mean peak aerobic capacity of 28.6 (SE 4.2) ml/kg/min 
which was not significantly different to subjects with class II second mutations [31.7 
(SE 5.4) ml/kg/rnin] (Table 5.2). Subjects with a class III CFTR second mutation had a 
peak aerobic capacity 38.0% (p<0.05) greater than subjects with the class I CFTR 
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second mutation. Subjects with a class IV CFTR second mutation had a peak aerobic 
capacity 22.3% (p<0.05) greatcjf than those with class III CFTR second mutation. 
Duncan's Post Hoc ANOVA analysis demonstrated that while the mean peak aerobic 
capacity of subjects with class IV and class V CFTR second mutations was not 
significantly different from each other, it was significantly greater than subjects with 
class III CFTR second mutation which in turn was greater than those with class II and I 
CFTR second mutations. 
Anaerobic power testing demonstrated that subjects with class III CFTR second 
mutations were 7.8% (p<0.05) stronger than subjects with class I and II CFTR second 
mutations, but were 10.9% (p<0.05) weaker than subjects with class IV and V CFTR 
second mutations. Duncan's Post Hoc analysis revealed three groups of strength with 
those with class I and II CFTR second mutations the weakest, individuals with class III 
mutations intermediate strength and class IV and V CFTR mutations the strongest. 
Duncan's Post Hoc analysis revealed that BMI could be divided into two groups 
based on CFTR mutations, with those with second CFTR mutations belonging to class I 
and II having a significantly lower (17.6%, p<0.05) body mass index than those with 
class III, IV and V CFTR second mutations. The Shwachman score of disease severity 
followed the same trend as body mass index when analysed with Duncan's Post Hoc 
analysis. Subjects with class I and class II CFTR second mutations had significantly 
worse disease as measured by the Shwachman score than subjects with class III, IV and 
V CFTR second mutations. 
no 
Lung function, as indicated by forced expiratory volume in one second, was not 
significantly different between the groups and was thus unrelated to genotype. 
The results from subjects without a copy of the delta F508 mutation are 
summarised in Table 5.3. Subjects with the rarer CFTR mutations tended to have highly 
variable aerobic capacity, anaerobic power, lung function, body mass index and 
Shwachman score, and analysis of the data did not reveal any statistically significant 
differences. 
I l l 
TABLE 5.1 Demographic details of subjects 
a
 age shown in years with standard deviation in brackets 
PS pancreatic sufficient 
PI pancreatic insufficient 
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TABLE 5.2- Aerobic and anaerobic performance and BMI in patients with at least 
one copy pf the delta F508 CFTR mutation 
Aerobic capacity 
ml/kg/rnin 
FEVI 
% predicted 
Anaerobic power 
watts/ kg 
Body mass index 
Shwachman score 
CFTR Second Mutation Class 
I 
28.6(4.2) 
51.0(5.4) 
15.0(2.2) 
17.0(1.8)" 
56.0(7.0)T 
II 
31.7(4.9) 
57.2(6.1) 
14.7(2.0) 
18.2(2.5) T 
51.0(7.3)" 
in 
43.9(6.4)* 
55.0(6.0) 
16.7(2.4)* 
20.0(2.3) 
65.0(6.5) 
IV 
53.0(7.2) 
.58.3(6.3) 
17.7(2.1) 
20.1(2.4) 
64.0(6.0) 
V 
53.7(6.8) 
55.9(5.9) 
17.8(2.0) 
20.4(2.0) 
60(5.9) 
* Significantly greater than class I and II and signficantly lower than class IV and V 
(Duncans ANOVA, p < 0.05). 
+ Significantly lower than class III, IV and V (Duncans ANOVA, p<0.05) 
FEVi Forced expiratory volume in one second 
Mean values are shown with standard error of the mean in brackets 
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TABLE 5.3 Aerobic and anaerobic performance and BMI in patients without a 
copy of de!taF508 CFTR mutation 
Aerobic capacity 
ml/kg/min 
FEVi 
%predicted 
Anaerobic power 
watts/kg 
Body mass index 
Shwachman Score 
III/I 
(n=2) 
38.4 (7.9) 
56.0 (6.2) 
15.9(4.2) 
17.9(3.2) 
63.0(6.4) 
CFTR mutation class 
III/IV 
(n=4) 
44.2(8.1) 
60.0(7.5) 
17.2(5.1) 
20.2(2.9) 
60.4(7.9) 
IV/IV 
(n=4) 
53.9(7.2) 
57.9(6.2) 
17.7(6.0) 
21.1(3.2) 
71.2(8.0) 
FEVi Forced expiratory volume in one second 
Mean values are shown with standard error of the mean in brackets 
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5.4 Discussion 
This study has demonstrated that there is a significant relationship between the class of 
the second CFTR mutation and aerobic capacity, anaerobic power and body mass index 
in patients with CF with at least one copy of the delta F508 gene mutation. Those who 
possessed a second CFTR mutation belonging to either class I or II, were not 
significantly different from each other in terms of any of the exercise parameters 
measured. They had however, a significantly low$r peak aerobic capacity and anaerobic 
power than those with a second CFTR mutation belonging to class III. Patients who 
possessed a second CFTR mutation belonging to either class IV or V, were not 
significantly different from each other in terms of aerobic capacity and anaerobic power. 
They did however, have significantly higher values than those who had a second CFTR 
mutation belonging to class III. Patients with a second CFTR mutation belonging to 
class I and II had a significantly lower body mass index and Shwachman score than 
patients who had a second CFTR mutation belonging to class III, IV, or V. However, 
there were no statistically significant differences in the lung function of patients with the 
different classes of CFTR mutations, suggesting that this is a less sensitive indicator of 
disease severity. Despite these results being obtained from a single center, power 
analysis for the different classes of CFTR mutations, suggested that type Il^errors were 
niinimal. 
Kaplan et al [1996] demonstrated no differences in terms of nutrition and 
exercisf tolerance between patients who were homozygous and heterozygous for the 
delta F508 grae mutation. The study was Hunted by the very small sample size. In 
addition, the study grouped all heterozygous patients together, failing to take into 
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account the vast spectrum of disease noted amongst heterozygous patients. By 
classifying the patients according to the cellular physiological function conferred by 
class of the CFTR mutation, this study has demonstrated significant differences in 
exercise tolerance, muscle power and nutrition. 
Although CF genotype has been shown to be highly predictive of exocrine 
pancreatic function [Kristidis et al, 1992], to date there has been no proven association 
between genotype and pulmonary status [Hamosh and Corey, 1993]. Most recent 
approaches toward understanding the genotype-phenotype correlation in cystic fibrosis 
are centered on in-vitro studies of CFTR function. Sheppard et al [1994] studied the 
expression of normal and delta F508 CFTR in epithelial cells and demonstrated that the 
delta F508 CFTR produced only an immature core glycosylated type of protein due to 
defective processing. Tsui [1992] and Welsh and Smith [1993] suggested mechanisms 
by which the different classes of mutations disrupt CFTR function. The delta F508 gene 
belongs to class II mutations and results in defects in protein processing. Class I 
mutations result in defects in protein production, class III mutations result in defects in 
protein regulation and class IV mutations result in defects in protein conduction to the 
apical membrane. Class V mutations result in reduced level of ribonucleic acid (RNA). 
These classes of mutations were adopted for this study and the results indicate that the 
deficits conferred on epithelial function by the mutations may also affect processes 
involved in aerobic and anaerobic fitness. 
This study has important implications in terms of long term prognosis as well as 
response to various therapies jb interventional studies. It may be that patients with class 
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Ill, IV or V CFTR mutations have a better overall prognosis, or, are more likely to 
respond to* therapies. Previous ambiguity about the relationship between genotype and 
phenotype in cystic fibrosis may now be clarified if interpreted in the light of the 
molecular mechanisms as proposed by Tsui [1992,1995] and Welsh and Smith [1993]. 
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CHAPTER 6 
A comparison of resting energy expenditure, activity levels in girls with mild Cystic 
Fibrosis with healthy controls 
6.1 Introduction 
Life expectancy among patients with cystic fibrosis (CF) has dramatically improved 
over the past twenty years [Fitzsimrnons et al, 1993; Curtis et al, 1997]. However, there 
remains a significant gender difference in survival rates. This is most evident in females 
with CF under the age of 20 years, who are 60% more likely to die than males of the 
same age [Rosenfeld et al, 1997]. The aetiology of this gender difference is poorly 
understood. Rosenfeld et al [1997] demonstrated that while nutritional status, pulmonary 
function and airway microbiology were independent predictors of survival, none of these 
parameters could account for the gender difference in survival rates. Orenstein and 
Nixon [1991] have demonstrated that girls with CF had a lower peak aerobic capacity 
than boys with CF of the same age. As aerobic capacity is an important predictor of 
survival [Nixon et al, 1992], the aetiology of the gender difference in the survival of 
patients with CF may be related to differences in muscle function. Moreover, compared 
to reference values obtained in healthy girls, girls with moderate to sever&XF related 
lung disease have a significantly lower peak aerobic capacity, which has been attributed 
to reduced daily physical activity levels and nutritional status [Orenstein and Nixon, 
1991]. On this basis, girls with mild CF disease without exercise limitation, should have 
similar peak aerobic capacity, activity levels and resting energy expenditure as healthy 
girls of the same age. The aim of this study was to investigate the validity of this 
premise by comparing aerobic and anaerobic capacity as well as resting energy 
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expenditure in girls with mild CF who, participated in organised sport at an eilt? level 
with that in healthy girls participating in the same sport. 
6.2 Materials and Methods 
Subjects 
Girls with CF who were 13 years of age or older,'.who had "mild" CF disease and were 
participating in representative level (either at regional or state level), competitive sport 
were recruited for the study. "Mild CF" disease for the purposes of this study was 
defined by normal pulmonary function tests (forced expiratory volume in one second of 
greater than 80% predicted) and a Shwachman score of greater than 70 [Shwachman and 
Kulczycki, 1958]. The subjects were excluded if there was a history of pulmonary 
exacerbation in the three months preceding the test. The control population consisted of 
the female training partners of the girls with CF who were matched for age and pubertal 
stage [Tanner et al% 1966]. 
Parameters of Assessment 
Lean body mass was calculated using skinfold thickness and the equations provided by 
Durnin and Rahaman [1967]. Height was measured by a Harpenden stadiometer and 
weight by electronic scales. 
Peak aerobic capacity was assessed using a modified Bruce protocol on an 
electronic treadmill (Cardiovit 100, Schiller, Switzerland). Breath by breath gas analysis 
was used to determine peak oxygen uptake (VO2), minute ventilation (VE), and 
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respiratory quotient (RQ). The peak aerobic capacity was assessed twice in each subject. 
The anaerobic threshold was calculated using the method described by Beaver et al 
[1986]. In addition, the subjects were requested to estimate their level of exertion using 
the Borg's rating of perceived exertion score [Borg, 1982]. 
The dominant leg strength was assessed using a Cybex dynamometer (Lumex 
Inc, Ronkonkoma, NY). The muscles tested were the quadriceps femoris and the 
hamstrings. The best of three repetitions was recorded as the strength of the tested 
muscle group. The strength tests were performed on the same day as the exercise tests. 
Anaerobic power was measured using the Wingate test [Ayalon et al, 1974]. Peak power 
and mean power were corrected for lean body mass for both groups of girls. 
Resting energy expenditure (REE) was measured by open circuit, flow through 
ventilated hood indirect calorimeter as described by Tomezsko et al [1994]. A 
computerized metabolic cart (Sensormedics 2900 Z, Yorba Linda, CA) was used to 
measure REE over a 30 minute interval. All subjects fasted overnight for twelve hours 
before testing and medications were withheld during the twelve hour fast. The modified 
equation developed by De Weir [1949] was used to calculate energy equivalency from 
oxygen consumption and carbon dioxide production. 
Pulmonary function tests consisted of measuring forced expiratory volume in one 
second (FEVi) and forced vital capacity (FVC) using a spirometer (Sensormedics 2000, 
Yorba E|nda, CA) and the values presented by Polgar and Promadhat [1971] as the 
reference range. 
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Each subject was asked to complete a seven day activity diary to assess activity 
levels. These diaries have previously been validated by Bratteby et al [1997]. In 
addition, on the days on which the seven day activity diary was being completed, the 
subjects were asked to wear an activity accelerometer, WAM 7164 (Computer Science 
and Applications, Shalimar, Florida) which has been validated by Melanson etal [1995]. 
The study was approved by the Ethics Committee of the Royal Alexandra 
Hospital for Children and written consent was obtained from all participants and their 
parents where applicable. 
Data Analysis 
The group mean and standard error of the mean (SEM) was calculated for each 
parameter. Thez scores were calculated for each subject's height and weight using data 
from the National Center for Health Statistics [1979]. The lean body mass calculated 
from skinfold thickness was used to express the peak aerobic capacity. 
Two tailed paired f tests were used to compare mean differences between the 
group with CF and healthy controls. To adjust for multiple comparisons, Duncan's Post 
Hoc test of analysis of variance was used. Values above the 95% confidence interval 
were considered statistically significant (p<0.05). 
6.3 Results 
Twelve girls with CF and their training partners took part in the study. All the subjects 
played representative sport and each girl with CF was paired with her training partner. 
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The sports each pair of subjects participated in were netball (n=4), basketball (n=2), 
swimming (n=3), hockey (n=l), gymnastics (n=l) and water polo (n=l). 
The girls with CF had mild disease with a mean Shwachman score of 85.0 (SD 
7,0), and a mean forced expiratory volume in one second of 88% (SD 9) predicted and 
were all pancreatic insufficient requiring daily pancreatic enzyme replacement. The 
mean age and pubertal stage [Tanner et al, 1966] of the girls with CF participating in the 
study was 15.0 years (range 13.2 - 17.3 years) and stage 4.3 (SD 0.6) respectively. This 
was not significantly different to the control subjects' mean age and pubertal stage of 
14.9 years (range 13.4-17.5) and stage 4.4 (SD 0.7) respectively. The demographic 
details of the study population is demonstrated in Table 6.1. There were no significant 
differences between the girls with CF and their training partners in terms of the 
anthropometric details. 
A comparison of the results in the girls with CF and their training partners is 
presented in Table 6.2. The resting energy expenditure was 7.6% (p<0.05) higher in the 
girls with CF which increased to 8.8% (p<0.05) when the resting energy expenditure 
was adjusted for body mass index. The girls with CF were also significantly more active 
both in terms of the activity diary (18.7%, p<0.01), as well as the activity counts 
obtained from the accelerometer (15.0%, p<0.01). The peak aerobic capacity in girls 
with CF was 21.7% (p<0.01) lower than their training partners. Both groups of study 
subjects exercised to exhaustion as demonstrated by the respiratory quotients being 
greater#an 1.10. The anaerobic threshold occurred at 46.8% and 59.9% of peak aerobic 
capacity for the girls with CF and controls respectively, which was also significantly 
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different (p<0.01). The dyspnoea index and Borg's rating of perceived exertion was not 
significantly different between the two groups. 
Girls with CF were significantly weaker when strength was measured using the 
Cybex dynamometer (p<0.05). Similarly, the peak anaerobic power achieved in girls 
with CF was significantly lower compared to healthy controls (p<0.05). 
TABLE 6.1: Demographic details of study population 
Age in years 
Weight z score 
Height z score 
Body fat(%) 
BMI 
Training partners 
14.9(1,2) 
-0.10(0.85) 
-0.06 (0.72) 
24.3 (2.35) 
18.91 (1.12) 
Cystic Fibrosis 
15.0(1.3) 
-0.15 (0.92) 
-0.12(0.89) 
23.2(2.78) 
18.64(1.85) 
Values shown are mean values with standard deviation values in brackets 
TABLE 6.2: Aerobic capacity, anaerobic power and resting energy expenditure in 
adolescent female athletes with CF and their training partners 
Peak aerobic capacity 
ml/kg/min 
Respiratory quotient 
Anaerobic threshold 
ml/kg/min 
Dyspnoea Index (VE/MW) 
Borg's Score 
FEVl 
% predicted 
FVC 
% predicted 
Resting energy expenditure 
kJ/24hr 
Resting energy expenditure 
kJ/BM/24hr 
Activity level activity diary 
MJ/24hr 
Activity Count 
Units 
Peak power 
watts/kg 
Leg strength 
Nm 
Training partners 
41.02(7.89)** 
1.27(0.18) 
24.60 (6.9)** 
0.55 (0.08) 
8.90(1.01) 
92(7) 
100(9) 
5689 (363)* 
301 (21)* 
11.72(2.20)** 
11282(490)** 
16.20* (2.70) 
169 (32)* 
Cystic Fibrosis 
32.10(6.90) 
1.24(0.09) 
15.05(7.20) 
0.60 (0.07) 
9.10(1.12) 
88(9) 
97(10) 
6159(952) 
330 (28) 
13.91 (2.63) 
12974 (720) 
12.60 (2.45) 
110(26) 
*p<0.05, **p<0.001 
FEVi Forced expiratory volume in one second 
FVC Forced Vital Capacity 
VE Minute ventilation 
M W Maximal voluntary ventilation (= 35XFEV0 
All values shown are mean values with standard error of the mean values in brackets 
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6.4 Discussion 
This study, has shown that young athletes with mild CF have significantly lower peak 
aerobic capacity, anaerobic power and leg strength than their training partners. However, 
the resting energy expenditure and daily activity levels were significantly higher in the 
female athletes with CF than their training partners. 
Although girls with CF had a significantly lower peak aerobic capacity compared 
to healthy controls, neither group had significant respiratory limitation as measured by 
the Dyspnoea Index [Wasserman et al, 1994] at the termination of the study. The effort 
expended in performing the test in both groups was similar as demonstrated by the 
respiratory quotient and the Borg's score of perceived exertion measured at the end of 
the exercise test. The girls with CF however, reached their anaerobic threshold at an 
earlier stage of the exercise test than healthy controls. This suggests that muscle 
conditioning was a more important limiting factor in girls with CF than healthy controls. 
Girls with CF similarly had weaker lower limbs than their training partners as 
measured by the Cybex unit. The generated peak power assessed by the Wingate test 
was also significantly lower in girls with CF. While sedentary lifestyles may account for 
the reduced peak aerobic and anaerobic capacity in children with more severe CF 
disease [Lands et al, 1992], this is unlikely to be the explanation for these findings in 
this group with mild disease. The girls with CF in this study had more active lifestyles 
than their training partners as measured by the activity diary and the accelerometer. As 
all results were corrected for lean body mass, these differences cannot be explained by 
discrepancies in lean body mass as suggested by Gulmans et al [1996]. Other 
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explanations for the reduced exercise tolerance demonstrated in patients with CF have 
been based on the relative nutritional deficiency in patients compared to healthy controls 
[Coates et al, 1980; Marcotte et a\ 1986b]. The nutritional status, as measured by the 
body mass index of both the healthy controls and the girls with CF were however, good 
and not significantly different between the groups. In addition, normal nutritional status 
in the girls with CF was achieved despite all the patients being pancreatic insufficient. 
Gulmans et al [1996] demonstrated that patients with CF had a greater oxygen 
consumption compared to healthy controls for a given quantity of submaximal work. De 
Meer et al [1995] demonstrated a lower efficiency of adenosine triphosphate (ATP) 
synthesis in patients with CF compared to controls. Differences in the efficiency of ATP 
synthesis between the groups were not investigated in this study, but are a possible 
explanation for our observed differences in aerobic and anaerobic capacity. 
The resting energy expenditure of the girls with CF was significantly greater than 
their training par tn» . As all the patients were clinically stable, the resting energy 
expenditure values were likely to be repeatable [Bell et al, 1999]. All the subjects with 
CF were colonised with the microorganism Pseudomonas aeruginosa and as 
Pseudomonas colonisation has been shown to increase the metabolic demand [Vinton et 
al, 1999], this may explain the higher resting energy expenditure. It does however, seem 
implausible that colonisation alone in the absence of symptoms could account for the 
greater resting energy expenditure. This implausibility is supported by evidence that 
even acute pulmonary exacerbations are not associated with increased resting energy 
expenditure [Stallings et al, 1998]. "While our study demonstrated similar differences in 
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resting energy expenditure between patients with CF and controls as those found by 
Zemel et al, [1996], the difference was not of the same magnitude as that demonstrated 
by Shepherd [1997] and Girardet et al, [1994] in infants with and without CF. It is 
unclear why increases in resting energy expenditure compared to healthy controls are 
greater in infancy, where disease is usually milder than in older children with CF. Zemel 
et al [1996] performed longitudinal analyses over a 3 year study period in prepubertal 
children with CF and demonstrated that resting energy, expenditure increased 
significantly in the girls but not in the boys. 
Selection bias may be a confounder in this study if female athletes with mild CF 
acquired their energy to perform exercise through a different mechanism to sedentary 
subjects with mild CF. However, there is currently no evidence that active subjects with 
CF acquire their energy through different metabolic mechanisms to sedentary subjects, 
and therefore this form of selection bias would seem unlikely. It could however form the 
basis of future research. Other biases could arise from the fact that the absence of a 
clinical history of diabetes and a negative glycosylated haemoglobin test does not 
exclude cystic fibrosis related diabetes which may potentially influence muscle 
metabolism. However, the current recommendations that are followed by our institution 
is to perform formal oral glucose tolerance tests if there is a history suggestive of 
diabete^ and unexplained deterioration in disease status and, or, if there is an abnormal 
glycosylated haemoglobin test [Moran et al, 1999]. Thus it is unlikely we have 
overlooked the presence of CF related diabetes in these patients although it is possible 
that peripheral insulin sensitivity may be a contributing factor to the inefficient muscle 
metabolism in these pancreatic insufficient patients [Moran et al, 1994] 
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These significant differences between girls with mild CF disease and healthy 
controls in aerobic capacity, anaerobic power and resting energy expenditure may have 
important implications. This study suggests that there is significant muscle impairment 
in girls with CF compared to healthy controls. If there is inefficiency in muscle function, 
a greater nutritional requirement would be needed to maintain activities of daily living. 
Muscle inefficiency may also limit the respiratory muscle capabilities of girls with CF 
who develop acute on chronic respiratory failure. Further studies of muscle metabolism 
in terms of substrate energy availability and, or utilisation are needed and may delineate 
a defect at the mitochondrial level, and these studies are presented in chapter 7. 
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CHAPTER 7 
A comparison of oxidative capacity in active girls with mild Cystic Fibrosis and 
healthy controls. 
7.1 Introduction 
The association between increased severity of pulmonary disease and reduced nutritional 
status with reduced exercise tolerance in patients wr& Cystic Fibrosis (CF) has 
previously been established [Coates et al, 1980]. The pathophysiology of reduced 
exercise tolerance in patients with cystic fibrosis is however, not completely understood. 
Although intrinsic abnormalities in the skeletal muscle cells of patients with CF have 
been identified, the clinical impact of these abnormalities is unclear. Abnormalities have 
been demonstrated in the mitochondria of fibroblasts and leucocytes and include 
increased calcium concentration [Shapiro, 1989], lower nicotinamide adenosine 
dehydrogenase activity (respiratory chain enzyme complex) [Dechecchi et al, 1988] and 
a higher pH optimum of nicotinamide adenosine dehydrogenase [Shapiro et al, 1979]. 
De Meer et al [1995] assessed in vivo mitochondrial performance in a small group of 
patients with moderate to severe cystic fibrosis during oxidative work and demonstrated 
increased intracellular pH. It was not clear if the intracellular differences were due to the 
primary defect conferred by the CFTR mutation on skeletal muscle, or, the secondary 
effects of severe CF disease, such as, poor nutrition, low physical activity levels and 
deconditioning. In order to attribute the cause of the intracellular differences to primary 
or secondary effects of CF disease, it is necessary to study patients with mild CF disease, 
who are physically active with good nutritional status. 
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Gender differences in life expectancy are most evident in females with CF under 
the age of 20 years, who are 60% more likely to die than males of the same age 
[Rosenfeld et al, 1997]. Orenstein and Nixoa [1991] have demonstrated that girls with 
CF had a lower peak aerobic capacity than boys with CF of the same age. As aerobic 
capacity is an important predictor of survival [Nixon et al, 1992], the aetiology of the 
gender difference in the survival of patients with CF may be related to differences in 
muscle function. This study therefore aimed to study intracellular differences in muscles 
of girls with mild CF compared to healthy matched controls. 
7.2 Materials and Methods 
Subjects 
Girls with CF who were 13 years of age or older, who had participated in the previous 
study on resting energy expenditure and activity levels and who had "mild" CF disease 
were recruited for the study (chapter 6). Only subjects who were;§till participating in 
representative level (regional or state), competitive sport were eligible for the study. 
"Mild CF" disease for the purposes of this study was defined as normalpulmonary 
function tests (forced expiratory volume in one second of greater than 80% predicted) 
and a Shwachman score of greater than 70 [Shwachman and Kulczycki, 1958]. The 
subjects were excluded if there was a history of pulmonary exacerbation in the three 
months preceding the test. The control population consisted of the female training 
partners of the girls with CF who were matched for age and pubertal stage [Tanner et al, 
1966]. 
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Parameters of Assessment 
Lean body mass was calculated using skinfold thickness and the equations provided by 
Durnin and Rahamaa [1967]. Height was measured by a Harpenden stadiometer and 
weight by electronic scales. The aerobic and anaerobic performances, and activity levels 
of each subject was assessed and reported in the previous chapter. The genotype of each 
subject with CF was recorded. The girls with CF were assessed for CF related diabetes 
(CFRD) by obtaining a history and checking their serum glycosylated haemoglobin 
(HbAlC). 
Each subject exerted maximal force for 2 seconds against a purpose- designed 
balloon followed by a 1 second rest period while lying prone in the MR spectroscope 
(1.5 Tfila NMR Spectrometer, Philips SI5 HP). The exercise was repeated until 
exhaustion, as determined by the Borg score of dyspnoea [Borg, 1982]. A computerised 
audio-visual metronome, designed specifically for the study, guided the subject through 
each phase of the exercise. Measurements of inorganic phosphorous (Pi), 
phosphocreatine (PCr) and intracellular pH were taken from the vastus lateralis muscle 
of the non dominant leg. The force output was measured for each contraction and total 
work calculated for the complete exercise protocol in the spectroscope. The same 
exercise protocol was repeated three times for each subject using a Cybex dynamometer 
(Lumex Inc, Ronkonkoma, NY) to assess the reproducibility of the total work output 
during the exercise protocol. 
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The study was approved by the Ethics Committee of the Royal Alexandra 
Hospital for Children and written consent was obtained from all participants and their 
parents where applicable. 
Data Analysis 
The group mean and standard error of the mean (SEM) was calculated for each 
parameter. The z scores were calculated for each subject's height and weight using data 
from the National Center for Health Statistics [1979]. The lean body mass was 
calculated from skinfold thickness. 
To assess the reproducibility of the exercise protocol, multiple comparisons were 
adjusted for, using ANOVA, to obtain the mean difference in total work output. Further, 
the correlation between the total work output during the Cybex dynamometer test and 
the same exercise protocol in the MR spectroscope was assessed using Pearson's 
correlation (r). A curve utilising non-linear least squares analysis, based on mixed 
Lorentzian and Gaussian line shapes, was used to calculate the areas under Pi, PCr and 
beta-ATP peaks. This method has previously been described by Zanconato et al, [1992]. 
The ratios Pi/ PCR and PCr/ beta ATP were then determined. Measurements were 
compared at rest, and at 25 %, 50%, and 75% of maximal work output, and when 
maximal work output was reached. To compare the results from the MR spectroscopy, 
two tailed paired Students /- tests were used to compare mean differences between the 
group with CF and healthy controls. Values above the 95% confidence interval were 
considered statistically significant (p<0.05). 
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7.3 Results 
Eight girls with CF and their training partners took part in the study. All subjects played 
representative sports. The sports each pair of subjects (CF patient and training partner) 
participated in were netball (n= 4), basketball (n=2), hockey (n=l), and gymnastics 
(n=l). 
The girls with CF had mild disease as demonstrated by a mean Shwachman score 
of 89.0 (SD 7.3), and a mean forced expiratory volume in one second of 88% (SD 9.0) 
predicted and were all pancreatic Insufficient requiring daily pancreatic enzyme 
replacements. Three girls with CF were homozygous for the delta F508 gene mutation. 
The other five subjects were heterozygous for the delta F508 gene mutation (second 
mutation G551D, n=3; G542X, n= 1; N1303K, n=l). None of the girls with CF had any 
evidence of CF related diabetes mellitus. The mean age and pubertal stage [Tanner et al 
1966] of the girls with CF participating in the study was 15.8 years (range 14,6 - 17.1 
years) and stage 4.6 (SD 0.7), respectively. This was not significantly different to the 
control subjects' mean age and pubertal stage of 15.9 years (range 14.7-17.0) and stage 
4.8 (SD 0.6) [Tanner et al, 1966], respectively. The demographic details of the study 
population are presented in Table 7.1. There were no significant differences between the 
girls with CF and their training partners in terms of anthropometric details. 
The exercise protocol was highly repeatable with a mean difference in total work 
output of 6.5 J (SD 3.19, 95% CI -2.46 ,8.18) between each repetition of the test. The 
mean total work output generated by girls with CF using this exercise protocol was 170 J 
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(SD 35) while the healthy controls produced 246 J (SD 41). This difference in total work 
output was statistically significant (paired sample t test, p<0.05). There were however, 
no significant differences between the two groups in the Borg's score at the termination 
of the test (9.5 SE 0.8 for CF m. 9.4 SE 0.7 for controls). 
There were no significant differences in intracellular pH between the two groups 
at rest (7.02 SE 0.04 for girls with CF vs 7.04 SE 0.06 for controls). However, girls with 
CF had a significantly higher pH 6.99 (SE 0.06) than controls pH 6.90 (SE 0.05) 
(pO.Ol) when 25% of the total work output was reached. This difference was 
maintained until maximal work output was reached (pH 6.96 SE 0.06 vs 6.82 SE 0.05, 
pO.Ol) and is demonstrated graphically in Figure 7.1. When comparison was made of 
the muscle pH between girls with CF after maximal work output was reached and the 
matched controls after the same work output was achieved, significant differences were 
demonstrated (girls with CF pH 6,96 SE 0.06 vs healthy controls 6.86 SE 0.05, p<0.05). 
At rest, girls with CF had an inorganic phosphate / phosphocreatine ratio of 0.24 
(SE 0.08) compared with healthy controls who had a ratio of 0.23 (SE 0.07). The 
difference in the ratio was statistically significant when 25% of total work output was 
reached where the ratio was 0.34 (SE 0.07) and 0.41 (SE 0.08) for girls with CF and 
healthy controls respectively (p<0.05). At maximal work output, the inorganic phosphate 
/ phosphocreatine ratio was 0.54 (SE 0.08) and 0.88 (SE 0.07) for girls with CF and 
healthy controls respectively (p<0.01). This is demonstrated graphically in Figure 7.2. 
When comparison was made of the inorganic phosphate/ phosphocreatine ratio between 
girls with CF after maximal work output was reached and the matched controls after the 
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same work output was achieved, significant differences were demonstrated (0.54 SE 
0.08 in girls with CF vs 0.43 SE 0.06 in health controls, p<0.05). 
There were no significant differences in the phosphocreatine/ beta ATP ratio at 
rest between girls with CF (2.85 SE 0.28) and healthy controls (2.90 SE 0.31). At 25% 
of maximal work the ratio was 2.58 (SE 0.25) for girls with CF and 2.37 (SE 0.29) for 
controls (pO.Ol). At maximal work output, the ratio of phosphocreatine/ beta ATP was 
1.90 (SE 0.26) for girls with CF and 1.69(SE 0.28) for controls (pO.Ol). This is 
demonstrated graphically in Figure 7.3. When comparison was made of the 
phosphocreatine/ beta ATP ratio between girls with CF after maximal work output was 
reached and the matched controls after the same work output was achieved, significant 
differences were demonstrated (1.90 SE 0.26 for gg&i with CF vs 2.07 SE 0.28 for 
healthy controls, p<0.05). 
The recovery rate after exercise measured in terms of the inorganic phosphate to 
phosphocreatine ratio was 0.24 /min for girls with CF and 0.42 /min for healthy controls. 
This difference was also statistically significant (p<0.01). 
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TABLE 7.1: Demographic details of study population 
All values shown are the mean values with the standard deviation in brackets 
FIGURE 7.1: Comparison of intracellular pH in girls with mild CF and healthy 
matched controls at maximal work output. 
Solid bars indicate values from patients with CF while open bars indicate values from 
the matched controls 
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FIGURE 7.2: Comparison of Inorganic phosphate/ Phosphocreatine ratio in girls 
with mild CF and healthy matched controls at maximal work output 
Solid bars indicate values from patients with CF while open bars indicate values from 
the matched controls 
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FIGURE 7.3: Comparison of Phosphocreatme/ beta ATP ratio in g\A with mild 
CF and healthy matched controls at maximal work output. 
Solid bars indicate values from patients with CF while open bars indicate values from 
the matched controls 
7.4 Discussion 
The results of this study demonstrate that girls with mild CF had significant differences 
in intracellular pH, inorganic phosphate / phosphocreatine ratio and phosphocreatine/ 
beta ATP ratio during high intensity exercise when compared to healthy matched 
training partners. These differences became increasingly apparent as the total work 
output increased. Girls with CF demonstrated significant deficiencies in anaerobic 
metabolism as well as inefficient and insufficient oxidative metabolism compared to 
healthy controls. As the subjects with CF were physically active with good nutritional 
status, the secondary effects of severe CF disease appear to be non contributory. The 
results provide support for Shapiro's hypothesis [1989] that that there is an intrinsic 
mitochondrial and cellular defect in the muscles of patients with Cystic Fibrosis. 
The high intensity exercise protocol required the subjects to repeatedly exert 
maximal force. Thu^ although aerobic and anaerobic mechanisms for ATP production 
run concurrently, the anaerobic mechanism provided an increasing proportion of energy 
as the work output increased. As muscle work output increases, adenosine diphosphate 
(ADP) and inorganic phosphate (Pi) are released from the breakdown of ATP and 
phosphocreatine (PCr). The ratio of Pi/ PCr is thus directly proportional to the rate of 
mitochondrial oxidative metabolism [Chance et al, 1986]. As the rate of ATP hydrolysis 
approaches fee maximal rate of tissue oxidative phosphorylation, anaerobic glycolysis, 
activated by ADP and Pi9 becomes the principle metabolic mechanism for energy 
production. Glycolysis results in the accummulation of lactic acid and hydrogen. By 
measuring hydrogen, the MR spectrsocope is able to quantify intracellular acidosis. This 
study demonstrated that despite high intdftity exercise, girls with CF did not develop 
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significant intracellular acidosis. This suggests that the rate of anaerobic glycolysis in 
girls with CF may be insufficient to meet the energy demands of the exercising muscle. 
This is the first study to demonstrate deficiencies in anaerobic glycolysis in girls 
with CF. The Pi/ PCr ratio at maximal work output, which reflects mitochondrial 
oxidative metabolism, was significantly lower in girls with CF compared to healthy 
controls. This suggests that the maximal mitochondrial oxidative capacity is reduced in 
CF. When the same work output was performed, the Pi/ PCr ratio was however, 
significantly higher in girls with CF compared to healthy controls. This suggests that 
mitochondrial oxidative metabolism in girls with CF is inefficient, requiring utilization 
of greater phosphocreatine stores to perform the same amount of work as the healthy 
controls. The ratios of PCr/ beta ATP is similarly consistent with a reduced maximal 
mitochondrial oxidative capacity as well as inefficient mitochondrial oxidative 
metabolism compared to healthy controls. The inefficient oxidative metabolism 
demonstrated in this study is consistent with the results of De Meer et al [1995]. De 
Meer et al [1995] however, demonstrated these differences in adolescents with moderate 
to severe CF disease with impaired nutrition, whereas this study has demonstrated the 
differences are present in girls with mild CF, who are physically active and well 
nourished. It may be that the Cystic Fibrosis Transmembrane Regulator, which is 
involved in transmembrane chloride transport, and, is expressed in skeletal muscles 
[Denning et al, 1992a; Sheppard and Welsh, 1999], may be affecting both oxidative and 
anaerobic metabolism,. 
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Ramjeesingh et al [1999] demonstrated the catalytic and chloride channel gating 
properties of CFTR. Of importance to this study, CFTR has ATPase ac#i ty which 
results in depletion of energy stores such as phosphocreatine. Gadsby et al [1998] 
demonstrated that CFTR causes ATP hydrolysis. This is a possible mechanism for the 
inefficient oxidative and anaerobic metabolism demonstrated in this study. Essential 
fatty acid deficiencies may be another mechanism of inefficient energy utilisation 
[Freedman et al, 1999]. The subjects in this stuSy did not however, demonstrate the 
clinical features of fatty acid deficiency. Quantitative or, qualitative abnormalities of 
insulin action in skeletal muscles may produce the observed effects on glycolysis but not 
oxidative phosphorylation [Majer et al, 1998]. Cystic fibrosis related diabetes mellitus 
was excluded in all the subjects with CF by obtaining a history and serum glycosylated 
haemoglobin. The results were not therefore confounded by this possibility. 
Subjects with CF and who are pancreatic insufficient but without overt diabetes 
have been demonstrated to have significanly increased peripheral insulin sensitivity 
[Moran et al, 1994]. As insulin inhibits glycogenolysis [Boiteux and Hess, 1981] the 
acquisition of energy through skeletal muscle glycogenolysis may be reduced in this 
group of subjects. Skeletal muscle glycogenolysis is necessary for aerobic and anaerobic 
work and therefore, this may be a cause of exercise limitation in subjects with CF. 
The exercise protocol used, consisting of 2 seconds squeezing and 1 second rest 
until exhaustion, was demonstrated to be highly reproducible using the Cybex 
dynamometer. Comparisons were made between the subject and control groups both at 
designated percentages of maximal work output as well as at the raw maximal work 
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output of the subject. This enabled conclusions to be drawn about the efficiency and 
maximum capacity of oxidative and anaerobic metabolism in girls with CF and healthy 
controls. 
Selection bias may be a confounder in this study if female athletes with mild CF 
acquired their energy to perform exercise through a different mechanism to sedentary 
subjects with mild CF. However, as there is no evidence that active subjects with CF 
acquire their energy through a different metabolic mechansisms to sedentary subjects, 
this form of selection bias would seem unlikely. It could form the basis of future 
research. Other biases could arise from the fact that the absence of a clinical history of 
diabetes and a negative glycosylated haemoglobin test does not exclude diabetes. 
However, the current recommendations that are followed by our institution is to perform 
formal oral glucose tolerance tests if there is a history suggestive of diabetes, 
unexplained deterioration in disease status and, or, if there is an abnormal glycosylated 
haemoglobin test [Moran et al, 1999]. Thus it is unlikely we have overlooked the 
presence of CF related diabetes l a these patients although it is possible that peripheral 
insulin sensitivity may be a contributing factor to the inefficient muscle metabolism in 
these pancreatic insufficient patients [Moran et al, 1994] 
In conclusion, this study has demonstrated that girls with mild CF had deficient 
anaerobic metabolism as well as inefficient and deficient oxidative metabolism 
compared to healthy controls during high intensity exercise. Further studies need to be 
performed to elucidate if sedentary patients with mild CF demonstrate a similar profile 
of muscle metabolism. 
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CHAPTER 8 
Changes in lung function, peak aerobic capacity and quality of life in hospitalised 
children with Cystic Fibrosis. 
8.1 Introduction 
Lung function tests are commonly used to assess both the severity of lung disease and 
the response to treatment for an acute pulmonary exacerbation in patients with CF. 
However, as there is a high degree of within patient variability-of lung function tests in 
patients with CF [Nickerson et al, 1980; Cooper et al, 1990], its usefulness has been 
questioned [Gozal et al, 1993]. Redding et al [1982] suggested that the minimum change 
in forced expiratory volume in one second (FEVi) and forced vital capacity (FVC) that 
was likely to be clinically significant in patients with CF was greater than 15 % of 
predicted values. Lung function tests in more severe disease may be even more 
unreliable due to variablity in flow at low lung volumes [Nickerson et al, 1980]. 
While lung function tests are often used to monitor clinical improvement, it is 
not known how they compare with maximal exercise tests in detecting change. The 
purpose of this study was to compare lung function tests and maximal exercise tests, and 
ascertain which test had a greater change from admission and which test correlated 
better with changes in quality of life, and weight gain. 
8.2 Materials and Method 
Subjects 
Patients with CF, between the ages of 7 and 17 years, who were admitted to hospital 
with a pulmonary exacerbation between January 1997 and June 1997 were eligible for 
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the study. A pulmonary exacerbation, for the purpose of this study, was defined as an 
increase in cough and sputum production. Patients were excluded if they were unable to 
reliably perform lung function tests. 
Study Design 
The severity of CF disease using the Shwachman score [Shwachman and Kulczycki, 
1958] was recorded on all patients by their usual physician. All patients were treated 
with intravenous antibiotics according to the previous sputum cultures and modified, if 
necessary, after sputum cultures from admission became available. The patients also 
received regular intensive chest physiotherapy and participated in gym activities. They 
did not participate in a particular prescribed exercise program. Supplemental oxygen 
therapy and nutritional support was provided if clinically indicated. 
Total body mass was measured on the day of admission and again on discharge 
from hospital. Lung function tests were performed within 24 hours of admission. The 
best forced vital capacity (FVC), and forced expiratory volume in one second (FEVi) 
were obtained and corrected for body temperature and atmospheric pressure. The 
functional residual capacity (FRC), residual volume (RV) and total lung capacity (TLC) 
were measured with a body plethymograph (Sensormedics 2800 Autobox, Yorba Linda, 
CA). The values presented by Polgar and Promadhat [1971] was used as the reference 
range. 
The subjects performed an incremental treadmill (Cardiovit 100 Schiller, 
Switzerland), exorcise test using the modified Bruce protocol [Stranghelle, 1998], 
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During the test, breath by breath gas analysis was performed and minute ventilation 
(VE), oxygen uptake (V02), carbon dioxide production (VCO2) and respiratory 
quotients (RQ) were recorded. The exercise tests were performed within 36 hours of 
admission, and on the day of discharge from hospital. 
An assessment of quality of life was made using the quality of well being scale 
as reported by Orenstein et al9 [1989]. This was measured within 24 hours of admission 
to hospital and again within 1 week of discharge from hospital. 
Data Analysis 
The mean change from baseline for the parameters of assessment was calculated and a 
two- tailed paired Student's t test was used to assess the statistical significance of any 
changes from baseline. Significance was assigned when p<0.05. Group differences for 
the repeated measures were analysed using Duncan's test of multivariate analysis of 
variance. The SPSS-PC+ package (version 5.0) was used for statistical analysis. The 
correlation between changes in lung function and peak aerobic capacity after hospital 
therapy and changes in quality of life was assessed using Pearson's correlation. 
8.3 Results 
Thirty five children, comprising 16 boys and 19 girls, with a mean age of 13.3 (SD 3.2) 
years were enrolled in the study. The mean duration of admission was 18.4 (SD 4.0) 
days. The mean score for disease severity, using the Shwachman score was 66 (SD 19). 
Twenty patients had a score of > 70 and 15 had a score < 70. There were no major 
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complications such as haemoptysis or pneumothorax in any of the patients with CF. All, 
but two of the patients were pancreatic insufficient necessitating pancreatic enzyme 
replacement. Four patients received supplementary overnight nasogastric feeds. Thirty 
two patients isolated at least one strain of Pseudomonas aeruginosa in their sputum, two 
isolated Staphylococcus aureus and or© isolated Haemophilus influenzae. 
As a group, patients demonstrated significant improvements in FEVi, FVC and 
RV from admission to discharge. There were also significant improvements in aerobic 
capacity, dyspnoea index, quality of life and body mass (Table 8.1). However, when the 
results were analysed according to the severity of CF disease, using Duncan's test of 
multivariate analysis of variance, patients with mild disease (Shwachman score > 70) 
had significantly greater improvements in FEVI than patients with moderate to severe 
disease (Shwachman score < 70). The change in FEVi from admission to discharge, was 
not statistically significant in patients with moderate to severe disease (Table 8.2). The 
changes in FVC and TLC from admission to discharge were not significantly different 
between those with mild and those with moderate to severe disease. RV was 
significantly reduced in both mild and severe disease on discharge and there was no 
significant difference in the magnitude of change between the two groups. 
Peak aerobic capacity and breathing reserve (as measured by the dyspnoeic 
index) improved by almost fifteen percent from admission to discharge regardless of the 
severity of disease (Table 8.2). Quality of life also improved by a similar magnitude in 
both groups of disease severity. Body mass improved by about three percent in both 
groups. Changes in quality of life, as measured by the quality of well being scale, 
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correlated better with changes in peak aerobic capacity (Pearson's r = 0.57, p<0.05) than 
changes in FEVi (Pearson's r = 0.32). 
Using the Duncan's Post Hoc test of multivariate analysis, peak aerobic capacity 
had the greatest magnitude of change from admission to discharge followed by dyspnoea 
index, quality of life and RV. FEVi and FVC, from admission to discharge, were poor 
predictors of change especially in the more severely affected patients with CF. 
TABLE 8-1: Mean lung function and exercise test results at admission and 
discharge in 35 patients hospitalised with pulmonary exacerbation. 
FEV| Forced expiratory volume in one second 
FVC Forced vital capacity 
TLC Total lung capacity 
RV residual volume 
V02 Aerobic capacity 
Dyspnoea Index = Breathing reserve 
* p<0.05 ** pO.Ol ( Students t test) 
Values shown are the mean values with the standard error of the mean in brackets 
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TABLE 8.2 Percent changes in 20 patients with Shwachman score <70 compared to 
15 patients with Shwachman score > 70 
Values shown are the mean percentage changes from admission to discharge with 
standard error of the mean values in brackets. 
* Statistically significant difference from admission to discharge (p < 0.05, Students t 
test) 
+ Statistically significant difference between improvement in groups with 
Shwachman scores above and below 70 (p<0.05, Students t test) 
FEVj Forced expiratory volume in one second 
FVC Forced vital capacity 
TLC Total lung capacity 
RV residual volume 
' V02 Aerobic capacity 
Dyspnoea Index = Breathing reserve ' •* 
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Figure 8.1: Changes in quality of life compared to percent changes in peak aerobic 
capacity (V02) and lung function (FEVl). 
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8.4 Discussion 
This study has demonstrated that hospital therapy for acute pulmonary exacerbations 
produced improvements in peak aerobic capacity, dyspnoea index and quality of life. 
Lung function test parameters such as FEVi and FVC did not change as much as these 
other parameters, especially in patients with more severe CF disease. Furthermore, 
changes in quality of life correlated better with peak aerobic capacity than changes in 
lung function. 
To date, a great deal of emphasis has been placed on lung function tests by 
physicians and patients when assessing response to hospital therapy for pulmonary 
exacerbations in CF. However, lung function tests have previously been demonstrated 
to have significant intra-individual variability [Nickerson et al, 1980; Cooper et al, 
1990]. Although Redding et al, [1982] documented serial changes in lung function in 
children hospitalised with CF, the only study to date to analyse the changes according to 
severity of CF disease was by Gozal et al, [1993]. As in the present study, Gozal et al 
[1993] demonstrated that changes in lung function (FEVi, FVC) in patients with 
moderate to severe CF disease did not reach statistical significance. Gozal et al, [1993] 
also measured single breath nitrogen washout and concluded that changesnn nitrogen 
washout after hospital therapy, were better measures of change in patients with moderate 
to severe CF. It was postulated that this was because improved nitrogen washout 
reflected the improved pulmonary ventilation after hospital therapy. However, there was 
marked variability in the test, thought to be due to the effect of bronchodilators. Further, 
the equipment to measure nitrogen washout is not available in all lung function 
laboratories. 
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Exercise tests have obvious advantages over lung function tests and the nitrogen 
washout test in that while they also measure pulmonary ventilation, they are highly 
reproducible [Brown et al, 1985] and correlate significantly better with quality of life. 
As with the nitrogen washout test, exercise testing in this study detected significant 
changes in patients with moderate to severe disease which were not apparent with 
standard lung function tests. This is likely because exercise tests, and in particular 
aerobic capacity and dyspnoea index, are indirect measures of alveolar ventilation. 
Quality of life was assessed uSing the quality of well being score [Orenstein et al, 
1989]. This assessment has only been validated in the outpatient setting. In this study, 
the assessment was administered on the day of admission to hospital and again within 1 
week of discharge. The emphasis of the admission assessment was on how the subject 
felt over the two weeks preceding admission, although the subjects' dislike of being 
admitted to hospital may have affected this assessment. 
All the children who were admitted to hospital for therapy were encouraged to 
be as active as possible while in- patients. Thus, while a formal training program was not 
undertaken, all the children participated in thrice weekly activities such as basketball 
games and bicycle riding. Each session lasted 20 minutes and this may account for the 
lack of deconditioning in the children while in hospital. 
In conclusion, this study has demonstrated that clinical improvement in children, 
with moderate to severe CF disease, after hospital therapy for pulmonary exacerbation 
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was not associated with significant spirometric changes but was associated with 
significant changes in aerobic capacity. Thus, exercise testing was a better indicator of 
change in children with moderate to severe CF than lung function testing which 
underestimates the degree of clinical improvement. 
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CHAPTER 9 
" Validation of the shuttle tests in children with Cystic Fibrosis 
9.1 Introduction 
Exercise testing is a valuable tool for gauging the physiological impact of chronic lung 
diseases such as Cystic Fibrosis (CF). Exercise tolerance reduces as the patient's lung 
function deteriorates [Cropp et al, 1982] and there is a high correlation between exercise 
tolerance measured by aerobic fitness and long term survival [Nixon et al, 1992]. As 
exercise tolerance has become an important outcome measure of the effectiveness of 
interventional trials in patients with CF [Ramsey and Boat, 1994], there is clearly a need 
to validate a reliable, and sensitive test of maximal, aerobic fitness in children with CF. 
While a maximal test on a treadmill is considered the "gold standard" [Orenstein, 1998], 
it is expensive, not readily accessible and threatening to young children. To facilitate 
assessment in children, the test should be non-threatening, simple to perform, 
inexpensive and easy to adrninister [Orenstein, 1998]. 
Shuttle tests, in which a subject walks (10m test) or runs (20m test) between two 
markers, are potentially very useful in measuring the effectiveness1 ~~of clinical 
interventions. The two shuttle tests commonly in use are the 10m shuttle walk which 
was developed by Singh et al [1992, 1994] and the 20m shuttle run which was 
developed by Leger et al [1988]. These tests are effective measures of the aerobic fitness 
as they measure the linear relationship between the rise in maximal oxygen uptake 
(V02) and changes in running or walking speed [Menier and Pugh, 1968]. Assessment 
of their validity has been made in healthy children [Van Mechelin et al, 1986; Leger et 
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al, 1988; Liu et al, 1992; McVeigh et al, 1995], athletes [Ramsbottom et al91988], and a 
sedentary adult population [Paliczka et al, 1987]. Neither of the shuttle tests have 
however been validated in children with lung disease. The aim of this study therefore 
was to assess the reproducibilty and validity of the shuttle tests, by comparing results 
obtained in these tests with those obtained from assessing treadmill peak aerobic 
capacity in children with Cystic Fibrosis. 
9.2 Materials and Methods 
Subjects 
Children aged 6 to 16 years who attended the CF clinic at the Royal Alexandra Hospital 
for Children were invited to take part in the study. We excluded children with 
intercurrent infective exacerbation, those known to have pulmonary hypertension, and 
those who were oxygen dependent. Power calculations demonstrated that to detect a 0.5 
standard deviation difference in peak aerobic capacity between the treadmill test and the 
shuttle test, with a significance of 0.05 and power of 80% a total of 30 subjects would 
be required. Approval for the study was obtained from the Royal Alexandra Hospital for 
Children Ethics Committee, and written informed consent was obtained from parents, or 
where appropriate from the study participant. 
Study Design 
Treadmill testing on all children was performed using the modified Bruce protocol 
[Orenstein, 1998]. Children performed either the 10m shuttle walk or the 20m shuttle 
run, or both tests. The 10m shuttle walk was used for all children who were 7 years of 
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age and younger, and those deemed too ill to perform the longer test. The 20m shuttle 
run was used in children older than 7 years. For the study, the children performed two 
identical shuttle tests and one treadmill test within a week. The order in which the 
shuttle tests and treadmill tests were undertaken was randomised. In those children 
doing both the 10m walk and the 20m run shuttle tests, the order of the testing was also 
randomised. 
The 10m test was performed as previously described by Singh and coworkers 
[1992] and the 20m test was performed as described by Leger and colleagues [1988]. 
Shuttle tests required the child to walk (10m test) or, run (20m test), between two 
markers delineating the respective course, at a set incremental speed determined by a 
computer generated signal which is played by a standard audio cassette player. The test 
was terminated when the subject was unable to keep up with the paced signals. A 
validated Rating of Perceived Exertion scale, also known as the Borg score [Borg, 1982; 
Burdon et al9 1982; Wilson and Jones, 1989] was administered to quantify dyspnoea 
after the shuttle runs and treadmill tests. 
The shuttle tests were performed with the subject wearing a firmly fitted 
facemask attached to the Cardiovit 100 CS Spirometry Module (Schiller, Switzerland) 
which has an in-built gas analyzer allowing measurement of breath by breath gas 
analysis throughout the test. The subject's heart rate was measured at rest and then 
continuously during testing using a heart rate monitor (Cardiosport, Australia). Pulse 
oximetry was measured via a finger probe (Biox 3700e, Ohmeda, Boulder, CO USA) 
throughout the test. The velocity for the 10m shuttle test is set at 1.8 km/hr for the first 
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minute and increased by 0.61 km/hr for every minute thereafter. The velocity (V) for the 
20m shuttle test is set at 8km/h for the first minute and increased by 0.5km/h for every 
minute thereafter. 
Prior to testing, each child's body weight, height and skinfold thickness were 
recorded. The skinfold assessment was made from four sites - the triceps, biceps, 
subscapular and suprailiac regions and was used to calculate the lean body mass [Durnin 
and Rahaman, 1967]. The aerobic capacity was recorded in terms of the lean body mass. 
Data Analysis 
In addition to the raw VO2 obtained by breath by breath gas analysis, the peak VO2 
values were calculated for the 20m shuttle test using previously published regression 
equations [Leger et al, 1988] namely V0 2 peak = 31.025 + (3.238 x Vmax) - (3.248 x A) 
where Vmax is the maximal velocity attained in the last stage in km/h and A is the age in 
years. Vmax was calculated as follows, Vmax (km/h)= V + 0.5x n/60, where V is the 
velocity maintained during the next to last stage and n is the number of seconds the last 
stage was maintained. 
Reproducibility between the first and second shuttle runs was measured by 
comparing the mean difference in peak aerobic capacity, heart rate, oxygen saturation, 
Borg score and distance cowed obtained in the two runs. Comparison of the results 
obtained for peak aerobic capacity, heart rate, oxygen saturation, Borg score and 
distant eovered for the shuttle test and treadmill tests were used to assess the validity of 
the shuttle test. 
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All data analysis was performed using the SPSS software package and 
differences in probability less than 5% (p<0.05) were considered significant. Mean 
differences were compared using paired Student's t-tests to assess reproducibility of the 
shuttle tests. The correlation between the peak aerobic capacity obtained by the shuttle 
test method and the treadmill method was measured using Pearson's correlation (r). 
Agreement between the shuttle test and the treadmill tests was demonstrated graphically 
using Bland-Altaian plots [Bland and Altman, 1986], 
9.3 Results 
The demographics of the children who participated in the study are shown in Table 9.1. 
The 10m shuttle test was completed by 35 children, the 20m shuttle test by 58 children 
and both the 10m and 20m comparison by 30 children. The shuttle tests were generally 
well tolerated by the children. Three children did not complete the initial 10m shuttle 
test due to coughing spasms. Another child withdrew due to joint pains. All four 
children did however, repeat the test without incident. Similarly, the treadmill tests were 
abandoned on four other children because of coughing spasms but, again, the tests were 
repeated without incident. Of the total of 108 subjects studied, 100 preferred the shuttle 
tests over the treadmill tests, 5 did not favour one type of testing over the other and 3 
preferred the treadmill test. 
10m shuttle test 
The results indicate that the 10m shuttle walk is a very reproducible test (Table 9.2, 
Figure 9.1 A). There were no significant differences between the first and second runs of 
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each shuttle test for maximal heart rate, distance walked, maximal saturato®, peak 
aerobic capacity and Borg score. For example, the mean difference in peak aerobic 
capacity measured in successive shuttle runs was 2.41ml/kg/min (SD 4.19, limits of 
agreement 3.46, -0.18). 
The 10m shuttle test also correlated well with the treadmill test (Table 9.3, 
Figure 9.2A). For example, the peak aerobic capacity measured using the shuttle test 
and the treadmill test differed by a mean of 5.30 ml/kg/min (SD 4.63, limits of 
agreement 7.46, -1.18) and the Pearson's correlation was 0.76 (p<0.05). Although the 
values for the other measured parameters assessed were lower in the shuttle test 
compared to the treadmill test, these differences were not statistically significant. 
The relationship between the distance walked and the peak measured aerobic 
capacity was strong (r = 0.91) and is represented by the regression equation: VO2 = 
[0.0289 x distance] + 17.46 where the distance that was walked is expressed in meters 
and the VO2 in ml/kg/min. 
20m shuttle test 
The 20m shuttle test was also very reproducible. There were no significant differences 
between the two shuttle runs in the measured heart rate, distance walked, saturation 
(oximetry), peak aerobic capacity and Borg score (Table 9.2, Figure 9.IB). As with the 
10m test, the mean different in peak aerobic capacity was very low, 2.07 ml/kg/min 
(SD 2.51, limits of agreement 3.90, -0.60). 
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The 20m shuttle test also correlated well with the standard treadmill test (Table 
9.3, Figure 9.2B). The peak aerobic capacity measured using the 20m shuttle test and the 
treadmill test differed by a mean of 3.50 rnl/kg/min (SD 3.20, limits of agreement 4.90, -
1.60). 
The Pearson's correlation between the peak aerobic capacity (measured by direct 
gas analysis) during the 20m shuttle test and the calculated aerobic capacity (using the 
formulae described above) was r = 0.71 (p<0.05). This correlation improved when 
weight age rather than the chronological age was used as the age variable (A). With this 
amendment, the Pearson's correlation between the raw and calculated value was r = 0.84 
(p<0.01).The mean difference between the direct gas analysis and the calculated value 
was 2.23 ml/kg/min (SD 1.32, limits of agreement 2.60, -1.93). A Bland and Altman plot 
comparing the two methods of estimating aerobic capacity is presented in figure 9.3. The 
relationship between direct gas analysis and the calculated method is presented by the 
regression equation: V02peak (direct)= 0.8 x VO2 (calculated) + 8.53. 
10m vs 20m shuttle test 
There was a moderate correlation [r = 0.60 (p<0.05)] between the measured peak 
aerobic capacity obtained by the 10m and 20m shuttle tests. The peak aerobic capacity 
measured using the 20m shuttle test and the 10m shuttle test differed by a mean of 7.89 
ml/kg/min (SD 3.67, limits of agreement -0.90, 9.90).However, when the peak aerobic 
capacity was corrected for the maximal heart rate attained during the test (oxygen pulse) 
the correlation was 0.83 (pO.Ol). 
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Eight subjects completed all the levels of the 10m shuttle test (mean age 13.6, 
range 12.0 to 16.5 years). The mean respiratory quotient (RQ) of these children was 
0.99, which demonstrated that the test was submaximal. The measured aerobic capacity 
at the conclusion of the test was recorded and included in the analysis despite these 
children not reaching maximal effort. 
The mean difference between the Borg Scpre after the two shuttle runs was -
0.75 units (SD 0.32, p<0.05). When the eight subjects who completed all the stages of 
the 10m shuttle test were excluded from analysis, the mean difference was no longer 
statistically significant (0.42, SD 0.22). 
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TABLE 9-1: Demographic details of Subjects 
flmean age in years 
BWZ mean body weight z score 
FEVi Forced expiratory volume in one second 
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Table 9.2: Repeatability of the 10m and 20m shuttle tests 
a
 difference in parameters measured in the first and second shuttle tests 
value measured using the gas analyser 
VO2 peak aerobic capacity 
HR heart rate 
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TABLE 9.3: Comparison of the shuttle and treadmill tests 
a
 difference in parameters measured in the first and second shuttle tests 
value measured using the gas analyser 
VO2 peak aerobic capacity 
HR heart rate 
FIGURE 9.1: Reproducibility in measurement of aerobic capacity in successive 
shuttle tests (A) 10 m shuttle walk, (B) 20 m shuttle run 
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FIGURE 9.2: Comparison of aerobic capacity measured by the shuttle and 
treadmill tests (A) 10m shuttle walk, (B) 20m shuttle run 
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Figure 9.3: Comparison of the measured and calculated methods of estimating 
aerobic capacity for 20m shuttle test (Bland and Altman plot). 
Difference (inl/kg/min) = measured aerobic capacity - calculated aerobic capacity 
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9.4 Discussion 
The results of this study demonstrate that both the 10m and 20m shuttle tests are valid 
measures of aerobic capacity in children with Cystic Fibrosis. The tests are reproducible 
and correlate well with the treadmill tes| in terms of peak aerobic capacity, maximal 
heart rate, maximum desaturation and Borg's score of exertion. 
The 10m arid the 20m shuttle tests correlated well with each other when the peak 
aerobic capacity was adjusted for heart rate. This was due to the fact that the fitter 
subjects were able to complete all the stages of the 10m shuttle walk without reaching 
peak aerobic capacity or maximal heart rate, but did reach these peaks with the 20m run 
test. To correct for this submaximal effort in the 10m shuttle test, the aerobic capacity 
was expressed in terms of the heart rate (known as the oxygen pulse). Similarly, while 
the Borg' score of exertion was significantly different between the two tests, the 
difference can be attributed to the eight children who completed the 10m shuttle test 
without reaching functional limitation. When the eight children were excluded from 
analysis, there was no longer a significant difference between the tests. These results 
suggest that while the 10m and 20m shuttle tests are independently valid tests, they can 
only be used interchangeably if the subject reaches maximal functional limitation in 
both. If this is not achieved, the oxygen pulse should be the parameter of choice. None 
of the children who completed all the stages of the 10m shuttle test were less than 7 
years of age. 
On the basis of our study, we suggest that 10m shuttle walk test should be used 
when studying either the young child (7 years of age or younger) or those with advanced 
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disease who are able to walk but not run. The 20m shuttle test should be used when 
studying children older than 7 years who are able to run. 
Both the shuttle tests and the treadmill tests resulted in steady increments in heart 
rate with the increase in exercise intensity. Although, the peak heart rate did not reach 
statistical significance, that reached during the treadmill test was greater than that 
obtained during the shuttle tests. This may be due to either the relatively more 
threatening laboratory environment of the treadmill test, or, that the treadmill test was 
genuinely a more maximal test. The former explanation is more likely given that the 
resting heart rates were also greater with the treadmilll test, although, this difference was 
not statistically significant. 
Given the excellent correlation between the measured VO2 and the calculated 
VO2, there is no necessity for direct gas analysis and hence, no requirement for 
expensive gas analysis machines and face masks. The peak VO2 can be calculated 
accurately from the subjects weight age and distance walked. This makes the shuttle test 
a very useful tool in clinical interventional trials. In our study, we modified the equation 
provided by Leger and colleague [1988] for calculating the peak aerobic capacity from 
the 20m shuttle test by substituting weight age for chronological age. The weight age is 
a commonly used parameter for assessing nutritional status in children. It is the age in 
years which corresponds to the point where the subject's weight meets the fiftieth 
percentile on a standard growth chart. 
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The validity of the 10m shuttle test has been assessed in adults with chronic 
airflow limitation and shown to be reproducible [Singh et al, 1992] and have good 
criterion validity with the treadmill VO2 [Singh et al, 1994]. The validity of the 20m 
shuttle test has been assessed in children without underlying cardiorespiratory disease 
and shown to be reproducible [Leger et al, 1988]. This study has added to these by 
validating Hie shuttle tests in children with cystic fibrosis. 
To date, the six minute walk test [Gulmans et al, 1996] and the step test 
[Balfour- Lynn et al, 1998] have been validated in children. However, the limitation of 
the six minute walk test is that being self paced, is it subject to great variability and 
hence is not suited to clinical intervention trials. The step test does not measure a 
maximal functional capacity and the workload will vary according to the step height, 
and the weight and height of the subject and therefore, is not suited to longer-term 
clinical intervention trials. The shuttle tests overcome these limitations by being 
externally paced maximal tests which measure maximal aerobic capacity. 
Unlike the treadmill or cycle ergometer test, the shuttle tests are non threatening. 
The subject can terminate the test at any point they choose. This was "particularly 
obvious in younger children and children with advanced disease who required 
persuasion to perform the treadmill test, but they were eager to perform the shuttle test. 
As the shuttle tests require tbe child to either wn or walk (depending on the test) 
between two markers, 4he tests do not necessitate acquisition of new skills to participate. 
This was reflected in our study by the overwhelming preference for the shuttle test over 
the treadmill tes t 
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Shuttle tests are frequently used in schools and by sporting teams, and therefore 
the children did not require extenrfve instructions on how to participate. The subject is 
accompanied for only the first minute of the test by the investigator. There was no 
significant "learning effect" seen in the study. 
A portable pulse oximeter was used for the study. To improve the accuracy, the 
probe was taped to the index finger and the lead was strapped to the arm [Orenstein et 
al, 1993a]. Movement artifact was a problem encountered infrequently with the 10m 
shuttle walk and more commonly with the 20m shuttle run. A finger probe was preferred 
over the use of an ear lobe probe because of the improved accuracy as demonstrated by 
the studies performed by Gaskin and Thomas [1995]. 
In conclusion, the 10m shuttle walk and the 20m shuttle run tests are 
reproducible, valid assessments of maximal function limited aerobic capacity. Given the 
much greater patient preference over the treadmill test, the shuttle tests should be 
utilised in the assessment of aerobic capacity in the child with cystic fibrosis as well in 
interventional studies. 
173 
CHAPTER 10 
A randomised controlled study of in-hospital exercise training programs in 
children with Cystic Fibrosis 
10.1 Introduction 
Lung function and exercise tolerance are maintained in patients with mild Cystic 
Fibrosis (CF), but deteriorate as the disease progresses [Cropp et al, 1982]. Patients with 
high levels of aerobic fitness have a much better long term survival than those with 
lower levels of fitness [Nixon et al, 1992], Exercise traimng programs aim to preserve 
and improve aerobic fitness and are recognised as essential components of pulmonary 
rehabilitation [Boyle et al, 1976; Lacasse et al, 1996, ACCP/AACVPR Guidelines 
1997]. 
The two commonly used exercise training programs are aerobic training (at) and 
resistance or weight training (rt). The principal difference is that aerobic training is 
directed at improving cardiovascular conditioning and resistance training is aimed at 
improving muscle strength. Most studies on the effect of exercise training programs 
have been performed in adult CF patients [Orenstein et al, 1981; O'Neill et al, 1987; 
Heyerman et alt 1991; De Jong et al, 1994]. There are a limited number "of aerobic 
training studies performed in children with CF, These were all performed in the 
outpatient setting and had small sample sizes [Zach et al, 1982; Edlund et al, 1986; 
Andreasson et al, 1987; Gulmans et al, 1996]. There have been no previous studies on 
the effect of training programs in children with CF admitted to hospital with an infective 
pulmonary exacerbation, or, on the effect of resistance training in children with CF. 
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The aim of this study was to compare groups performing aerobic and resistance 
training with a control group in children with Cystic Fibrosis admitted to hospital with 
an intercurrent pulmonary infection. 
10.2 Materials and Methods 
Subjects 
Children with CF, between the ages of eight and sixteen years, who were admitted to the 
Royal Alexandra Hospital for Children for the treatment of an infective pulmonary 
exacerbation were eligible for the study. An infective pulmonary exacerbation was 
diagnosed if there were features of increased cough and purulent sputum. An abnormal 
chest X ray, weight loss and generalised malaise were frequently associated with the 
infective pulmonary exacerbation. Children with known pulmonary hypertension or, 
wi© required daytime oxygen prior to the infective exacerbation which lead to the 
hospital admission were excluded from the study. 
Power calculations revealed that to a total of 60 subjects would be required to 
detect a 0.5 standard deviation difference in aerobic capacity and muscle strength 
between each of the training programs, with a significance of 0.05% and power of 
80%. 
Study Design 
Each subject received the standard in hospital care which included intravenous 
antibiotics (chosen on the basis of the sensitivities of the pathogenic organism in the 
sputum or bronchoalveolar lavage), chest physiotherapy and nutritional 
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supplementation. The subjects were randomised into three training groups within the 
first day of admission. The randomisation was performed in blocks of six, using 
concealed information inside opaque envelopes. The three training groups were aerobic 
trainings resistance Wining and control group. 
Parameter of Assessment 
Anthropometrics 
All subjects had their weight measured using an electronic scale (Metier IDI multimap, 
Tiel, The Netherlands) between 9am and 10am. The height was also recorded at the 
same time (Holtain, Crymich, UK). The measurements were transformed into standard 
deviation scores [Hamill et al, 1979]. The fat free mass (FFM) was calculated using the 
skin fold thickness from four sites (biceps, triceps, subscapular and supra iliac crest) 
Purnin and Rahaman, 1967]. 
Pulmonary Function Tests 
Pulmonary function tests were performed within 36 hours of admission and repeated on 
discharge from the hospital and again at one month after discharge. Measurements of 
forced expiratory volume in one second (FEVi) and forced vital capacity1 (FVC) were 
obtained (Sensormedics 2800 Autobox, Yorba Linda, CA). The values presented by 
Polgar and Promodhat [1971] was used as the reference range. 
Exercise Tests 
All subjects performed an incremental treadmill (Cardiovit 100 Schiller, Switzerland). 
exercise test using the modified Bruce protocol. During the test, gas analysis was 
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performed and minute ventilation (VE), oxygen uptake (V02), carbon dioxide 
production (VCO2) and respiratory quotients (RQ) were recorded. The exercise tests 
were performed within 36 hours of admission, on discharge and one month after 
discharge from hospital on all subjects. Lower limb strength was measured using a 
Cybex dynamometer (Lumex Inc, Ronkonkoma, NY). The muscles tested were the 
quadriceps femoris and the hamstrings of the non-dominant leg. The best of three 
repetitions were recorded as the strength of the tested muscle group. The strength tests 
were performed on the same day as the incremental exercise tests. 
Quality of Life 
An assessment of quality of life was made using the quality of well being scale as 
reported by Orenstein et al, [1989] and Kaplan et al, [1989], As this scale was 
previously validated only in the outpatient setting, it was administered on the day of 
admission and one month after discharge from hospital. 
Levels of Activity 
Subjects completed a seven day activity diary [Bouchard et al, 1983; Bratteby et al, 
1997] as well as wearing an activity accelerometer [Freedson et al, 1998; Trost et al, 
1998] for seven days prior to admission to hospital. These subjects repeated the seven-
day activity diary as well as wearing the activity monitor for a week one month after 
discharge from hospital. 
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Study Design 
Aerobic Training 
Children randomised to the aerobic training group participated in aerobic activities for 
five sessions (each of thirty minutes duration) a week. The aerobic activities comprised 
running on a non motorised treadmill, or cycling on a stationary bicycle at a speed which 
maintained the heart rate at seventy percent of the maximal heart rate for thirty minutes. 
Subsequent to the exercise test performed on admission where expired gas analysis was 
performed, each subject performed a maximal exercise test (non motorised treadmill or 
cycle, without gas analysis), every five days to determine the individual's peak heart 
rate. The peak heart rate from the most recent exercise test was used to determine the 
target heart rate (70% of peak heart rate) for the training program. The training was 
terminated earlier than the mandatory thirty minutes if a subjective index of dyspnoea, 
also known as the Borg score [Borg, 1982], reached seven. 
Resistance Training 
Subjects randomised to the resistance training group exercised both upper and lower 
limbs against a graded resistance machine (Tidro-power, Keylink, Adelaide, South 
Australia). At each visit, the subject would increase the resistance until a Borg score of 
WUa was reached. At this level of resistance, the subject would perform five sets often 
repetitions before exercising the same movement in the contralateral limb. The 
procedure was repeated for both arms and legs. As with the aerobic training group, 
subjects in the resistance-training group attended five sessions per week. 
178 
Control Group 
Subjects in the control group received the standard chest physiotherapy as well as 
intravenous antibiotics and nutritional supplementation. 
Data Analysis 
The parameters of assessment measured on admission, discharge and one month after 
discharge were lung function (FEVi, FVC), peak aerobic capacity, total body mass, fat 
free body mass, muscle strength and levels of activity. Quality of life, using the quality 
of well being scale, was compared at admission and one month after discharge from 
hospital. The peak aerobic capacity was expressed in terms of the fat free mass. 
The mean change from baseline for each of the three groups for the parameters 
of assessment was calculated and a two tailed paired Student's t test was used to assess 
the statistical significance of any changes from baseline. Significance was assigned 
when p<0.05 [Airman 1991]. Group differences for the repeated measures were analysed 
using Duncan's test of multivariate analysis of variance. The SPSS-PC+ package 
(version 5.0) [Nie 1975] was used for statistical analysis. The correlation between 
changes in lung function and peak aerobic capacity after hospital therapy and~changes in 
quality of life was assessed using Pearson's correlation. 
10.3 Results 
Sixty six children participated in the study. Four children initially consented to the study 
tb®& subsequently were excluded prior to randomisation due to patient and, or parental 
concerns about the possibility of being randomised into the control group. The 
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demographic details of the children who participated in the study are presented in Table 
10.1. There was a wide range of disease severity in the study sample and no significant 
differences between the groups for any of the assessed parameters. The male to female 
ratio was, likewise, not significantly different between the three groups. Although none 
of the children were withdrawn from the study, one subject in the control group 
developed haemoptysis on day 9 of admission and withdrew from the study for the 
subsequent 2 days. One subject in the aerobic training group injured her ankle while on a 
day pass and missed the subsequent 2 days of aerobic training. The mean duration of the 
hospital admission for the aerobic training, resistance training and control groups was 
not significantly different (18.6 (SD 3.9), 18.8 (SD 4.1) and 18.6 (SD 3.8) days 
respectively). 
The changes from admission to discharge for each of the parameters of 
assessment (except for the quality of life score which was measured on admission and 
one month after discharge) are presented in Table 10.2. Aerobic training produced 
significant improvements in peak aerobic capacity (21.64%), FEVi (6.54%), quality of 
life (14.28%) and body mass (2.09%). Resistance training produced significant 
improvements in FEV! (10.09%), lower limb strength (18.32%) and body mass (7.25%). 
The control group had significant improvements in FEVi (4.51%) and body mass 
(2.69%). Although the peak aerobic capacity and lower limb muscle strength decreased 
in the control group, this reduction did not reach statistical significance. 
There were no significant changes in any of the objective parameters from the 
time of discharge to one month post discharge (Table 10.2). However, subjects who 
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participated in aerobic training while in hospital continued to improve their aerobic 
fitness, irispite of the lack of a supervised training program. Subjects who received 
resistance training lost some muscle strength in the month after discharge but this did 
not reach statistical significance. Subjects in the control group improved their aerobic 
fitness as well as strength in the one month after discharge from hospital but, again, this 
improvement did not reach significance. The changes in each of the parameters of 
assessment according to each type of training is graphically presented in Figure 10.1. 
Of the 49 subjects who were also part of a separate study on activity levels in 
children with CF, 15,18 and 16 were randomised to the aerobic training, resistance 
training, and control groups, respectively. These children had their activity levels 
measured when well, prior to their chest infection and again one month after discharge 
from hospital. The ^tivity levels in children who received aerobic training improved by 
8.64 % from the pre pulmonary infection level. This improvement was significantly 
greater than the improvement obtained by resistance training (3.81 %). The control 
group had a reduction in activity level (-1.02 %). The results are reported in Table 10.3. 
Duncan's test of ANOVA for multiple measures identified aerobic training as the 
best training program for improving peak aerobic capacity, and quality of life. 
Resistance training was identified as the best training program for improving FEVi, 
body mass, fat free mass, and leg strength. Changes in quality of life as measured by the 
quality of well being scale correlated better with changes in peak aerobic capacity (r = 
0.57) than changes in FEVl (r = 0.32). The regression is graphically presented in 
Figures 10.2 and 10.3 respectively. 
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TABLE 10.1: Baseline results for the different training groups. 
Values shown are the mean values with the standard error of the mean shown in brackets. 
TABLE 10.2: Changes from admission for each training program 
Student's t test ** p<0.01 *p<0.05 
A Change from admission to one month after discharge 
Values shown are the mean values with the standard error of the mean shown in 
brackets. 
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TABLE 10.3: Changes in activity levels with training programs 
Students / test ** p<0.01 * p<0.05 
FIGURE 10.1: Change between admission and discharge for aerobic training, resistance 
training and control groups 
FEV] Forced expiratory volume in one second 
VO2 Peak aerobic capacity 
QoL Quality of life 
Error bars depict SEM 
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FIGURE 10.2: Relationship between changes in quality of life and changes in peak 
aerobic capacity.. 
VO2 Peak aerobic capacity 
QoL Quality of life 
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FIGURE 10.3: Relationship between changes in quality of life and changes in lung 
function (FEVi). 
Percent change in quality of life 
FEVi Forced expiratory volume in one second 
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1D.3 Discussion 
This study has demonstrated that children with CF admitted to hospital with an infective 
pulmonary exacerbation, who participated in either aerobic or resistance training 
programs, were better in terms of the parameters of assessment than the control group 
which received no formal training program. Children who received aerobic training had 
significantly better peak aerobic capacity, activity levels and quality of life than children 
who received the resistance training program. Children who received resistance training 
had better weight gain (total mass, as well as fat free mass), lung function and leg 
strength than children who received aerobic training. The improvement in weight gain 
and lung function with resistance training is consistent with studies on adult patients 
with CF [Strauss et al, 1987] and adult patients with chronic obstructive pulmonary 
disease [Bernard et al, 1999]. This study is the first such study in children with CF. 
Although, there was a significant improvement in lung function from baseline 
with aerobic training, it was not significantly different to the improvement obtained in 
the control group. Thus, the improvement in lung function is more likely due to the 
improvement in the chest infection from intravenous antibiotics and standard chest 
physiotherapy than any effect of the training program. This result is consistent with 
other studies, which also failed to detect any benefit in terms of lung function with 
aerobic training [Orenstein et al, 1981; Orentsein et al, 1983]. The deconditioning effect 
of hospitalisation is demonstrated in the control group by the reduction from baseline in 
leg strength, aerobic capacity and activity levels after discharge from hospital. With 
routine daily activities, the leg strength and peak aerobic capacity improved over the one 
month after discharge from hospital. While it has been previously reported that patients 
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with more severe disease, may have the potential to show greater improvement with 
training [Cerny et al, 1984], this study, by having a randomised control group, 
eliminated the chance of confounding bias for any given training group. 
This study demonstrated that the improvements in the parameters of assessment 
were maintained for one month after discharge from hospital despite the lack of a formal 
exercise training program. Zach et al, [1986] found that the improvements in aerobic 
capacity from a swirnming program were maintained for eight weeks. In this study, a 
subgroup of children whose daily activity levels were recorded a month after discharge 
from hospital, demonstrated significant improvements, especially in those in the aerobic 
Ixaining group. The increased day to day activity levels may be the reason aerobic 
capacity was maintained one month after discharge in spite of the lack of a supervised 
training program. Improvements in quality of life, as measured by the quality of well 
being score, reached statistical significance only in the aerobic training group. This is 
consistent with the fact that changes in quality of life correlated better with changes in 
peak aerobic capacity than changes in lung function which has previously been reported 
by Orenstein et al [1989]. 
In summary, this study has demonstrated that aerobic training and resistance 
training improve different parameters of assessment in children with cystic fibrosis. 
These improvements were maintained for at least one month after discharge from 
hospital. Both programs were better than the control group in which children became 
deconditioned while in hospital. It may be that a combination of the aerobic and 
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resistance training may be the best training program and future studies on this are 
indicated.' 
CHAPTER 11 
Summary 
In this thesis, the impact of Cystic Fibrosis (CF) on the ability of children to 
exercise was assessed, the role of exercise testing in the management of children with 
CF was further defined and the optimal exercise training program to use in children 
admitted to hospital with an intercurrent pulmonary exacerbation was determined. 
Children with mild CF were demonstrated to be more physically active than 
healthy children without CF. Those with moderate to severe CF had activity levels 
which were similar to control children. The effects of pancreatic insufficiency on 
activity levels were most apparent in the cardiorespiratory status of girls after the onset 
of puberty. Prior to the onset of puberty, the physical activity levels in pancreatic 
sufficient and insufficient children were similar. Further studies are necessary to 
compare the energy costs of defined physical activities in children with CF with varying 
degrees of disease severity and healthy controls. It may be that a given physical activity 
may have different energy costs for different subjects depending on their disease 
severity. The effects of hormonal changes in subjects with CF on physical activity 
levels, and muscle function also need to be studied. This may provide information as to 
why pancreatic function is of greater importance after the onset of puberty. 
Patients who were heterozygous for the delta F508 gene and possessed a second 
CFTR mutation belonging to either class I or II, had a significantly lower peak aerobic 
capacity and anaerobic power than those with a second CFTR mutation belonging to 
191 
class III. Patients, who possessed a second CFTR mutation belonging to either class IV 
or V, were' significantly fitter and stronger than those who had a second CFTR mutation 
belonging to class I, II or III. There were no statistically significant differences in the 
lung function of patients with different classes of CFTR mutations. Further studies need 
to be performed in children with combinations of CFTR mutations other than those with 
at least one Class II mutation. As these subjects are relatively uncommon, several CF 
centers would need to take part in the study, in order to get a sufficient sample size for 
meaningful comparisons. 
Female athletes with mild CF, who are intrinsically active, were demonstrated to 
have a significantly lower peak aerobic capacity, anaerobic power and leg strength than 
their healthy training partners. The resting energy expenditure and daily activity levels 
were however, significantly higher in female athletes with CF than their healthy training 
partners. These results suggested that some process other than poor activity levels and, 
or, nutritional factors contributes to the comparatively poor • aerobic capacity and 
anaerobic power. Magnetic resonance spectroscopy using 31-Phosphorous was used to 
determine the efficiency of muscle metabolism in these subjects. Girls with mild CF 
were shown to have deficient anaerobic metabolism as well as inefficient iand deficient 
oxidative metabolism during high intensity exercise compared to healthy controls. 
Further studies should include male athletes with CF to determine if these findings are 
apparent in both genders and also non athletic CF patients to confirm that this defect is 
also seen in this group of CF patients. 
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Hospital therapy for acute pulmonary exacerbation was shown to produce 
significant* improvements in peak aerobic capacity, lung function, quality of life and 
weight. However, in the group of children with moderate to severe CF disease, the 
parameters measured in the exercise tests, quality of life and weight demonstrated the 
greatest magnitude of change. Changes in lung function tests (apart from residual 
volume) did not reach statistical significance in patients with moderate to severe CF 
disease. It was concluded that peak aerobic capacity is a better assessment of change in 
patients with moderate to severe CF admitted with a pulmonary exacerbation than 
standard lung function testing. 
This thesis also assessed the validity of the 10m and 20m shuttle tests were 
assessed and it was concluded that the 10m shuttle walk and the 20m shuttle run tests are 
reproducible, valid assessments of maximal function limited aerobic capacity. Given the 
greater patient preference over the treadmill test, the shuttle tests should be utilised in 
the assessment of the child with CF as well as in interventional studies. 
The optimal exercise program to use in children admitted to hospital with a 
pulmonary exacerbation was determined by performing a randomised controlled study. 
Aerobic training produced the greatest improvement in quality of life, whereas 
resistance training improved weight gain and lung function the most. These 
improvements were maintained for at least one month after discharge from hospital. 
Both programs were better than the control group in which children became 
deconditioned while in hospital. It is possible that a combination of aerobic and 
resistance training may produce the best outcome, but, this requires further study. 
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The studies presented in this thesis have accomplished the overall aim of 
addressing*deficiencies in the understanding of the role of exercise and exercise testing 
in the management of children with cystic fibrosis* In doing so, the studies have 
generated further research questions that will need to be addressed in future studies. 
Some of these studies have already commenced. 
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